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                            ABSTRACT 
 
Ejaculatory dysfunction impacts large numbers of men of all ages and around the world. In 
addition, a great majority of men with chronic spinal cord injury (SCI) experience ejaculatory 
dysfunction, which negatively impacts the quality of life of these individuals and their partners. 
SCI men emphasize the significance of regaining sexual function as their main goal. Currently, 
there is a marked absence of literature reporting the alterations to sexual function and ejaculation 
in particular in animal models of chronic SCI.  In addition, there are many unanswered questions 
pertaining to the spinal cord control of ejaculation in healthy, intact men. It is known that 
ejaculation is controlled by a population of lumbar spinothalamic (LSt) cells in the lumbar spinal 
cord through their direct projections to preganglionic autonomic and motor neurons in the 
lumbosacral spinal cord. It is hypothesized that LSt cells control ejaculatory reflexes through the 
release of their neuropeptides galanin, cholecystokinin (CCK), gastrin-releasing peptide (GRP), 
and enkephalin onto receptors in autonomic and motor areas of the lumbosacral spinal cord. This 
hypothesis was tested in this thesis utilizing a paradigm in anesthetized and spinalized male rats, 
with stimulation of the sensory inputs via the dorsal penile nerve. Consistent with the hypothesis, 
mu and delta opioid receptor, galanin, CCK, and GRP receptor activation in LSt target areas in 
the lumbosacral spinal cord was demonstrated to be critical for ejaculatory reflexes. Next, the 
hypothesis that intrathecal infusions of the LSt neuropeptides can improve ejaculatory reflexes in 
male rats with chronic SCI was tested. Results indicated that intrathecal infusions of GRP and 
the mu opioid receptor agonist DAMGO improved ejaculatory reflexes in male rats with chronic 
contusion SCI. Finally, the hypothesis that the D3 receptor agonist 7-OH-DPAT will recover 
 iii 
 
ejaculatory function in male rats with chronic spinal cord injury was tested. Indeed, systemic 
infusions of 7-OH-DPAT greatly improved ejaculatory reflexes in SCI males. Together, the 
studies in this thesis further clarified the mechanisms involved in the spinal cord control of 
ejaculation in male rats and represent an initial but pivotal first step towards the recovery of 
ejaculatory function after chronic spinal cord injury. 
 
Key Words: ejaculation, spinal ejaculation generator, chronic spinal cord injury, lumbosacral 
spinal cord, spinal cord contusion, galanin, cholecystokinin, enkephalin, gastrin-releasing 
peptide, dopamine D3 receptor.    
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Chapter 1: Introduction 
 
 
Spinal cord control of ejaculatory reflexes in male rats: Effects of 
spinal cord injury 
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1.1 Introduction 
 
Male sexual dysfunction, including erectile and ejaculatory dysfunction, commonly occurs in 
adult men of all ages and around the world. While the mechanisms of erectile dysfunction are 
well-known and various effective treatment options are currently available, the mechanisms 
underlying the control of ejaculation remain largely unknown. Premature ejaculation is one of 
the most frequently reported ejaculatory dysfunctions and at present there are no effective 
treatment options available (Vale, 1999). Ejaculation is also severely altered in men with chronic 
spinal cord injury (SCI) (Brackett et al., 1998). However, among paraplegic men, the recovery of 
normal sexual function is the highest priority and is even ranked above recovery of locomotor 
function (Anderson, 2004). The current review will summarize literature describing the central 
control of ejaculation in humans and animal models. In addition, the effects of chronic SCI on 
ejaculation are reviewed. Finally, potential treatments geared toward the recovery of normal 
sexual function in men suffering from premature ejaculation and in men with chronic SCI will be 
reviewed.  
 
1.2 Ejaculation   
 
Male sexual behavior is highly complex and consists of several components including the pursuit 
and investigation of the female, mounts and intromissions finally culminating in ejaculation, a 
process that is closely associated with orgasm in men (Meisel R, 1994) and reward in male rats 
(Hull et al., 2002). Ejaculation is physiological process that refers to the expulsion of seminal 
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contents from the urethral meatus (Marberger, 1974; McKenna, 1999) and is composed of two 
separate components, emission and expulsion. Emission refers to the secretion of seminal 
contents from the accessory sex glands, including the vas deferens, seminal vesicles and prostate 
(Wang et al., 1991) and the closure of the bladder neck and external uretheral sphincter to avert 
retrograde ejaculation (Newman et al., 1982).  Expulsion refers to the coordinated, rhythmic 
contractions of the striated perineal muscles and the bulbocavernosus muscle (BCM) in 
particular, as well as the smooth muscles of the urethra, which forcefully expel semen from the 
urethral meatus (Breedlove and Arnold, 1980, 1981; Breedlove et al., 1983).  
 
1.3 The Spinal Ejaculation Generator  
 
It has been known for some time from studies of chronic SCI patients and animal models that 
ejaculation is a reflex and the central mechanisms that regulate this reflex are localized to the 
lumbosacral spinal cord (Comarr, 1970; Comarr and Gunderson, 1975; McKenna, 1997; 
McKenna, 1999). Previous studies have shown that vibratory penile stimulation is sufficient to 
trigger ejaculatory reflexes in men with complete spinal cord injuries above the 10th thoracic 
spinal segment (Brackett et al., 1998; Brackett, 1999; Sonksen and Ohl, 2002). Similarly, 
stimulation of the dorsal penile nerve (DPN), the sensory branch of the pudendal nerve, triggers 
ejaculatory reflexes in male rats with complete spinal cord transection (Staudt et al., 2010; 
Staudt, 2011; Kozyrev et al., 2012). The fact that ejaculatory reflexes persist in spinalized men 
and male rats (Comarr, 1970; Comarr and Gunderson, 1975; Pescatori et al., 1993; Brackett et 
al., 1998; McKenna, 1999) despite the complete absence of functional reciprocal connections 
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with supraspinal regions suggests that ejaculation is regulated by a control center in the 
lumbosacral spinal cord. This control center is known as the spinal pattern generator (McKenna 
et al., 1991; Carro-Juarez and Rodriguez-Manzo, 2007), spinal pacemaker (Sachs and Garinello, 
1979), or spinal ejaculation generator (Marberger, 1974; Marson and McKenna, 1994) and it 
controls ejaculation in two main ways. First, it coordinates sympathetic, parasympathetic and 
motor outflow to trigger the two components of ejaculation: emission and expulsion. Secondly, 
the spinal ejaculation generator integrates this autonomic and motor outflow with sensory inputs 
necessary to induce ejaculation which are conveyed during sexual activity (Coolen et al., 2004; 
Allard et al., 2005; Coolen, 2005; Young et al., 2009).   
 
1.3.1 LSt Cells Form an Integral Component of the Spinal Ejaculation Generator 
 
About a decade ago, substantial progress was made in identifying a population of interneurons in 
the lumbosacral spinal cord that form a critical component of the spinal ejaculation generator 
(Truitt and Coolen, 2002). These interneurons are located in lamina 10 around the central canal 
and the medial portion of lamina 7 in lumbar levels (L3 – L4) of the spinal cord and have direct 
projections to the parvocellular subparafascicular thalamic nucleus (SPFp) (Ju et al., 1987; 
Coolen et al., 2003; Truitt et al., 2003). Moreover, these lumbar spinothalamic (LSt) cells, named 
according to their anatomical position in the spinal cord and thalamic projections, are sexually-
dimorphic and show neural activation, visualized with Fos, specifically following ejaculation in 
male but not in female rats (Truitt and Coolen, 2002; Coolen et al., 2003; Truitt et al., 2003). In 
addition, LSt cells co-express several neuropeptides including galanin, cholecystokinin (CCK), 
enkephalin and gastrin-releasing peptide (GRP) (Newton, 1993; Nicholas et al., 1999; Phan and 
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Newton, 1999; Newton and Phan, 2006; Sakamoto et al., 2008; Kozyrev et al., 2012) and project 
their axons to autonomic preganglionic neurons (Xu et al., 2006) and pudendal motoneurons 
(Newton, 1993; Newton and Phan, 2006) in the thoracolumbar and lumbosacral spinal cord. 
Galanin, a marker of LSt cells, is expressed in axons projecting to preganglionic sympathetic and 
parasympathetic neurons as well as pudendal motor neurons (Newton, 1993; Truitt and Coolen, 
2002). Neural activation of LSt cells, based on Fos and galanin co-expression, is specifically 
related to the onset of ejaculation (Truitt et al., 2003; Coolen et al., 2004). Targeted lesions of the 
LSt cells with intraspinal injections of a neurotoxin SSP-Saporin abolished ejaculation in 
copulating male rats but spared all other components of male rat sexual behavior including 
pursuit and investigation of the female, mounts and intromissions (Truitt and Coolen, 2002). 
Furthermore, targeted lesions of the LSt cells with the same neurotoxin prevented rhythmic 
contractions of the BCM following DPN, urethral or pharmacological stimulation with the 
dopamine D3 receptor agonist 7-OH-DPAT, in anesthetized and spinalized male rats (Staudt, 
2011). In addition, in male rats with LSt lesions, galanin-immunoreactive fibers normally 
projecting to autonomic nuclei in the lumbosacral spinal cord were absent, confirming that LSt 
cells are required for these functional projections (Truitt and Coolen, 2002). Together these 
studies demonstrated that LSt cells are essential for ejaculation in male rats and that LSt cells 
regulate ejaculation through intraspinal connections to preganglionic autonomic and motor 
neurons in the lumbosacral spinal cord (Truitt and Coolen, 2002; Truitt et al., 2003; Staudt, 
2011). Thus, LSt cells are a population of interneurons in the lumbar spinal cord which comprise 
a pivotal component of the spinal ejaculation generator and transform sensory inputs during 
sexual activity into motor and secretory outputs (McKenna, 1999).   
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1.3.2 Spinal Inputs to the Ejaculation Generator 
 
During sexual activity, the DPN, the sensory branch of the pudendal nerve, plays a central role in 
the transmission of sensory inputs to the spinal ejaculation generator required to trigger 
ejaculation (Marberger, 1974; Hull et al., 2002). Indeed, electrical stimulation of the DPN 
triggers rhythmic contractions of the BCM similar to those observed in copulating male rats 
(Pescatori et al., 1993). Furthermore, both DPN stimulation in anesthetized and spinalized male 
rats and ejaculation in mating males triggers phosphorylated ERK (pERK) and phosphorylated 
NMDA receptor subunit 1 (pNR1) in LSt cells (Staudt et al., 2010, 2011).  Moreover, injections 
of antagonists for ERK and NMDA receptors blocked DPN stimulation-induced BCM bursting 
in male rats (Staudt et al., 2010, 2011). Pudendal nerve terminals are found in close proximity to 
the LSt cells in the lumbosacral spinal cord and are mainly localized to medial dorsal horn and 
dorsal gray commissure (DGC) (McKenna and Nadelhaft, 1986; Ueyama et al., 1987). 
Presumably, these sensory signals are relayed to the LSt cells through intraspinal connections 
between the LSt cells and the dorsal horn and DGC. However, precisely how this transfer occurs 
is currently unknown as there are no known direct projections from the dorsal horn and DGC to 
the LSt cells. These sensory inputs are conveyed by the DPN during sexual activity prior to 
ejaculation and activate the LSt cells to induce ejaculation and may include visceral sensory, 
somatosensory, proprioceptive or noxious inputs (Carro-Juarez and Rodriguez-Manzo, 2005). 
Some sensory inputs related to the summation of sexual activity may also be conveyed by the 
hypogastric and pelvic nerves (McKenna, 2001; Coolen et al., 2004; Coolen, 2005). Pelvic nerve 
afferents terminate in the vicinity of pudendal nerve afferent terminals in the lumbosacral spinal 
cord, at around segments L6 – S1 (Nadelhaft and Booth, 1984). Furthermore, the pelvic nerve 
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conveys sensory stimuli associated with mating to supraspinal regions including the central 
tegmental field and lesions of the pelvic nerve dramatically reduce neural activation of the 
central tegmental field induced by mating (Wersinger et al., 1993). Unlike the pudendal and 
pelvic nerves, the hypogastric nerve terminates in the dorsal horn of the thoracolumbar spinal 
cord, in segments T13 – L2 in male rats (De Groat W, 1990). Nevertheless, electrical stimulation 
of the intermesenteric nerve which contains fibers of the hypogastric nerve triggered seminal 
plug expulsion in anesthetized rats (Bernabe et al., 2007). In men, the penis is innervated by a 
large number of  sensory fibers which include mainly small, unmyelinated Aδ and C fibers 
terminating in free nerve endings (Halata and Munger, 1986). These sensory fibers of the penis 
can detect temperature, pain and mechanical stimuli including touch, pressure and stretch 
(Kitchell et al., 1982). In addition, the penis exclusively contains a genital end bulb which is a 
type of encapsulated nerve ending that may regulate sensory responses to stimulation of the glans 
(Coolen et al., 2004). Furthermore, the sensitivity of penile receptors is greatly enhanced by 
penile erection (Johnson, 1988). In summary, penile receptors convey sensory information 
regarding temperature, touch, stretch, pressure and pain via the DPN as well as the pelvic and 
hypogastric nerves to the lower thoracic, lumbar and sacral spinal cord. These sensory inputs 
ultimately converge in the spinal ejaculation generator and trigger the activation of LSt cells, 
which in turn triggers ejaculation.  
 
1.3.3 Outputs of the Spinal Ejaculation Generator  
 
During the emission phase of ejaculation, autonomic nuclei in the thoracolumbar and 
lumbosacral spinal cord supply sympathetic and parasympathetic innervation to the pelvic 
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viscera including the seminal vesicles, ductus deferens and prostate(Giuliano and Clement, 
2005). The intermediolateral cell column (IML) and dorsal central autonomic nucleus (DCN) 
located in the thoracolumbar spinal cord in spinal segments (T13 – L2) contain sympathetic 
preganglionic neurons that send sympathetic ouflow mainly through the hypogastric and pelvic 
nerves to the visceral organs (Hancock and Peveto, 1979a; Nadelhaft and McKenna, 1987; Baron 
and Janig, 1991; Giuliano et al., 1997). Among the two populations of sympathetic preganglionic 
neurons, it is those of the DCN which send projections to the prevertebral ganglia and are 
implicated in the control of the visceral organs while IML neurons are thought to be involved 
mainly in the control of cardiovascular function (Janig and McLachlan, 1987). Parasympathetic 
preganglionic neurons are located in the sacral parasympathetic nucleus (SPN) in spinal 
segments (S2-S5) which innervate the pelvic organs including the prostate (Orr and Marson, 
1998), urethra (Vizzard et al., 1995) and penis (Marson and Carson 3rd, 1999). In summary, the 
emission phase of ejaculation is under the control of both the sympathetic and parasympathetic 
preganglionic cell populations as are many of the physiological events leading up to emission, 
including contractions of the ductus deferens (Kolbeck and Steers, 1992; Kihara and de Groat, 
1997) and the discharge of prostatic contents into the urethra (Wang et al., 1991). The expulsion 
phase of ejaculation is under the control of pudendal motoneurons in the lumbosacral spinal cord 
(Coolen et al., 2004). These pudendal motoneurons are localized to the spinal nucleus of the 
bulbocavernosus (SNB) as well as the dorsolateral (DL) nucleus in male rats (Schroder, 1980; 
McKenna and Nadelhaft, 1986; Ueyama et al., 1987), and to Onuf’s nucleus in men (Schroder, 
1985; Thor et al., 1989). Motoneurons in these nuclei innervate the bulbospongiosus and 
ischiocavernosus striated perineal muscles and the external urethral and anal sphincters. 
Coordinated contractions of these muscles and sphincters trigger the ejection of semen from the 
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urethral meatus (Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and 
Sachs, 1991). Notably, the striated perineal muscle contractions occur concurrently with the 
pleasurable orgasmic sensations experienced at ejaculation (Gerstenberg et al., 1990).  
 
1.4 Supraspinal Sites Regulating Ejaculation  
 
Several supraspinal regions in the brain and brainstem provide descending modulation of the 
spinal ejaculation generator. These supraspinal regions exert excitatory and inhibitory influences 
over the spinal ejaculation generator to regulate ejaculation.  
 
1.4.1 The Medial Preoptic Area (MPOA) 
 
One such region is the medial preoptic area (MPOA) of the hypothalamus (Pehek et al., 1989; 
Markowski et al., 1994; Hull et al., 1997; Hull et al., 2004), a central area in regulating male 
sexual behavior (Hull et al., 2004). The MPOA exerts its excitatory effects on ejaculation 
through dopamine D2 (Hull et al., 1989; Hull et al., 1992) and D3 receptors (Kitrey et al., 2007) 
and electrical stimulation of the MPOA triggers contractions of the  striated penile muscles in 
anesthetized male rats (Sato and Christ, 2000). Moreover, the activation of D3 receptors has been 
recently shown to be critical for ejaculation in male rats (Clement et al., 2007; Kitrey et al., 
2007; Clement et al., 2009b). Since there are no known direct projections from the MPOA to the 
lumbosacral spinal cord, it is likely that the MPOA exerts its effects on ejaculation through 
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connections with other brain regions involved in the control of ejaculation, including the nucleus 
paragigantocellularis (NPGi)(Marson et al., 1992; Marson and McKenna, 1992; Yells et al., 
1992; Murphy et al., 1999) and the paraventricular nucleus of the hypothalamus (PVN) (Marson 
and McKenna, 1994).  
 
1.4.2 Nucleus of the paragigantocellularis (NPGi) 
 
Neurons of the NPGi in the ventral medulla are well-known for their inhibitory effects of 
ejaculation in male rats (Marson et al., 1992; Marson and McKenna, 1992; Yells et al., 1992). It 
is currently suggested that this descending inhibition is serotonergic in nature and is mediated by 
5-hydroxytryptamine (5-HT)(Marson and McKenna, 1992). Bilateral lesions of the NPGi 
enhanced sexual performance in sexually-naïve male rats, by reducing the frequency of mounts, 
intromission and latency to ejaculation. In addition, males with such lesions demonstrated 
increased latency to copulate to exhaustion and dramatically augmented numbers of ejaculations 
prior to the onset of sexual exhaustion (Yells et al., 1992). Furthermore, bilateral lesions of the 
NPGi markedly reduced the latency to the onset of ex copula reflexes (Marson et al., 1992).  
 In addition, 50% of anesthetized male rats with intact spinal cords displayed the urethrogenital 
reflex which can normally be elicited only in animals with completely transected spinal cords, 
following the removal of descending inhibition (Marson et al., 1992). NPGi neurons have direct 
projections to the ventral horn in the vicinity of pudendal motor neurons in the lumbosacral 
spinal cord (Marson and McKenna, 1992). Moreover, intrathecal infusions of 5-HT prevented 
the rhythmic contractions of the striated perineal muscles and ejaculation induced by stimulation 
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of the urethra while infusions of the 5-HT antagonist abolished this inhibitory effect (Marson and 
McKenna, 1992). This finding supports the notion that 5-HT exerts descending inhibitory 
influences on ejaculation. However, conflicting evidence exists for the inhibitory effects of 
serotonin on ejaculation. It has been demonstrated that the serotonin 1A receptor agonist 8-OH-
DPAT inhibits emissions elicited in the ex copula paradigm (Lee et al., 1990). In contrast, other 
studies demonstrated enhanced effects of 8-OH-DPAT on ejaculation in copulating animals 
(Haensel et al., 1991; Fernandez-Guasti et al., 1992; Coolen et al., 1996; Coolen et al., 1997b). In 
addition, another study found a facilitative effect of 8-OH-DPAT on urethral stimulation-induced 
rhythmic bursting patterns of the BCM, indicative of the expulsion phase of ejaculation (Carro-
Juarez and Rodriguez-Manzo, 2001). One proposed explanation for the discrepancies is that the 
two components of ejaculation: emission and expulsion can occur independently of one another 
(Staudt, 2011). Indeed, the seminal vesicles are not required for the contractions of striated 
perineal muscles in copulating male rats (Cukierski et al., 1991). Similarly, the emission of 
seminal fluids into the urethra or urethral stimulation is not required for the expulsion reflex in 
male rats (Holmes and Sachs, 1991). Therefore, the inhibitory effects of 8-OH-DPAT on 
emission can exist alongside enhanced effects of expulsion in mating animals. In summary, 
descending projections of the NPGi exert inhibitory influences on ejaculatory reflexes in the ex 
copula paradigm and on ejaculatory behavior in copulating male rats by acting on motor neurons 
in the ventral horn of the lumbosacral spinal cord. Moreover, bilateral lesions of the NPGi 
facilitated ejaculatory behavior in mating animals and ejaculatory reflexes in anesthetized rats, 
providing further evidence of the inhibitory effects of NPGi on ejaculation. However, due to 
conflicting results, it is currently unclear whether this inhibition of ejaculation is mediated by 
serotoninergic mechanisms or whether other neurotransmitters may be involved.  
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1.4.3 The paraventricular nucleus of the hypothalamus (PVN) 
  
The PVN is another brain region which provides descending excitatory modulation of 
ejaculation. Axons of PVN neurons terminate in the lumbosacral spinal cord and release the 
neurotransmitter oxytocin (Wagner and Clemens, 1991, 1993). Specifically, PVN neurons 
project to the pudendal motor neurons in the lumbar spinal cord around segments L5 – L6 in the 
region of the SNB (Wagner and Clemens, 1991). Moreover, neurophysin (the product of 
oxytocin and vasopressin) containing fibers and putative terminals were observed in close 
contact to SNB motor neurons(Wagner and Clemens, 1993). Lesions of the PVN resulted in an 
absence of neurophysin-containing fibers in the pudendal motor neurons, indicating that these 
fibers originated in the PVN (Wagner and Clemens, 1993). Additional support for the role of the 
PVN comes from a recent report that oxytocin receptors in the brain regulate ejaculation 
triggered by infusions of the D3 agonist 7-OH-DPAT (Clement et al., 2008). Specifically, i.c.v. 
infusions of an oxytocin antagonist resulted in a dose-dependent blockade of sexual responses 
elicited by 7-OH-DPAT, including changes in seminal vesicle pressure (SVP), intracavernosal 
pressure (ICP) and rhythmic bursting of the BCM (Clement et al., 2008). In addition, intrathecal 
administration of the oxytocin antagonist to the L6 lumbar segment significantly diminished 
ejaculation and the duration of BCM bursting but had no effect on ICP responses (Clement et al., 
2008). From these results, the authors concluded that while brain oxytocin receptors mediate 
ejaculatory responses triggered by infusions of 7-OH-DPAT, spinal oxytocin receptors only 
control the occurrence of ejaculation. These findings provide further support to the idea that 
oxytocin is released from axon terminals of the PVN onto oxytocin receptors expressed on 
13 
 
pudendal motor neurons in the lumbosacral spinal cord to modulate ejaculation in male rats 
(Clement et al., 2008).  Furthermore, the levels of oxytocin in blood plasma are substantially 
enhanced in male rats (Stoneham et al., 1985), rabbits (Todd and Lightman, 1986) and men 
(Murphy et al., 1987) following ejaculation. PVN lesions do not prevent ejaculation but reduce 
the amount of seminal contents ejected in copulating male rats suggesting that the PVN is critical 
for the emission component of ejaculation (Ackerman et al., 1997).  
 
1.5 Supraspinal network displaying neural activation specifically with ejaculation 
 
It has been demonstrated that certain regions of the posterior thalamus, MPOA, bed nucleus of 
the stria terminals (BNST) and medial amygdala (MEA) express Fos, a marker of neural 
activation, following various components of sexual behavior in male rats (Coolen et al., 2004). In 
addition, certain subdivisions of these regions express Fos specifically following ejaculation and 
not following other components of male rat sexual behavior including intromissions and mounts 
(Coolen et al., 2004). These regions include subdivisions of the posterior thalamus, BNST and 
MEA. In particular, these include the medial subregion of the parvocellular subparafascicular 
thalamic nucleus (SPFp), the lateral zone of the posterior medial MEA, the posterior medial 
BNST and the posterodorsal preoptic nucleus (PDPn) (Baum and Everitt, 1992; Coolen et al., 
1996, 1997a). Although all of these regions show neural activation with ejaculation, most of 
these, in particular the posterior medial MEA and PDPn, are not critical for the display of 
ejaculatory behavior (Coolen et al., 2004). In contrast, lesions of the SPFp, including the zona 
incerta abolished ejaculation in male rats (Maillard and Edwards, 1991). However, when lesions 
were restricted to the SPFp, ejaculatory behavior was not affected (Heeb and Yahr, 2000). These 
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results indicate that the SPFp is involved in the relay of sensory signals associated with 
ejaculation but is not involved in inducing ejaculation in male rats (Coolen et al., 2004).  
 
1.6  LSt-SPFp pathway 
 
It has long been unknown precisely how sensory signals associated with ejaculation are 
conveyed to supraspinal regions. Several years ago, a candidate pathway was identified which 
transmits sensory information associated with ejaculation from the sexual organs to the thalamus. 
Specifically, the DPN transmits sensory signals from the periphery to the LSt cells and from 
there these signals are relayed to the medial SPFp in the thalamus by way of the spinothalamic 
pathway (Ju et al., 1987; Coolen et al., 2003). The LSt – medial SPFp pathway is involved in the 
transmission and processing of sensory information associated with ejaculation (Truitt et al., 
2003). In support of this hypothesis, the SPFp and the LSt cells demonstrate neural activation 
specifically following ejaculation (Truitt et al., 2003). Neural activation, visualized with Fos 
expression, is not observed following other aspects of male sexual behavior including mounts 
and intromissions. Moreover, several neuropeptides are expressed in the LSt – medial SPFp 
pathway including galanin, CCK and enkephalin (Ju et al., 1987; Nicholas et al., 1999; Coolen et 
al., 2003). Of these neuropeptides, galanin infusions in the medial SFPp have been shown to 
suppress sexual behavior in male rats, indicating that endogenous galanin is released in the 
medial SFPp following ejaculation and acts to suppress subsequent mating for a short duration 
during the post-ejaculatory interval or for a longer duration once sexual satiety is reached 
(Coolen et al., 2004).  
15 
 
 
1.7 Summary: Spinal cord control of ejaculation 
 
 In summary, ejaculation is controlled by the LSt cells in the lumbosacral spinal cord 
which form a critical component of the spinal ejaculation generator. Sensory signals from the 
periphery are conveyed by the DPN to activate the LSt cells and trigger ejaculation. In turn, the 
LSt cells convert these sensory signals into secretory or motor outputs to induce the emission and 
expulsion components of ejaculation. Outputs of the LSt cells include sympathetic and 
parasympathetic preganglionic neurons in the IML, CAN and SPN respectively as well as motor 
neurons in the SNB. Both sympathetic and parasympathetic preganglionic neurons are involved 
in initiating the emission component of ejaculation by triggering the secretion of seminal fluids 
into the prostatic urethra, closure of the bladder neck and contractions of the seminal vesicles, 
prostate and vas deferens. Expulsion is controlled by motor neurons which induce contractions of 
the striated perineal muscle thereby eliciting the ejection of seminal contents from the urethral 
meatus. In addition, supraspinal regions in the brain and brainstem provide excitatory and 
inhibitory descending modulation of ejaculation. Excitatory input is provided by the MPOA and 
PVN while inhibitory modulation originates in the NPGi in the ventral medulla. Finally, sensory 
signals associated with ejaculation are conveyed from the LSt cells to the medial SPFp in the 
posterior thalamus through the spinothalamic pathway. Neural activation of the SPFp specifically 
following ejaculation or infusions of galanin inhibit sexual behavior in male rats. In addition, the 
medial SPFp has a number of connections with other brain regions including the BNST, MPOA 
and MEA that are involved in male rat sexual behavior and that demonstrate neural activation 
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specifically with ejaculation. Therefore, the medial SPFp likely exerts inhibition of mating 
through its connections with these brain regions.  
 
1.8  Ejaculation is severely impaired following chronic spinal cord injury  
 
Traumatic spinal cord injury (SCI) radically alters erectile and ejaculatory function in men. In 
particular, SCI is associated with severely disrupted ejaculation. Of men with SCI, 0% to 55% 
(with a median of 15%) can achieve ejaculation with a partner during sexual intercourse or 
during masturbation (Biering-Sorensen and Sonksen, 2001). Moreover, the majority of SCI men 
can only ejaculate with the aid of intense penile vibratory stimulation or electroejaculation and 
both of these procedures are effective first-line treatment of ejaculatory disorders in SCI men 
(Soler and Previnaire, 2011). Complete transection of the spinal cord results in a loss of 
sensation and voluntary muscle control below the level of the lesion in the spinal cord. Even 
though SCI men can ejaculate through intense vibratory stimulation and electroejaculation, the 
ejaculation is sometimes retrograde, suggesting that ejaculatory dysfunction in SCI men may be 
due to the lack of coordination between sympathetic, parasympathetic and motor neurons (Soler 
and Previnaire, 2011).  
 It is known that fewer than 10% of men with complete SCI are able to ejaculate with 
sexual intercourse or genital stimulation (Bors, 1960; Comarr, 1970). Preliminary studies of men 
with SCI determined that vibratory penile stimulation is an effective means to trigger ejaculation 
in patients with spinal cord lesions above the 12th thoracic segment (Brindley, 1984). More 
recently, similar studies of men with SCI found that an intact spinal cord between the 10th 
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thoracic and 2nd lumbar segments (T10 – L2) as well as an intact sacral spinal cord is necessary 
to elicit ejaculation (Soler et al., 2008). Therefore, the preservation of intact preganglionic 
autonomic and motor neurons is necessary in order to integrate the autonomic and somatic 
outflow required to trigger ejaculation with sensory inputs conveyed by the DPN during sexual 
intercourse or genital stimulation. In addition, these regions of the spinal cord must be intact to 
coordinate the autonomic and motor outflow to trigger the two phases of ejaculation: emission 
and expulsion.   
 Among available treatments for ejaculatory dysfunction following SCI, midodrine 
appears to have promising results. Midodrine, an alpha1-adrenergic agonist, is predominantly 
used as a remedy for neurogenic orthostatic hypotension (Soler et al., 2008), is a vasoconstrictor 
of venous capacitance vessels as well as arterial resistance and has been shown to be effective in 
the treatment of anejaculation in men with SCI (Staerman et al., 2001; Soler et al., 2007; 
Courtois et al., 2008). In addition to enhancing ejaculation and orgasmic sensations in men after 
SCI, midodrine use also has a low reported incidence of autonomic dysreflexia, a dangerous 
condition which frequently accompanies ejaculation and orgasm in SCI patients (Sheel et al., 
2005; Courtois et al., 2008). The dramatic increase in blood pressure and heart rate immediately 
prior to ejaculation typically return to normal within minutes following ejaculation in healthy 
able-bodied men (Littler et al., 1974; Nemec et al., 1976; Kruger et al., 1998). However, in men 
with SCI, these considerable increases in blood pressure and heart rate do not return to baseline 
levels for several hours, and sometimes for days following ejaculation (Sheel et al., 2005).  
Autonomic dysreflexia is a cardiovascular deficit associated with SCI and occurs due to a 
dysregulation of the sympathetic nervous system following SCI (Sheel et al., 2005). Autonomic 
dysreflexia is particularly common in SCI patients with lesions of the cervical or upper thoracic 
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spinal cord, at or above T6 and involves a sudden, extreme rise in blood pressure, headache, 
perspiration, bradycardia and anxiety (Karlsson, 1999; Teasell et al., 2000).   
 Intense penile vibratory stimulation is considerably more effective than sexual 
intercourse in eliciting ejaculation in SCI with 65% of SCI men reaching ejaculation by these 
means compared to 5 – 15 % achieving ejaculation through sexual intercourse (Soler et al., 2007, 
2008). During penile vibratory stimulation, there is a strong activation of the autonomic nervous 
system in response to intense stimulation of the DPN (Soler et al., 2007, 2008). Moreover, 
vibratory stimulation can be used as a home treatment to enhance bladder capacity and alleviate 
spasticity in SCI men (Biering-Sorensen et al., 2005). In addition, penile vibratory stimulation 
can be utilized to facilitate ejaculatory reflexes in SCI men and with repeated use can improve 
ejaculatory function and responsiveness during sexual intercourse (Elliott, 2002; Soler et al., 
2008).  Patients with upper motor neuron lesions (above T10) are often able to ejaculate and 
orgasm when penile vibratory stimulation is combined with midodrine (Soler et al., 2007, 2008). 
Indeed, penile vibratory stimulation in conjunction with midodrine elicited ejaculation in 84% of 
men with complete SCI and of these, 59% were able to reach orgasm as well (Soler et al., 2008). 
However, vibratory stimulation is ineffective in SCI men with injuries to the T11-S4 spinal 
segments, since this method depends on intact preganglionic autonomic neurons in the 
lumbosacral spinal cord (Brackett et al., 2010). Penile vibratory stimulation triggers ejaculation 
through intense stimulation of the DPN and subsequent powerful activation of the autonomic 
nervous system. Because the spinal cord must be intact between segments T11-S4 for vibratory 
stimulation to be effective, this suggests the presence of a spinal ejaculation generator in humans, 
which is localized to the lumbosacral spinal cord. While the existence of the spinal ejaculation 
generator is well-established in male rats, it is not known whether this generator also exists in 
19 
 
men and whether it is located in the lumbosacral spinal cord. However, studies in SCI men 
indicate that if a spinal ejaculation generator indeed exists in men, it is localized to the 
lumbosacral spinal cord, to coordinate the autonomic and motor outflow required for ejaculation 
and to integrate this outflow with sensory signals from the sexual organs during sexual activity.  
Electroejaculation is utilized as a treatment for ejaculatory dysfunction in SCI men in 
whom penile vibratory stimulation is ineffective in eliciting ejaculation or who have spinal cord 
lesions caudal to T11 which disrupt the ejaculatory reflex arc (Brackett et al., 2010). The 
electroejaculation protocol involves inserting an electrical probe into the rectum such that the 
probe is adjacent to the rectal wall in close proximity to the seminal vesicles and prostate gland 
(Soler and Previnaire, 2011). Next, electrical stimulation of the prostate and seminal vesicles is 
administered in waves, with increasing voltage as the procedure progresses until ejaculation 
ensues. One disadvantage of electroejaculation is the considerable discomfort experienced by 
patients undergoing the procedure. These patients tend to have some residual sensation following 
the SCI and an invasive procedure like electroejaculation can produce painful sensations 
requiring the administration of spinal anesthetics (Halstead et al., 1987; Bennett et al., 1988; 
Biering-Sorensen and Sonksen, 2001). Because electroejaculation is a procedure which is 
invasive, requires the use of medical equipment and may require the use of spinal anesthesia, it 
cannot be used as a home treatment for anejaculation in men with SCI. Another disadvantage of 
electroejaculation is that it often results in retrograde ejaculation with very low antegrade sperm 
motility and motile sperm counts compared to a procedure such as penile vibratory stimulation 
(Halstead et al., 1987; Bennett et al., 1988; Ohl et al., 1996; Ohl et al., 1997). Therefore, penile 
vibratory stimulation is a more suitable procedure for sperm retrieval for reproductive purposes 
compared to electroejaculation in SCI men (Halstead et al., 1987; Bennett et al., 1988; Ohl et al., 
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1996; Ohl et al., 1997). One significant advantage of electroejaculation is that it has a success 
rate of nearly 100% in triggering ejaculation in men with SCI that do not respond to genital 
stimulation or penile vibratory stimulation. Moreover, the effectiveness of electroejaculation 
does not depend on the level of spinal cord lesion or on an intact ejaculatory reflex arc (T11-S4) 
(Halstead et al., 1987; Bennett et al., 1988).  
 
1.9 Summary: Effects of spinal cord injury on ejaculation  
 
 In summary, ejaculation is severely impaired and a greater amount and intensity of 
stimulation may be necessary to trigger ejaculation in men with SCI (Elliott, 2002). One 
possibility is that ejaculatory function is dramatically diminished following chronic SCI due to 
the loss of supraspinal influences on the ejaculatory reflex arc in the lower thoracic, lumbar and 
sacral spinal cord (Soler and Previnaire, 2011). Intense penile vibratory stimulation is a 
promising treatment of ejaculatory dysfunction in SCI men (Sonksen et al., 1994; Ohl et al., 
1997; Brackett et al., 1998) which induces intense vibratory stimulation of the DPN and as a 
result triggers powerful activation of autonomic nuclei in the lumbosacral spinal cord (Soler et 
al., 2007). It is not clear whether penile vibratory stimulation also triggers activation of motor 
neurons in Onuf’s nucleus, in the sacral spinal cord. In male rats, stimulation of the DPN triggers 
rhythmic bursting of the perineal muscles, including the BCM, which are under the control of 
motor neurons in the SNB in the lumbosacral spinal cord (Pescatori et al., 1993; McKenna, 1999; 
Staudt et al., 2010; Kozyrev et al., 2012; Kozyrev, 2013c, 2013b). Moreover, rhythmic bursting 
of the BCM is required for the expulsion phase of ejaculation indicating that vibratory 
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stimulation likely triggers the activation of autonomic as well as motor neurons in the 
lumbosacral spinal cord, to induce the emission and expulsion components of ejaculation in SCI 
men. The DPN is required for ejaculation induced by penile vibratory stimulaiton since local 
anesthesia of the DPN prevents ejaculation in SCI men (Wieder et al., 2000). Penile vibratory 
stimulation in combination with midodrine is even more effective and can restore ejaculation and 
orgasmic sensations in up to 80% of SCI men (Soler et al., 2007, 2008). In addition, SCI men 
who do not respond to vibratory stimulation alone are more likely to ejaculate and experience 
orgasmic sensations when this type of stimulation is supplemented with midodrine (Soler et al., 
2007, 2008). Interestingly, repeated sessions of penile vibratory stimulation can reduce the 
threshold necessary to trigger ejaculation in SCI men (Elliott, 2002) suggesting that recurrent 
DPN stimulation can improve the conductance of sensory signals required to activate autonomic 
and motor nuclei in the lumbosacral spinal cord and induce ejaculation. Therefore, repeated 
sessions of penile vibratory stimulation can be useful in treating ejaculatory dysfunction and may 
be easily administered at home (Elliott, 2002).  
1.10 Animal models of chronic spinal cord injury  
 
Animal models, by imitating the human experience, can be used to study the effects of SCI on 
ejaculation. Currently, there are three validated models of human SCI that are frequently utilized 
in animal studies. The first model, complete spinal transection, results in the complete 
denervation of the spinal cord from supraspinal regions and is a model of complete spinal cord 
injury (Wrathall, 1992; Jacob et al., 2001; Young, 2002; Gris et al., 2003; Jacob et al., 2003; 
Onifer et al., 2007). The second model is the clip compression model in which an aneurysm clip 
is positioned around the spinal cord but the dura is left undisturbed. Next, the clip is tightly 
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clasped around the cord for one minute to induce trauma to the spinal cord. The last method, 
contusion injury of the spinal cord, is performed using a spinal cord impactor, such as the Infinite 
Horizon IH0400 Impactor (200 kdyne, Precision Systems and Instrumentation). The clip 
compression model and the contusion injury models are considered to be models of partial SCI 
and are validated models of SCI in humans (Wrathall, 1992; Young, 2002; Onifer et al., 2007).  
 
1.11 Thesis rationale and objectives  
 
Given that men with SCI emphasize the importance of regaining sexual function as their primary 
goal (Anderson, 2004), it is astounding to observe the absence of literature describing the 
changes to sexual function and ejaculation in particular in animal models of chronic SCI.  In 
addition, many more questions remain regarding the spinal cord control of ejaculation in intact, 
healthy men. Although some progress has been made in the spinal cord research of ejaculatory 
reflexes, the literature is still lacking and treatment options for ejaculatory dysfunction are 
unsatisfactory. However, recent advances in science have generated insight into the spinal cord 
control of ejaculation. It is currently known that ejaculation is under the control of LSt cells in 
the lumbosacral spinal cord (Truitt and Coolen, 2002; Truitt et al., 2003; Staudt, 2011). Targeted 
lesions of the LSt cells abolish ejaculation and ejaculatory reflexes via their direct projections to 
preganglionic sympathetic neurons in the IML and CAN and to preganglioninc parasympathetic 
neurons in the SPN as well as motor neurons in the SNB (Truitt and Coolen, 2002; Staudt, 2011). 
My overall hypothesis is that LSt cells control ejaculatory reflexes via release of their 
neuropeptides galanin, CCK, GRP, and enkephalin in the IML, CAN, SPN, and pudendal 
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motorneurons. In these LSt target areas, neuropeptide receptor activation is therefore critical in 
triggering ejaculation. This hypothesis is tested in Chapters 2, 3, and 4 utilizing the DPN 
stimulation model described above in anesthetized, spinalized male rats. In Chapter 5, I will 
determine the effects of chronic spinal injury using a contusion paradigm on ejaculatory reflexes. 
Moreover, I will next test the hypothesis that administration of the LSt neuropeptides can 
alleviate the detrimental effects of chronic spinal cord injury in male rats. Finally, in Chapter 6, I 
will test the hypothesis that D3 receptor agonist will improve ejaculatory function in male rats 
with chronic spinal cord injury. The D3 receptor agonist 7-OH-DPAT has been demonstrated to 
facilitate ejaculation in spinal intact and acutely spinalized rats (Ahlenius and Larsson, 1995; 
Clement et al., 2007), but the effect of this agonist on impaired ejaculatory function in rats with 
spinal cord injury has not been determined. 
Together, the studies in this thesis further elucidate the mechanisms by which the spinal 
ejaculation generator controls ejaculatory function in male rats. Moreover, these studies will 
form a first, but critical step towards an improvement of ejaculatory dysfunction following 
chronic spinal cord injury. 
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Chapter 2: Activation of gastrin-releasing peptide 
receptors in the lumbosacral spinal cord is required for 
ejaculation in male rats1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 Research article published in J Sex Med: 9(5) 1303 – 1318  
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2.1 Introduction 
 
Male sexual behavior is a complex and rewarding behavior that ultimately results in 
ejaculation (Hull et al., 2002). Ejaculation is defined as the expulsion of seminal fluid from the 
urethral meatus (Marberger, 1974; McKenna, 1999) and comprises two phases: emission and 
expulsion. Emission refers to the secretion of seminal fluids from the accessory sex glands, 
contraction of the ductus deferens, and closure of the bladder neck and external urethral 
sphincter. Expulsion refers to the forceful ejection of semen which is produced by the rhythmic 
contractions of the striated perineal and smooth muscles of the urethra, and the bulbocavernosus 
muscle (BCM) in particular (Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; 
Holmes and Sachs, 1991; Pescatori et al., 1993).  
It is well known that ejaculation is a reflex and that the central components that regulate 
the ejaculatory reflex are located in the lumbosacral spinal cord (Griffith et al., 1973; Pescatori et 
al., 1993; McKenna, 1999) (Figure 1). Indeed, ejaculatory reflexes remain intact in animals and 
men with complete spinal cord transection (Griffith et al., 1973; Pescatori et al., 1993; McKenna, 
1999). Thus, ejaculation is mediated by a spinal control center, referred to as a spinal ejaculation 
generator (Marberger, 1974; McKenna, 1999; Carro-Juarez and Rodriguez-Manzo, 2007), spinal 
pattern generator (McKenna et al., 1991), or spinal pacemaker (Sachs and Garinello, 1979). This 
spinal ejaculation generator is suggested to coordinate sympathetic, parasympathetic, and motor 
outflow to induce the emission and expulsion phases of ejaculation. In addition, the spinal 
ejaculation generator is hypothesized to integrate this autonomic and motor outflow with sensory 
inputs associated with the summation of sexual activity, thereby triggering ejaculation.  
 Figure 1 Schematic diagram of the spinal ejaculation generator
Lumbar spinothalamic (LSt) cell
activity via the dorsal nerve of the penis (DPN), triggering activation of the LSt cells. LSt cells 
send axonal projections to preganglionic sympathetic neurons in the central autonomic nucleus 
(CAN) and intermediolateral cell column (IML), to preganglionic parasympathetic neurons in the 
sacral parasympathetic nucleus (SPN), and to pudendal motorneurons in the sacral nucleus of the 
bulbocavernosus (SNB). It is hypothesized that the neuropeptides ex
termimals of the LSt cells trigger ejaculatory reflexes by acting in the LSt target
 
The spinal ejaculation generator is composed of a population of interneurons in the 
central gray of lumbar levels L3
hypothesized to convert sensory signals into motor or secretory outputs
population of interneurons is located in lamina 10 and the medial portion of lamina 7 of lumbar 
 
 
s receive sensory inputs related to the summation of sexual 
pressed in the axon 
 
-4 that play a pivotal role in the control of ejaculation, and are 
 (Truitt et al., 2003)
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segments 3 and 4 (L3-4), contain the neuropeptides galanin, cholecystokinin, gastrin releasing 
peptide, and enkephalin (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt et al., 
2003; Sakamoto et al., 2008), and have projections to a nucleus in the thalamus: the parvocellular 
subparafascicular thalamic nucleus (Ju et al., 1987; Coolen et al., 2003; Truitt et al., 2003). 
Based on their anatomical location in the spinal cord and thalamic projections, these particular 
cells are referred to as lumbar spinothalamic (LSt) cells (Truitt and Coolen, 2002).  
Moreover, LSt cells have additional characteristics that are consistent with their role as a 
critical component of the spinal ejaculation generator. Mating-related sensory inputs induce 
activation of LSt cells, thereby triggering ejaculation (Sachs and Garinello, 1979; Pescatori et al., 
1993; McKenna, 2001; Coolen et al., 2004). These sensory inputs are relayed via the sensory 
branch of the pudendal nerve, or dorsal penile nerve (DPN) (Staudt et al., 2010, 2011). Mating or 
stimulation of the DPN, which reliably triggers ejaculatory reflexes in anesthetized and 
spinalized male rats, induces expression of markers of neural activation cFos (Truitt et al., 2003)  
and phosphorylated MAP kinase (pERK) (Staudt et al., 2010) in LSt cells. Moreover, inhibition 
of MAP kinase kinase (MEK) completely abolished ejaculation induced by DPN stimulation 
(Staudt et al., 2010) . Therefore, DPN fibers transmit sensory inputs to LSt cells and in turn 
trigger ejaculation via activation of the MAP kinase pathway.  
LSt cells are ideally located to coordinate outflow necessary for ejaculation. LSt cells 
have axonal projections to target regions of the spinal cord implicated in ejaculatory control 
(Newton, 1993; Allard et al., 2005; Xu et al., 2006). Specifically, LSt cells project to 
preganglionic sympathetic neurons in the intermediolateral cell column (IML) and central 
autonomic nucleus (CAN) of the thoracolumbar spinal cord and to the preganglionic 
parasympathetic neurons in the sacral parasympathetic nucleus (SPN) of the lumbosacral spinal 
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cord (McKenna, 1997; Allard et al., 2005) and motor neurons in the spinal nucleus of the 
bulbocavernosus (SNB) (Newton, 1993; Sakamoto et al., 2008). LSt cells and their axonal 
projections contain several neuropeptides, including galanin, cholecystokinin, enkephalin and 
gastrin releasing peptide (GRP) (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt 
et al., 2003; Sakamoto et al., 2008). Thus, we hypothesize that these neuropeptides act in the LSt 
target areas to mediate ejaculatory reflexes. In support of this hypothesis, GRP, a member of the 
family of bombesin-like peptides (McDonald et al., 1979; Battey and Wada, 1991), has been 
implicated in male erectile and ejaculatory function in spinally-intact males utilizing the ex-
copula reflex paradigm (Sakamoto et al., 2008).  However, in order to study the role of GRP in 
ejaculatory reflexes, it is necessary to eliminate supraspinal influences on the spinal ejaculation 
generator. 
 Therefore, the purpose of the present study was to test the role of GRP in the control of 
ejaculation using a physiologically-relevant model of ejaculation involving electrical stimulation 
of the DPN in anesthetized, spinalized male rats. Stimulation of the DPN reliably triggers 
ejaculation in all mammals, including rats (Pescatori et al., 1993), monkeys (Herbert, 1973) and 
humans (Wieder et al., 2000). Moreover, in anesthetized and spinalized male rats, DPN 
stimulation elicits rhythmic contractions of the BCM similar to those observed in a mating 
animal during ejaculation (Coolen et al., 2004; Staudt et al., 2010), and reflexive penile erections 
are evident (Pescatori et al., 1993; Rampin et al., 1997b). The aim of the present study was 
twofold. First, it was confirmed that GRP is expressed in LSt cells and their axon terminals in 
autonomic and motor areas in the lumbosacral spinal cord. Next, it was tested whether GRP 
receptor activation is required to trigger the emission and expulsion phases of ejaculation and 
whether GRP is sufficient to trigger ejaculatory reflexes in the absence of DPN stimulation.  
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2.2 Materials and Methods  
 
2.2.1 Animals 
 
Adult male Sprague Dawley rats (4-5 months) were obtained from Charles River 
(Sherbrook, Quebec, Canada and Wilmington, MA, USA) and were housed in pairs in standard 
housing cages on a 12-hour light/dark cycle with lights off at 10 a.m. Food and water were 
available ad libitum. All procedures were approved by the University Committee on Use and 
Care of Animals at Western University and the University of Michigan and conform to the 
guidelines outlined by the National Institutes of Health.   
 
2.2.2 Experimental designs 
 
2.2.2.1 Intrathecal infusion of GRP receptor antagonist RC-3095 
Male rats were anesthetized with urethane (1.5 g/kg, i.p.), a laminectomy was performed 
between the 6th and the 8th thoracic spinal segments and the spinal cord was completely 
transected.  Next, the dorsal penile nerve (DPN) and the muscle of the bulbocavernosus (BCM) 
were exposed and the surrounding connective tissue was removed. In preparation for 
electromyographic (EMG) recordings, silver recording electrodes, connected to the 
PowerLab/7SP Data Acquisition System (ADInstruments, Inc., Colorado Springs, CO) were 
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inserted bilaterally into the BCM and a ground electrode was placed into the muscle of the right 
thigh. A bipolar stimulating electrode connected to the SD9 Square Pulse Stimulator (Grass 
Technologies, West Warwick, RI) was positioned directly on top of the DPN. Initial stimulation 
of the DPN was performed in order to verify the completeness of the spinal cord transection, 
indicated by a rhythmic bursting pattern of the BCM (Figure 2). Electrical stimulation of the 
DPN comprised square wave pulses of 1 ms duration, 4 V at 60 Hz for 10 seconds. These 
stimulation parameters have previously been demonstrated to trigger rhythmic bursting of the 
BCM indicative of the expulsion phase of ejaculation in 100% of control animals (Staudt et al., 
2010, 2011). Experiments started 2 hours following transection of the spinal cord to allow for 
potential acute effects of spinal cord transection to subside. A second laminectomy was 
performed at spinal level T10 in preparation for intrathecal administration of neuropeptides. A 
small incision was made in the dura mater at the site of the second laminectomy and a 
polyethylene catheter (Caly-Adams PE-10, Parsippany, NJ, USA) was inserted into the 
subarachnoid space at lumbar levels, to deliver drugs presumably to the entire lumbosacral spinal 
cord. First, 10 µl/min of saline was infused and BCM EMG activity was recorded for 25 minutes. 
Following these 25 minutes, the DPN was stimulated twice with 5 minute intervals between 
stimulation, at 30Hz and 60Hz in a counter balanced manner (testing trial 1; control trial). BCM 
activity was recorded for 90 seconds, the time period for a typical BCM bursting activity (Lodder 
and Zeilmaker, 1976). One hour later, the procedure was repeated in the same animals, which 
now received a 10 µl infusion (over 1 minute) of either 0.9% saline (N = 10) or one of two doses 
of the GRP receptor antagonist RC-3095, 20 nmol (N = 9) and 10 nmol (N = 6) (Sigma-Aldrich 
Canada Ltd. (Oakville, Ontario)). BCM activity was recorded for 25 minutes, after which the 
 DPN was stimulated at 30Hz and 60 Hz as described above in a counterbalanced
BCM EMG activity was recorded (testing trial 2
Figure 2 Example of characteristic BCM EMG induced by DPN stimulation.
Dashed lines in the EMG trace in (
seconds of EMG recording showing BCM events (activity above baseline) and clusters of events, 
i.e. BCM bursts. Time is presented on horizontal scale (Scale bar in 
and activity amplitude (in µV) on vertical scale. The 
of recording) are shown on an enlarged time scale in (
events within bursts and the return to baseline activity between bursts.
 
; drug trial).   
 
A) represent the period of DPN stimulation f
A represents 20 seconds) 
four bursts indicated by the box (16 seconds 
B) to clearly show the clusters of BCM 
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2.2.2.2 Intrathecal infusion of GRP20-29 agonist  
A separate group of male rats was anesthetized, spinalized, and prepared as described above. 
Males received intrathecal 10 µl infusions of 0.9 % saline (N=11) and BCM EMG was recorded 
for 10 minutes following infusion. Then, the DPN was stimulated at 5 HZ, 10 HZ, 30 HZ and 60 
HZ in a randomized and counterbalanced manner and BCM EMG was recorded for a period of 
90s following stimulation (testing trial 1; control trial). One hour after the last DPN stimulation, 
the procedure was repeated in the same group of animals, which now received 10 µl intrathecal 
infusions of either 0.9% saline (N=11) or one of two doses of GRP agonist (GRP20-29 0.2 nmol, 
n=7; 0.5 nmol, n=7 (Phoenix Pharmaceuticals Inc. USA, Burlingame, CA)) and BCM EMG was 
recorded for 10 minutes after infusion of vehicle or drug. Next, the DPN was stimulated at 5, 10, 
30 and 60 HZ in a counterbalanced order as described above (testing trial 2; drug trial).  
 
2.2.3 BCM EMG analysis  
BCM EMG recordings were analyzed for the 25 or 10 minutes following the infusion of the 
antagonist or agonist respectively, and for 90 seconds following each DPN stimulation. The 
numbers of events and bursts, as well as latencies to first event were analyzed. The analysis of 
numbers of events was performed using LabChart 7 (AD Instruments), and all events that were 
above baseline activity were recorded (Staudt et al., 2011). In addition, numbers of bursts were 
analyzed by two independent observers blinded to experimental treatment groups. Bursts were 
defined as a group of 10 or more events, without return to baseline activity between events. 
These criteria were based on a detailed analysis of the BCM bursting activity in a subgroup of 
control animals (n = 15). The average number of events per burst, number of bursts and time 
intervals between successive bursts during a period of 90 seconds following a 30 or 60 Hz DPN 
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stimulation were calculated, There was an average of 48.56 (ranging from 10 – 253) or 62.57 
(ranging from 10 – 315) BCM events per burst after 30 and 60 Hz DPN stimulation respectively. 
Furthermore, there was a mean of 7.4 bursts (ranging between 3 – 12 bursts) or 8.07 bursts 
(ranging between 4 – 12 bursts) following 30 or 60 Hz resp. Analysis of time (s) between bursts 
revealed that there was an average of 2.54 seconds between successive bursts (ranging from 0.2 - 
7 seconds).   
Effects of antagonist treatments on numbers of events or bursts were compared both 
within animals (between the two testing trials (control and drug trials) and within the same drug 
treatment group) and between groups (within each of the two testing trials, and between drug 
treatment groups), separately for the 30 or 60 Hz stimulations, using two-way repeated ANOVA 
(factors: Drug treatment and Testing trial) and Holm-Sidak post hoc tests, Effects of agonist 
treatments on numbers of events or bursts were compared within animals (between the five 
stimulations (following infusion without stimulation, 5, 10, 30, 60 Hz)) and between treatment 
groups (within each stimulation setting), separately for each of the two testing trials, using a two-
way repeated ANOVA (factors: Drug treatment and Stimulation) and Holm-Sidak post hoc tests, 
A 95% confidence level was used for all tests. 
 
2.2.4 Immunohistochemistry experiments:  
 
2.2.4.1 GRP expression in LSt cells 
In order to verify that LSt cells and their axon terminals in autonomic and motor areas express 
GRP, 8 male rats were perfused transcardially with 10 mL 0.9 % saline followed by 500 mL of 
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4% paraformaldehyde in phosphate buffer (0.1 PB). Spinal cords were removed and postfixed 
for 1 hour in the same fixative and subsequently placed in cryoprotective solution (20 % sucrose 
in 0.1 PB with 0.01 % sodium azide) until further processing for immunohistochemistical 
detection of GRP and galanin, a marker for LSt cells (Truitt and Coolen, 2002; Truitt et al., 
2003; Coolen et al., 2004; Staudt et al., 2010, 2011). 
 
2.2.4.2 DPN stimulation-induced pERK after RC-3095  
To verify that GRP antagonist did not prevent activation of LSt cells, expression of 
phosphorylation of ERK (pERK) in LSt cells was examined following stimulation of the  DPN 
(Staudt et al., 2010). Male rats (n = 6) were anesthetized and spinalized as described above. Two 
hours after spinalization, the DPN and BCM were exposed and vehicle (saline, n = 3) or drug 
(RC-3095; Sigma-Alderich Inc.; 20 nmol; n = 3) were infused in a volume of 10 µl intrathecally 
as described above. 25 Minutes later, the DPN was stimulated at 30 Hz and BCM EMG activity 
was recorded for 90 seconds. Five minutes following DPN stimulation, animals were perfused 
transcardially with 5 mL 0.9 % saline solution and 500 mL of 4% paraformaldehyde in 0.1M PB. 
Spinal cords were removed and postfixed for 1 hour in the same fixative and subsequently placed 
in cryoprotective solution (20 % sucrose in 0.1 PB with 0.01 % sodium azide) until further 
processing for immunohistochemical detection of pERK and galanin. The stimulation parameters 
and time of perfusion were previously shown to be optimal for visualization of pERK expression 
in LSt cells (Staudt et al., 2010). Moreover, it was previously shown that spinalization and 
exposure of DPN and BCM without electrical stimulation of the DPN did not induce pERK 
expression in LSt cells (Staudt et al., 2010), hence negative control groups were not included in 
this experiment.  
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2.2.5 Immunohistochemistry  
Spinal cords were sectioned using a freezing microtome (Thermo Fisher Scientific, Walldorf, 
Germany) into 12 parallel series of 35 um coronal sections in cryoprotectant solution (30 % 
sucrose, 30 % ethylene glycol in 0.1 M PB with 0.01 % sodium azide) and stored at -20 C until 
further processing. Free floating sections containing lower thoracic, lumbar, and sacral spinal 
levels were thoroughly rinsed in 0.1 M saline buffered sodium phosphate (PBS) between 
incubations and blocked with 1% H2O2 for 10 minutes prior to incubation. All antibody 
incubations were performed in incubation solution containing 0.1% bovine serum albumin and 
0.4% Triton X-100 (BP151-500, Thermo Fisher Scientific, Ottawa, Ontario) in PBS at room 
temperature with gentle agitation.  
 
Galanin/GRP Dual Fluorescence: One series of sections for four animals (2 spinal intact and 2 
spinalized) were dual stained for galanin and GRP. Sections were incubated overnight with 
rabbit anti-galanin (1:60,000; T-4334; Bachem, Torrance, CA) and with biotinylated goat anti-
rabbit for one hour (1:500; Vector Laboratories, Burlingame, CA, USA), avidin horseradish 
peroxidase complex (ABC-elite, 1:1000 in PBS; 1 hour; Vector Laboratories), biotinylated 
tyramine (BT; 1:250 in PBS containing 1uL/ml of 3% H2O2 for 10; NEL700 /700A; PerkinElmer 
Life Sciences, Boston, MA), and Alexa 488-conjugated streptavidin (1:100 in PBS, 30 minutes 
(Jackson ImmunoResearch Laboratories, West Grove, PA). Next, sections were incubated with 
rabbit anti-GRP (1:2,000; Phoenix (H-027-13)) and Alexa 555-conjugated goat anti-rabbit for 30 
minutes in PBS (1:100; Jackoson ImmunoResearch Laboratories, West Grove, PA) and mounted 
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on plus charged slides, coverslipped with gelvatol and stored in the dark at 4°C. One series of 
sections of 4 animals (2 spinal intact and 2 spinalized) was stained using this same procedure, 
but were first processed for GRP immunoreactivity (-ir; using rabbit-anti-GRP; 1:40,000) and 
subsequently for galanin (rabbit anti-galanin; 1:3,000).  
 
Galanin/pERK Dual Fluorescence: One series of sections were processed using the same 
protocol as described above using rabbit anti-pERK (1:1,000; overnight; Cell Signalling # 26L) 
and rabbit anti-galanin (1:3,000).  
For all procedures, the omission of primary antibodies resulted in a complete loss of signal at 
specific wavelengths and served as a control manipulation. Moreover, all primary antibodies 
have been previously characterized (Truitt et al., 2003; Staudt et al., 2010, 2011) .  
 
2.2.6 Data Analysis:  
 
2.2.6.1 Analysis for Galanin/GRP co-localization 
Sections of the lumbosacral spinal cord containing LSt cells were analyzed for expression of 
GRP using a Leica DM5000B (Leica Microsystems, Wetzlar, Germany). In all 8 animals 
included in the analysis, all galanin-ir and CGRP-ir cells were analyzed for co-expression of 
GRP-ir or galanin-ir respectively. The percentages of galanin-ir co-expressing GRP and vice 
versa were determined for each animal and a group mean was calculated. In addition, the co-
localization of galanin and GRP was analyzed in LSt axons in the intermediolateral cell column 
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(IML), central autonomic nucleus (CAN), sacral parasympathetic nucleus (SPN), and spinal 
nucleus of the bulbocavernosus (SNB) using a Zeiss laser-scanning confocal microscope system 
(Zeiss LSM510; Carl Zeiss MicroImaging, Inc., Thornwood, NY). Alexa 555-fluorescence was 
imaged using a 567 nm emission filter and a HeNe laser and Alexa 488 was imaged using a 505 
nm filter and Argon laser. Images were generated by projecting several 1 µm optical sections 
collected at 1 µm intervals through areas of interest in the z-axis using a 63x water-immersion 
objective.   
 
2.2.6.2 pERK Expression in LSt cells  
pERK expression in LSt cells was analyzed on a DM5000B Leica fluorescent microscope (Leica 
Microsystems, Wetzlar, Germany). Specifically, all lumbar cells expressing galanin-ir were 
analyzed for expression of pERK. Data are expressed as the mean percentages of LSt cells that 
express pERK for each animal. The group means were calculated and compared between animals 
that received an infusion of RC-3095 (20nmol) and saline-treated controls, using Student t tests 
with 95% confidence levels.  
 
2.2.6.3 Pressure recording in seminal vesicles 
Based on findings from the above described experiments, an additional experiment was 
conducted to analyze pressure in the seminal vesicles (SV), which is considered an indicator of 
the emission phase (Clement et al., 2008). Spinal cords were transected, and BCM and DPN 
were exposed as described above. In addition, the right SV was exposed by coeliotomy. SV 
pressure (SVP) was measured using a pressure catheter (ADInstruments, model number: SPR-
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671(1.4F, Single, Straight, 15cm, Ny) attached to a catheter interface cable (ADInst, model 
number: AEC-IOD) and connected to a Bridge AMP (ADInst). The pressure catheter was 
inserted into the lumen of the SV and secured prior to recording. SVP and BCM EMG (as 
described above) were simultaneously recorded and analyzed using LabChart 7 (ADInst). There 
were three groups of animals (N=3 per group). The first group of control animals received DPN 
stimulation at 5, 10, 30 and 60 Hz 10 minutes after intrathecal saline infusion (control Trial 1) 
and identical treatment in trial 2 (control Trial 2). The second group of animals received 
intrathecal saline and DPN stimulation at 30 and 60 Hz 25 minutes later (control Trial 1), and 
subsequent intrathecal RC-3095 (20 nmol; Trial 2; drug trial) again followed by DPN stimulation 
at 30 and 60 Hz 25 minutes after each infusion. The third group of animals received intrathecal 
saline and DPN stimulation at 5,10, 30, and 60 Hz 10 minutes later (Trial 1; control trial) and 
subsequent GRP agonist (GRP20-29; Trial 2; drug trial) followed by DPN stimulation at 5, 10, 30, 
and 60 Hz 10 minutes after each infusion.  
 
Analysis: BCM EMG was analyzed as described above and numbers of bursts were compared 
within animals and between trails 1 and 2 using t-tests or the Mann-Whitney –Wilcoxon test. 
SVP was analyzed using LabChart7 (ADInst). SVP increased simultaneously with BCM EMG 
bursts and the numbers of times that increased SVP occurred were counted and compared within 
animals between trials 1 and 2 using t-tests with confidence levels of 95%. 
 
2.3 Results  
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2.3.1 GRP expression in LSt cells and axons  
GRP was co-expressed by all LSt cells analyzed, based on analysis of 119 galanin-IR cells in 
eight animals (Figure 3). Moreover, 100% GRP-IR neurons in the lumbosacral spinal cord co-
expressed galanin-IR, suggesting that GRP is exclusively expressed by LSt cells. There was no 
effect of spinal transection on co-expression of galanin and GRP-ir. In addition, qualitative 
analysis showed that virtually all galanin-IR axons in IML, CAN, SPN, and SNB co-expressed 
GRP (Figure 3). Hence, GRP may be released in autonomic and motor areas to mediate 
ejaculation  However, a few GRP-IR fibers that did not co-express galanin-IR were detected 
dorsal to the SPN (Figure 3J-L), raising the possibility that the SPN also receives a minor GRP 
input from cells other than LSt neurons and outside the lumbosacral spinal cord.  
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Figure 3 The co-expression of galanin-ir and GRP-ir in LSt cells, IML, CAN and SPN of 
the male rat 
Confocal images (1 µm optical sections) illustrating the co-expression of galanin-ir (A) and 
GRP-ir (B) in LSt cells (A-C), IML (D-F), CAN (G-I), and SPN (J-L) in a spinal intact male rat. 
Galanin-ir was immunoprocessed using TSA amplification, while GRP was immunoprocessed 
using a conjugated secondary antibody. Arrows in (C) indicate putative close contacts of 
galanin/GRP-ir axon terminals with LSt cells. Arrows in L indicate GRP-ir fibers dorsal to the 
SPN that do not co-express galanin-ir. Scale bars indicate 20 µm.  
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2.3.2 GRP receptor antagonist blocked ejaculatory reflexes  
GRP receptor antagonist RC-3095 significantly reduced DPN stimulation-induced ejaculatory 
reflexes at both 30 and 60 Hz stimulation frequencies as evidenced by the reduced numbers of 
BCM events and bursts (Figure 4C-F). There were main effects of testing trial on the numbers of 
BCM events for both 30 (F(1, 43) 13.760; p=0.002; Figure 4C) and 60 Hz stimulation 
frequencies (F(1, 41) 12.727; p=0.003; Figure 4D).  Post hoc analyses revealed that animals 
treated with either dose of RC-3095 during the second, drug trial (trial 2; Figure 4B) had 
significantly decreased BCM events in response to 30 and 60 Hz DPN stimulation compared to 
their DPN stimulation-induced BCM events following saline treatment in their first control trial 
(trial 1; 60 Hz: p=0.008 (10nmol); p=0.040 (20nmol); 30 Hz: p=0.022 (10nmol); p=0.029 
(20nmol); Figure 4C-D and Figure 5C-D). There were no significant differences between the two 
groups treated with the lower and higher doses of RC-3095. Saline treated animals did not differ 
in their BCM events during trial 2 compared to trial 1 (30 Hz: p=0.130; 60 Hz: p=0.280, Figure 
4C-D and Figure 5A-B), demonstrating that the reduction in BCM events was not an effect of 
repeated testing, but rather of RC-3095 treatment. Similarly, there were main effects of testing 
trial on the numbers of BCM bursts for both 30 Hz (F(1,48) = 56.209; p < 0.001; Figure 4E) and 
60 Hz (F(1,48) = 41.878; p < 0.001; Figure 4F) stimulation frequencies. Males treated with either 
dose of RC-3095 during trial 2 (drug trial) had significantly lower numbers of BCM bursts 
compared to trial 1 (control trial) with saline treatment (30Hz: p < 0.001 (10 nmol), 60 Hz: p < 
0.001 (20nmol). Once again, there was no effect of the dosage of the antagonist and of repeated 
testing, as saline-treated animals did not differ in the numbers of BCM bursts during the second 
compared to the first testing trial (Figure 4E-F). 
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 Figure 4 Effects of GRP receptor antagonist RC
events and bursts in male rats 
Quantitative analysis of BCM events and bursts following infusions with GRP receptor 
antagonist RC-3095 During Trial 1 
and 30 and 60 Hz DPN stimulation (bolt arrows; in counterbalanced manner
drug trial), the same groups received saline or RC
followed by 30 and 60 Hz DPN stimulation (bolt arrows; in counterbalanced manner). Numbers 
of BCM events are shown in (C)
shown in (E) (30 Hz) and (F) (60 Hz). # denotes significant differences from Trial 1 within the 
same treatment group. * indicates significant differences from controls within the same testing 
trial.    
 
 
 
-3095 infusion on the numbers of BCM 
(A; control trial), all groups received saline infusions (arrow) 
). During Trial 2 
-3095 (10 or 20 nmol) infusions (arrow) 
 (30 Hz) and (D) (60 Hz); while numbers of BCM bursts are 
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Figure 5 Infusions of RC-3095 prevent DPN stimulation-induced bursting of the BCM in 
male rats. 
Representative EMG recording traces depicting BCM activity induced by 60Hz DPN stimulation 
(indicated by arrow) following intrathecal infusions of saline or GRP antagonist RC-3095. DPN 
stimulation induced characteristic BCM bursting following infusion of saline in trial 1 (A, C) 
and again following saline in trial 2 (B; same animal as A). In contrast, infusion of the GRP 
antagonist RC-3095 (20nmol) in trail 2 completely prevented BCM activity (D; same animal as 
C). Each trace represents 90 seconds of BCM activity. 
 
A significant interaction between drug treatment and testing trial was detected for 
numbers of BCM events at the 60 Hz stimulation (F(2,48) = 6.941; P = 0.005). Post hoc analyses 
demonstrated that during trial 2 (drug trial), animals treated with 10 nmol RC-3095 had 
significantly fewer numbers of BCM events induced by 60 Hz stimulation compared to saline 
controls (p=0.004; Figure 4D). A trend towards significance was observed in animals treated 
with the higher dose of RC-3095 (20nmol) and received 60 Hz DPN stimulation (P = 0.06; 
Figure 4D). Interactions between drug treatment and testing trial were also detected for numbers 
of BCM bursts at 30 Hz (F(2,48) = 5.250; P = 0.014) and 60 Hz (F(2,48) = 6.941; P = 0.005) 
stimulations. Specifically, during trial 2 (drug trial), animals treated with the lower dose of RC-
3095 had significantly lower numbers of BCM bursts compared to saline controls for both 30 Hz 
(P = 0.01; Figure 4E) and 60 Hz (P < 0.001; Figure 4F) stimulations and animals treated with 
the higher dose had fewer BCM bursts compared to saline controls following 60 Hz stimulation 
(P = 0.003; Figure 4F). There were no significant differences between the two groups treated 
with the lower and higher doses of RC-3095. Finally, there were no differences in numbers of 
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BCM events nor bursts between groups during the first control trial, when all groups were treated 
with saline (Figure 4C-F), demonstrating that group differences during the second testing trial 
were caused by drug treatments, rather than differences in BCM bursting responses. 
 
2.3.3 RC-3095 did not affect DPN stimulation-Induced pERK in LSt cells  
In order to verify that GRP antagonist RC-3095 blocks BCM bursting via actions in LSt target 
areas rather than acting directly on LSt cells, DPN stimulation-induced neural activation of LSt 
cells was examined. In both antagonist treated and control males, DPN stimulation induced 
pERK in 97 ± 0.03% of LSt cells, similar to the activation reported previously in control males 
(Staudt et al., 2010). Thus, GRP receptor antagonist treatment did not affect the activation of LSt 
cells in response to DPN stimulation (Figure 6).  
 
 
Figure 6 Expression of pERK in LSt cells induced by DPN stimulation 
Confocal images (1 µm optical sections) demonstrating pERK expression (B) in LSt cells (A) 
induced by DPN-stimulation. The pattern of pERK labeling is representative of all antagonist- 
and control-treated animals. Scale bar indicates 20 µm. 
46 
 
 
2.3.4 GRP20-29 agonist facilitated BCM activity 
During the first testing trial (control trial), there was an overall effect of DPN stimulation 
parameters on the number of BCM events (F(4, 121)= 28.878; P < 0.001) and bursts (F(4,121) = 
54.775; P < 0.001). Post hoc tests showed that following 30Hz DPN stimulation, all treatment 
groups had significantly increased numbers of BCM events (compared to infusion, 5Hz, or 10Hz, 
P < 0.001; Figure 7C),  and bursts (compared to infusion, 5Hz, or 10Hz,  P < 0.001; Figure 7E). 
DPN stimulation at 60 Hz also increased numbers of BCM events and bursts (compared to 
infusion, 5Hz, or 10Hz, P < 0.001; Figure 7C, 7E). These data confirm that 30 and 60 Hz 
stimulations reliably trigger BCM bursting while 5 and 10 Hz represent sub-threshold levels of 
stimulation. Moreover, saline infusions alone (without DPN stimulation) did not trigger any 
BCM activity (Figure 7C, 7E, 8A). Finally, during control trial 1, there were no differences 
between treatment groups in the numbers of BCM events nor bursts (Figure 7C,7E),  
demonstrating that there were no initial group differences in BCM bursting responses and that 
repeated DPN stimulations in the randomized order did not affect BCM responses to subsequent 
stimulations. 
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Figure 7 Effects of GRP infusions on the numbers of BCM events and bursts in male rats. 
Quantitative analysis of BCM events and bursts following infusions with GRP20-29. During Trial 
1 (A; control trial) all groups received intrathecal saline (arrow) followed by four DPN 
stimulations (bolt arrows) at 5-60 Hz (in counterbalanced manner). During Trial 2 (B; drug trial), 
all groups received intrathecal GRP20-29 (10 or 20 nmol; arrow) again followed by four DPN 
stimulations at 5-60 Hz (bolt arrows; in counterbalanced manner). Numbers of events are shown 
in (C) (Trial 1) and (D) (Trial 2), while numbers of bursts are shown in (E) (Trial 1) and (F) 
(Trial 2). # denotes significant differences from BCM activity following infusion, 5 Hz, and 10 
Hz within the same treatment group and trial,  * indicates significant differences from the saline 
control group within the same DPN stimulation and trial.  
 
During the second testing trial (drug trial), there were overall effects of DPN stimulations 
on BCM bursts (F(4,120) = 2.795, P = 0.031)) and there were significant interactions between 
stimulations and drug treatments for events ((F(8, 119) = 5.048; P < 0.001) and bursts (F(8,120) 
= 8.053; P < 0.001). First, the GRP20-29 receptor agonist significantly triggered BCM activity in 
the absence of DPN stimulation in a subset of animals, (43% of 0.2 nmol and 43% of 0.5 nmol; 
Figure 7D, 7F and Figure 8F). Latencies to BCM activity were 149 ± 13.66 (0.2 nmol) and 148 ± 
5.69 (0.5 nmol) seconds post-infusion. Comparisons of numbers of BCM events and bursts 
showed a significant increase in BCM activity in animals treated with the low dose of GRP20-29 
(0.2 nmol) compared to saline controls (events: P = 0.015; bursts: P = 0.008) and a trend toward 
significance compared to animals treated with the high dose of GRP20-29 (0.5 nmol; events: 
P=0.07; Figures 7D, 7F). These results indicate that in a portion of the animals, the low dose of 
GRP20-29 was sufficient for triggering ejaculatory reflexes in the absence of sensory stimulation.   
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Furthermore, intrathecal infusions of GRP20-29 facilitated ejaculatory reflexes in response to 
subthreshold levels of DPN stimulation (5-10 Hz) as evidenced by the increased numbers of 
events and bursts (Figures 7D, 7F, 8D). Post hoc analyses revealed significantly increased BCM 
events in response to DPN stimulation in animals treated with low dose of GRP20-29 (0.2 nmol) at 
5 Hz (P = 0.022) and 10 Hz (P = 0.042) compared to saline-treated control animals (Figure 7D). 
Similarly, animals treated with the high dose of GRP20-29 (0.5 nmol) demonstrated significantly 
increased BCM events in response to 5 Hz DPN stimulation (P = 0.012; Figure 7D). Animals 
treated with the low dose of GRP20-29 (0.2 nmol) also had significantly more BCM bursts in 
response to 5 Hz DPN stimulation (P = 0.016) and a trend to significance at 10 Hz (P = 0.041) 
compared to saline-treated animals (Figure 7F). Similarly, animals treated with the high dose of 
GRP20-29 (0.5 nmol) demonstrated significantly increased BCM bursts after 5Hz (P = 0.001) and 
10 Hz (P = 0.012) DPN stimulation compared to saline controls (Figure 7F). 
 Figure 8 Effects of GRP infusions on BCM activity in male rats.
Representative EMG recording traces showing BCM activity induced by subthreshold 
stimulation of the DPN (5Hz; indicated by bolt arrows) following intrathecal infusion of saline 
(A-C) or GRP20-29 (D). Subthreshold DPN stimulation did not induce BCM activity
intrathecal infusions of saline in trial 1 
A). In contrast, subthreshold DPN stimulation following intrathecal infusion of GRP
nmol) did induce BCM activity (D; same animal as C
 
(A, C), or following saline in trail 2 (B; same animal as 
).  Infusion of GRP20-29 (0.2 nmol) 
50 
 
 following 
20-29
 (0.2 
(F) but 
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not saline (E; same animal as F) also induced BCM activity without DPN stimulation. Each 
trace represents 90 seconds of BCM activity. 
 
GRP20-29 treatment did not affect BCM activity at 30 Hz stimulation. But, unexpectedly, GRP 
agonist treatment significantly decreased BCM activity in response to high levels of DPN 
stimulation (60 Hz) at both the lower dose (events: p= 0.016; bursts: P < 0.001) and the higher 
dose (events: P < 0.001; bursts: P < 0.001) of GRP20-29 compared to saline-treated control 
animals (Figure 7D-F). Finally, saline treatment did not affect increased BCM events and bursts 
following 30 Hz (Events; infusion: P = 0.007, 5Hz: p=0.017, 10Hz: P = 0.037; Bursts; infusion: 
P < 0.001, 5Hz: P < 0.001, 10Hz: P = 0.001) or 60 Hz (Events; infusion, 5Hz, 10Hz: P < 0.001, 
30Hz: P = 0.006; Bursts; infusion, 5Hz, 10Hz: P < 0.001) DPN stimulation, confirming that 
there was no effect of repeated DPN stimulations (Figure 7D-F). 
 
2.3.5 GRP mediates SVP Increases following DPN stimulation  
The findings described above confirm a role for GRP in the expulsion phase of ejaculatory 
reflex. Next, we determined the role of GRP for increases in SVP, indicative of the emission 
phase. Since effects of DPN stimulation on SVP have not yet been documented, saline-treated 
controls were analyzed. DPN stimulation triggered SVP increases that were concurrent with 
BCM EMG bursts in saline treated animals (Figure 9). There were no significant differences in 
the numbers of SVP increases following DPN stimulation between trial 1 and trial 2 in animals 
treated with saline (at 5, 10, 30, or 60 Hz; Table 1), showing lack of effect of repeated DPN 
stimulation. Similarly, and in concordance to the results described above, there were no 
 significant differences in the numbers of BCM bursts induced by DPN stimulation between trial 
1 and trial 2 in saline treated animals (Table 1). The frequency of SVP increases was close
coupled to the numbers of BCM bursts. Each SVP increase was accompanied by a BCM burst, 
although a number of DPN-stimulation induced BCM bursts occurred in the absence of SVP 
increases, in animals that received 30 or 60 Hz DPN stimulation. In the absenc
following subthreshold levels of DPN stimulation (Trial 1: control trial; saline infusion, 5 Hz, 
and 10 Hz) there was a similar absence of SVP increases (Table 1). 
Figure 9 SVP and concurrent BCM activity induc
A representative example of a simultaneous recording of BCM activity and SVP (90 seconds 
duration) after 60 Hz DPN stimulation 10 minutes following intrathecal saline infusion.  The 
dotted lines in A and B indicate the end of DPN stim
A fragment of the trace indicated in the box area in A and B is enlarged in C and D to clearly 
show a BCM burst (C) coupled with a single increase in SVP (D) over 4 seconds of recording
e of BCM activity 
 
ed by DPN stimulation 
ulation. Stars in (B) indicate SVP increases. 
52 
ly 
 
 
53 
 
 
Table 1 Numbers of SVP increases and BCM bursts following infusions of saline, RC-3095 
and GRP in male rats. 
Numbers of seminal vesicle pressure (SVP) increases and BCM bursts in animals treated with 
saline-saline (n=3), saline-RC3095 (20nmol; n =3) or saline-GRP (0.2nmol; n = 3) in trial 1-trial 
2 respectively, and with DPN stimulation at 0, 5, 30, or 60 Hz frequencies. # indicates significant 
difference from trial 1 within the same treatment group and stimulation parameter.  
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Saline-saline  
(n = 3) 
Trial 1: Numbers of 
SVP 
Trial 2: Numbers of 
SVP  
Trial 1: Numbers of 
BCM bursts  
Trial 2: Numbers of 
BCM bursts  
Infusion  0 0 0 0 
5 Hz 0 0 0 0 
10 Hz 0 0 0 0 
30 Hz 3.33 ± 1.43 2.33 ± 0.94 8 ± 1.08 8.33 ± 0.62 
60 Hz 4 ± 0.71 2.33 ± 1.03 8.33 ± 0.24 9.33 ± 0.62 
Saline-RC3095  
20nmol (n = 3) 
Trial 1: Numbers of 
SVP 
Trial 2: Numbers of 
SVP  
Trial 1: Numbers of 
BCM bursts  
Trial 2: Numbers of 
BCM bursts  
30 Hz 4.66 ± 1.86 0 # 6.66 ± 0.47  0 # 
60 Hz 3.66 ± 2.03 0 (P =0.052) 8 ± 0.71  0 # 
Saline-GRP  
0.2nmol (n = 3)  
Trial 1: Numbers of 
SVP 
Trial 2: Numbers of 
SVP  
Trial 1: Numbers of 
BCM bursts  
Trial 2: Numbers of 
BCM bursts  
Infusion  0 3.66 ± 1.89 0 5 ± 2.86 
5 Hz 0 1.33 ± 0.24 # 0 4.33 ± 0.62 # 
10 Hz 0 2 ± 0.41 # 0 4 ± 0.71 # 
30 Hz 1 ± 0.41 3.33 ± 0.47  # 7.33 ± 0.62 6.66 ± 0.62 
60 Hz 4.33 ± 2.09 2 ± 0.41 8 ± 0.41 6.33 ± 0.62 
 GRP appears to be critically involved in the regulation of both BCM EMG activity and 
SVP increases (Table 1, Figure 10). Indeed, RC
both BCM EMG bursts (confirming results described above) and SVP increases in re
30 Hz (BCM: P < 0.001; SVP: p = 0.03) and 60 Hz 
stimulation (Table 1). Moreover, in 2/3 animals, GRP
increases in the absence of DPN stimulation (Table 1, Figure 10). In addition, GRP
BCM bursts and SVP increases in response to subthreshold levels: 5 Hz (BCM: p = 0.004; SVP: 
P = 0.005) and 10 Hz (BCM: P =
 
Figure 10 BCM activity and concurrent increases in SVP triggered by infusions of GRP in 
a male rat 
Simultaneous recording of BCM activity (A) and SVP (B) in one animal (45 seconds of EMG 
recording) 145 seconds after an intrathecal infusion of GRP
are magnified to show one BCM burst (C) occurring simultaneously with an increase in SVP 
(D).  
 
-3095 (20 nmol) treatment completely blocked 
(BCM: p = 0.001; SVP: 
20-29 triggered BCM bursts and SVP 
 0.005; SVP: P = 0.013) of DPN stimulation (Table 1).
20-29 (0.2nmol). The traces in A and B 
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2.4 Discussion 
 
The findings of this set of studies support the hypothesis that GRP plays a critical role in the 
control of ejaculation by acting in autonomic and motor areas targeted by LSt axons. GRP was 
found to be present in all LSt cells and LSt axon projections within the lumbosacral spinal cord. 
As predicted, intrathecal administration of GRP receptor antagonist RC-3095 severely disrupted 
both the emission and expulsion phases of ejaculation in response to sensory stimulation, 
reflected in the reduced numbers of SVP increases and BCM activity in response to DPN 
stimulation in RC-3095-treated male rats. In contrast, intrathecal infusion of GRP20-29 facilitated 
both the emission and expulsion phases of ejaculation, as evidenced by the surge in the numbers 
of SVP increases and BCM bursts respectively in male rats treated with GRP20-29. In particular, 
GRP20-29 was most effective in facilitating ejaculation after sub-threshold sensory stimulation (5-
10 Hz), signifying the presence of a cumulative effect of GRP receptor activation by intrathecal 
infusion of GRP and the release of endogenous GRP or other neuropeptides in response to 
stimulation of the DPN.  
GRP is a bombesin-like peptide that is widely distributed in the central nervous system of 
mammals (Marberger, 1974; Roth et al., 1982; McKenna, 1999) and is involved in many 
physiological processes including the suppression of feeding behavior (Merali et al., 1993) 
circadian rhythms (Drouyer et al., 2010; Francl et al., 2010; Gamble et al., 2011) and itching 
behavior (Sun and Chen, 2007). In the lumbosacral spinal cord, GRP was shown here to be 
exclusively expressed by LSt cells, as 100% of LSt neurons, identified by immunoreactivity for 
galanin, co-expressed GRP and vice versa. Moreover, virtually all galanin-IR LSt axons in the 
autonomic and motor areas co-expressed GRP. This finding is in slight contrast with a previous 
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report of a sub-population of GRP-IR neurons that do not co-express galanin dorsal to the central 
canal in the lumbar spinal cord (Sakamoto et al., 2008). The discrepancy is possible due to 
differences in the sensitivity of immunohistochemical detections: in the present study, two 
different immunohistochemistry protocols were performed in which either one of the 
neuropeptide signals were amplified for optimal sensitivity of peptide detection. Results from 
both protocols were identical and complete co-localization of galanin- and GRP-ir was found in 
soma and axon terminals. Moreover, the present study utilized spinal cord tissues from both 
spinal intact and spinal transected male rats, thereby correcting for the possibility of supraspinal 
influences on galanin or GRP expression. A few GRP-IR fibers that did not co-express galanin-
IR were observed in the region of and dorsal to the SPN, suggesting that the SPN receives inputs 
from GRP neurons outside of the spinal ejaculation generator and the lumbosacral spinal cord. 
Sources of GRP indeed exist outside of the spinal ejaculatory network (Roth et al., 1982).  The 
SPN is known for its role in erectile function (Rampin et al., 1997a; Tang et al., 1998; Giuliano 
and Rampin, 2004) and emission (Allard et al., 2005; Johnson, 2006) and destruction of sacral 
autonomic centers abolishes reflex erections (Everaert et al., 2010) but a specific role for SPN in 
the expulsion phase of ejaculation has not been documented.  Therefore, it is likely that GRP 
axons located dorsally to the SPN are predominantly involved in erectile function and emission, 
but not expulsion (Morgan et al., 1981; Rampin et al., 1997b; Tang et al., 1998). Indeed, one of 
the sources of GRP outside of the spinal ejaculation generator is the paraventricular nucleus of 
the hypothalamus (Roth et al., 1982), an area well known to be involved in erectile function 
(Chen et al., 1997; Argiolas and Melis, 2005) and to project to the lumbosacral spinal cord (Shen 
et al., 1990; Tang et al., 1998). It is currently unknown if GRP in the PVN or its projections 
mediate erection, and this possibility can be tested in future studies. 
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The expression of GRP in LST cells and projections is consistent with the proposed role of GRP 
in control of ejaculation via action in autonomic and motor areas in the lumbosacral spinal cord 
(see Figure 3), Moreover, intrathecal injections of GRP receptor antagonist RC-3095 blocked 
BCM bursting in response to DPN stimulation. It is assumed that RC-3095 acted primarily in the 
areas of the spinal cord that are located adjacent to the pia-arachnoid space, including all LSt 
target areas. Indeed, GRP receptor expression has been reported in the SPN and SNB of the 
lumbosacral spinal cord (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt et al., 
2003; Sakamoto et al., 2008), however its expression in other LSt target regions, including the 
CAN and IML requires further investigation. Another possibility is that GRP or GRP antagonist 
treatment acts directly on the LSt cells. Galanin- and GRP-ir axon terminals arising from LSt 
cells that make putative contacts with LSt cells have previously been observed (see Figure 5; 
(Truitt et al., 2003)) and thus GRP may be released directly onto LSt cells to control ejaculation. 
However, RC-3095 treatment did not decrease neural activity of LSt cells, indicated by pERK 
expression, substantiating that RC-3095 likely blocks the ejaculatory reflex by acting on GRP 
receptors downstream of the LSt cells, rather than directly disrupting activity of LSt cells.  
In a portion of the animals [33-43%], GRP20-29 was sufficient in triggering ejaculatory reflexes in 
the absence of DPN stimulation. It is possible that the differences in the ability of GRP to induce 
ejaculatory reflexes between groups of rats are due to differences in receptor densities for 
neuropeptides or receptors expressed in the spinal ejaculation generator, including GRP. In 
addition, GRP20-29 was not sufficient to trigger ejaculatory reflexes in all the animals indicating 
that a higher dose of GRP agonist may have been necessary to trigger BCM bursting and SVP 
increases in some animals. Alternatively, the lack of responses to GRP20-29 in all animals 
suggests that other neuropeptides expressed in LSt cells and potentially released in LSt target 
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areas may act in concert with GRP to control ejaculation. These neuropeptides include galanin 
(Newton, 1993; Kozyrev, 2013b), cholecystokinin (Ju et al., 1987; Kozyrev, 2013b) and 
enkephalin (Nicholas et al., 1999; Kozyrev, 2013c). An unexpected finding was that the higher 
dosages of GRP20-29 caused significant suppression of BCM activity induced by the highest 
stimulation parameters. A similar finding is that stimulation of the DPN at higher frequencies 
(such as 120 Hz) does not trigger ejaculatory reflexes (unpublished personal observations). 
Hence, such stimulation by agonists and high frequency may represent a super physiological 
manipulation that leads to dysfunction or possible muscle fatigue.  
An advantage of the current study of the role of GRP in ejaculation is the use of the DPN 
stimulation paradigm which utilizes anesthetized and spinalized male rats and elicits rhythmic 
contractions of the BCM and concurrent SVP increases, akin to those observed in freely-moving 
animals during mating (Beyer et al., 1982; Holmes and Sachs, 1991; Staudt et al., 2010; 
Normandin and Murphy, 2011; Staudt et al., 2011). Thus, complete transection of the spinal cord 
permits the study of ejaculation as a reflex response in the absence of supraspinal influences 
(Sachs and Garinello, 1980; Chung et al., 1988; Monaghan and Breedlove, 1992). The DPN is 
the primary afferent that transmits sensory information related to the summation of mating to the 
spinal ejaculation generator and triggers ejaculation (Hart, 1968; McKenna and Nadelhaft, 1986). 
Indeed, bilateral transection of the DPN blocks ejaculation in mating rats (Lodder and Zeilmaker, 
1976). Although the pathways whereby sensory information is transmitted from the DPN to the 
LSt cells are currently unknown, it has been shown  that DPN nerve fibers terminate in the lower 
lumbar and upper sacral levels of the spinal cord in the general vicinity of the LSt cells, dorsal 
horn and dorsal grey commissure (DCG) (McKenna and Nadelhaft, 1986; Ueyama et al., 1987; 
Yells et al., 1992; Rampin et al., 1997b). Furthermore, it has previously been shown that DPN 
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stimulation activates LSt cells in a similar manner as ejaculatory behavior in freely moving 
animals (Staudt et al., 2010; Staudt, 2011). The mechanism for LSt cell activation is through 
NMDA receptors (Staudt et al., 2011) and map kinsase signaling (Staudt et al., 2010). Moreover, 
this activation is required as pharmacological blockade of either of these components results in 
the blockade of DPN stimulation-induced ejaculatory reflexes in male rats (Staudt et al., 2010; 
Staudt, 2011). Therefore, the activation of LSt cells is essential for the transmission of sensory 
information from the DPN to the outputs of the spinal cord ejaculation generator (Staudt, 2011).  
A previous study demonstrated effects of GRP treatment on erectile and ejaculatory reflexes 
using an ex copula paradigm in spinal intact rats (Sakamoto et al., 2008).  However, in this 
paradigm, it is not possible to eliminate actions of GRP on the supraspinal areas that control 
ejaculation from the spinal ejaculation generator, including the nucleus of the 
paragigantocellularis (nPGi) (Marson and McKenna, 1992; Yells et al., 1992; Normandin and 
Murphy, 2011), the medial preoptic area (MPOA) (Marson, 2004) and the paraventricular 
nucleus of the hypothalamus (Marson and McKenna, 1990, 1994; Murphy and Hoffman, 2001; 
Normandin and Murphy, 2011).  Moreover, emissions or ejaculations as observed in the ex-
copula paradigm are not dependent on the spinal ejaculation generator (Staudt, 2011) as lesions 
of the LSt cells did not block sexual reflexes using this paradigm. While, in contrast, intact LSt 
cells were pivotal for ejaculatory reflexes as induced in three accepted paradigms for ejaculation 
(Staudt, 2011), including DPN or urethrogenital stimulation, and pharmacological activation of 
D3 receptors in spinal transected anesthetized male rats (Staudt, 2011) as well as for ejaculatory 
behavior in freely mating male rats (Truitt and Coolen, 2002).   
In conclusion, these data confirm that GRP receptor activation in the lumbosacral spinal cord is 
required for sensory stimulation-induced ejaculation reflex in anesthetized, spinalized male rats. 
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Furthermore, GRP appears to act by activating receptors in the outputs of the LSt cells. However, 
GRP receptor expression in the target regions of the LSt cells remains to be elucidated. In 
addition, the roles of other neuropeptides expressed in the LSt axons, including enkephalin, 
galanin and cholecystokinin in the control of ejaculatory behavior and reflexes remain to be 
investigated.  
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Chapter 3: Activation of mu and delta opioid receptors 
in the lumbosacral spinal cord is required for 
ejaculatory reflexes in male rats 
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3.1 Introduction 
 
Ejaculation is a complex physiological phenomenon that is highly rewarding and culminates in 
the ejection of seminal contents from the urethral meatus (Marberger, 1974; McKenna, 1999). 
Ejaculation involves two phases, emission and expulsion. During the emission phase, seminal 
fluids are secreted from the accessory sex glands, including the prostate, seminal vesicles and vas 
deferens and the bladder neck and external urethral sphincter shut to avert retrograde ejaculation. 
During the expulsion phase, rhythmic contractions of the striated perineal muscles, and the 
bulbocavernosus muscle (BCM) in particular, forcefully expel semen from the urethral meatus 
(Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and Sachs, 1991). 
Ejaculation is a reflex controlled by a spinal ejaculation generator in the lumbosacral spinal cord 
(Pescatori et al., 1993; McKenna, 1999). The spinal ejaculation generator (Marberger, 1974; 
McKenna, 1999; Carro-Juarez and Rodriguez-Manzo, 2007) is thought to control ejaculation by 
closely coordinating sympathetic, parasympathetic, and motor components to initiate emission 
and expulsion (Coolen et al., 2004; Allard et al., 2005; Coolen, 2005; Staudt et al., 2010; 
Kozyrev et al., 2012). In addition, it is postulated that the spinal ejaculation generator triggers 
ejaculation by integrating sensory inputs conveyed by the dorsal penile nerve (DPN), the sensory 
branch of the pudendal nerve, during copulation with autonomic and motor outflow. The spinal 
ejaculation generator consists of a set of interneurons in lamina 10 and the medial portion of 
lamina 7 of lumbar segments 3 and 4 (L3-4) that are integral in the control of ejaculation. These 
lumbar interneurons are referred to as lumbar spinothalamic (LSt) cells due to their anatomical 
position in the lumbar spinal cord and projections to the subparafascicular parvocellular nucleus 
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of the thalamus (Ju et al., 1987; McKenna, 1997; Coolen et al., 2003; Truitt et al., 2003). One 
proposed role of LSt cells is to transform sensory signals associated with the summation of 
sexual activity into motor or secretory outputs (Truitt and Coolen, 2002). LSt cells display neural 
activation specifically with ejaculation but not with other components of sexual behavior 
following copulation or electrical stimulation of the DPN in male rats (Sachs and Garinello, 
1979; Pescatori et al., 1993; McKenna, 1997; Coolen et al., 2004). Markers of neural activation 
in LSt cells with ejaculation include cFos (Truitt et al., 2003) and phosphorylated extracellular 
signal-regulated kinases 1 and 2 (pERK) (Staudt et al., 2010) and ejaculation is triggered through 
activation of the mitogen activated protein (MAP) kinase pathway (Staudt et al., 2010) following 
mating in intact animals or DPN stimulation in anesthetized and spinalized male rats.  
Furthermore, LSt cells have axonal projections to LSt target regions (Newton, 1993; 
Allard et al., 2005; Xu et al., 2006) including preganglionic sympathetic, parasympathetic and 
motor neurons in the thoracolumbar and lumbosacral spinal cord (Newton, 1993; McKenna, 
1997; Sakamoto et al., 2008). LSt cells express several neuropeptides including galanin, 
cholecystokinin, gastrin releasing peptide (GRP), and enkephalin (Ju et al., 1987; Nicholas et al., 
1999; Coolen et al., 2003; Truitt et al., 2003; Sakamoto et al., 2008). Thus, we hypothesize that 
these neuropeptides act in the LSt target areas to modulate ejaculatory reflexes. Indeed, our 
laboratory has recently revealed a critical role for GRP in the control of ejaculation in male rats 
(Kozyrev et al., 2012). Intrathecal infusions of GRP antagonist RC-3095 completely abolished 
ejaculatory reflexes while intrathecal infusion of GRP agonist GRP2029 triggered ejaculatory 
reflexes in 43-66 % of animals and facilitated ejaculatory reflexes in response to subthreshold 
frequencies (5-10 Hz) of DPN stimulation in 100 % of male rats (Kozyrev et al., 2012). In the 
current study we test if the opioid peptide enkephalin is critical for regulation of ejaculation. 
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A recent study has also identified a critical role for opioids in the control of ejaculatory 
reflexes in male rats (Carro-Juarez and Rodriguez-Manzo, 2009). Specifically, it was reported 
that intravenous injections of the opioid agonist morphine blocked ejaculatory reflexes in male 
rats and that this effect was reversed by systemic pretreatment with the opioid antagonist 
naloxone (Carro-Juarez and Rodriguez-Manzo, 2009). Furthermore, intravenous naloxone 
induced the genital ejaculatory motor pattern (Carro-Juarez and Rodriguez-Manzo, 2009). From 
these results, the authors concluded that endogenous opioids regulate the activity of the spinal 
ejaculation generator by exerting inhibitory effects.  However, the non-specific nature of the 
opioid agonist and antagonist used in this study as well as the intravenous mode of drug delivery 
constitute significant confounds in the interpretation of the results. Enkephalin, which is 
expressed by LSt cells and axons (Nicholas et al., 1999), is an endogenous ligand for both mu 
(MOR) and delta opioid receptors (DOR) (Cesselin, 1995), and can thus trigger ejaculation by 
acting on MOR and/or DOR in LSt target regions. Hence, the purpose of the present study was to 
investigate the individual contributions of MOR and DOR on ejaculatory reflexes induced by 
electrical stimulation of the DPN in anesthetized and spinalized male rats. Stimulation of the 
DPN in anesthetized and spinalized animals is a physiologically relevant model (Giuliano et al., 
2010), reliably inducing ejaculation in all mammals, including rodents (Pescatori et al., 1993), 
primates (Herbert, 1973), and men (Wieder et al., 2000).  First, it was tested whether enkephalin 
is required for ejaculatory reflexes in male rats using intrathecal delivery of MOR and DOR 
antagonists during simultaneous recordings of seminal vesicle (SV) pressure, a marker of 
emission, and rhythmic contractions of the BCM, a marker of expulsion in anesthetized and 
spinalized male rats. Next, it was tested whether enkephalin is sufficient to trigger ejaculation in 
male rats in the absence of DPN stimulation or following subthreshold levels of DPN stimulation 
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(5-10 Hz) that do not trigger ejaculatory reflexes in male rats in control conditions (Kozyrev et 
al., 2012) and intrathecal infusions of specific MOR and DOR agonists in the lumbosacral spinal 
cord during recordings of SV pressure and BCM contractions.  
 
3.2 Materials and Methods 
 
3.2.1 Animals 
 
Adult male Sprague Dawley rats (225-250 grams) were acquired from Charles River 
(Wilmington, MA, USA) and pair-housed in standard housing cages on a 12-hour light/dark 
cycle with lights off at 9 pm. Food and water were available ad libitum. All procedures were 
approved by the University Committee on Use and Care of Animals at the University of 
Michigan and conformed to the guidelines outlined by the National Institutes of Health. 
 
3.2.2 Experimental Designs 
 
3.2.2.1 Surgical procedures 
 
Male rats were anesthetized with urethane (1.5 g/kg, i.p.) and a laminectomy was carried out 
between the sixth and the eighth thoracic spinal segments. A complete transaction of the spinal 
cord was performed at the seventh thoracic spinal segment. Subsequently, animals were prepared 
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for electromyographic (EMG) recordings of bulbocavernosus muscle (BCM) bursting and 
seminal vesicle pressure (SVP); indicators of expulsion and emission components of ejaculations 
respectively (Pescatori et al., 1993; Clement et al., 2008). The BCM and the dorsal penile nerve 
(DPN) were surgically exposed and the surrounding connective tissue was removed. Silver 
recording electrodes, connected to the PowerLab/7SP Data Acquisition System (AD Instruments, 
Inc., Colorado Springs, CO, USA) were placed bilaterally into the BCM and a ground electrode 
was inserted into the muscle of the right thigh. In a subset of animals, the right seminal vesicle 
was exposed by coeliotomy and a pressure catheter (AD Instruments Inc., model number: SPR-
671(1.4 F, Single, Straight, 15 cm, Ny) connected to a catheter interface cable (AD Instruments 
Inc., model number: AEC-IOD) and attached to a Bridge AMP (AD Instruments Inc.), was 
gently guided into the lumen of the SV and fixed in place. Finally, for stimulation of the DPN, a 
bipolar stimulating electrode connected to the SD9 Square Pulse Stimulator (Grass Technologies, 
West Warwick, RI, USA) was arranged directly above the DPN. 2-4 Hours prior to any of the 
experiments, the DPN was stimulated (4 V at 60 Hz square wave pulses of 1 ms duration, for 
total of 10 seconds) in order to verify the completeness of the spinal cord transection. These 
established stimulation parameters consistently trigger rhythmic bursting of the BCM, indicative 
of the expulsion phase of ejaculation, in all animals (Staudt et al., 2010; Staudt, 2011; Kozyrev et 
al., 2012).  
 
3.2.2.2 Intrathecal infusion of opioid receptor antagonists  
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Pharmacological experiments began at least two hours following transection of the spinal cord in 
order to let the potential acute effects of spinal cord transection to diminish. A minor incision 
was performed in the dura mater at the site of the laminectomy and a polyethylene catheter 
(Caly-Adams PE-10, Parsippany, NJ, USA) was guided into the subarachnoid space until the 
open end reached the mid-lumbar levels, such that saline or drug infused through the catheter 
would bathe the entire lumbosacral spinal cord. First, 10 µL of saline was delivered (at 10 
µl/minute rate) and BCM EMG activity was recorded for 25 minutes. Next, the DPN was 
stimulated at 30 Hz and 60 Hz (4 V, square wave pulses of 1 ms duration, for total of 10 
seconds) in a counterbalanced manner, with 5-minutes between the stimulations (testing trial 1; 
control trial). BCM EMG and SVP were recorded. An hour later, the procedure was performed 
again in the same animals, which were now administered a 10 µL infusion of opioid receptor 
antagonists, after which the DPN was stimulated at 30 Hz and 60 Hz in a counterbalanced 
manner, and BCM EMG activity and SVP were recorded (testing trial 2; drug trial). We 
previously established that repeated stimulations and infusions of saline did not affect BCM 
EMG bursting in response to or without DPN stimulation (Kozyrev et al., 2012), therefore all 
animals received drug treatment in testing trial 2 (drug trial). In experiment 1, one of two doses 
of the mu opioid receptor antagonist H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) 
0.3 nmol (N = 7) or 3 nmol (N = 8) were infused and BCM EMG was recorded. In experiment 2, 
the most effective dose of CTOP was administered, 3 nmol, and BCM EMG and SVP were 
recorded simultaneously (N = 6). In experiment 3, one of three doses of the delta opioid receptor 
antagonist H-Tyr-Tic-Phe-Phe-OH (TIPP), [Bachem Americas, Inc. Torrance, CA, USA], 0.4 
nmol (N = 6), 4 nmol (N = 7), or 40 nmol (N = 6) were infused and BCM EMG and SVP were 
recorded.  
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3.2.2.3 Intrathecal infusion of opioid receptor agonists  
 
Four separate groups of male rats was anesthetized, spinalized, and prepared as described above. 
In testing trial 1: control trial, all male rats received 10 µL intrathecal infusions of 0.9% saline (N 
= 30) and BCM EMG and SVP were recorded for 10 minutes after infusion. Next, the DPN was 
stimulated at 5 HZ, 10 HZ, 30 HZ and 60 HZ in a randomized and counterbalanced order, and 
BCM EMG and SVP were recorded for the duration of 90 seconds following stimulation (testing 
trial 1; control trial). We previously determined that repeated stimulation using these parameters 
did not affect BCM EMG (Kozyrev et al., 2012). One hour following the final DPN stimulation, 
the procedure was repeated in the same groups of animals, which now received 10 µL intrathecal 
infusions of one of two doses of mu opioid receptor agonist (D-Ala2, N-Me-Phe4, glycinol5) – 
Enkephalin [DAMGO 0.1 nmol, N = 7; 10 nmol, N = 8; (Bachem Americas, Inc. Torrance, CA, 
USA)] or one of two doses of the delta opioid receptor agonist [DAla2] Deltorphin II, 1.3 nmol, 
N = 8; 13 nmol, N = 8; [American Peptide Co, Sunnyvale, CA, USA] and BCM EMG and SVP 
were recorded for 10 minutes after infusion. Finally, the DPN was stimulated at 5, 10, 30, and 60 
HZ in a counterbalanced manner as described above and previously (testing trial 2; drug trial; 
(Kozyrev et al., 2012)).  
 
3.2.3 BCM EMG and SVP Analysis  
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BCM EMG and SVP recordings were analyzed using methods we previously described (Kozyrev 
et al., 2012). Briefly, data were analyzed for the 25 or 10 minutes following the infusion of the 
antagonist or agonist, respectively. In addition, EMG and SVP were analyzed for 90 seconds 
following each DPN stimulation, which is the time span of a characteristic DPN-stimulation 
induced ejaculatory reflex in control male rats (Staudt et al., 2010; Staudt, 2011; Kozyrev et al., 
2012). The numbers of events, bursts, and SVP increases were analyzed (Kozyrev et al., 2012) 
using LabChart 7.35 (AD Instruments Inc.). An event is defined as an increase in EMG above 
baseline; a burst is a cluster of EMG events (10 or more events) without return to baseline; and 
an increase in SVP is counted each time it occurs concurrently with BCM EMG activity.  These 
definitions were previously determined (Kozyrev et al., 2012).  For the antagonist experiments, 
the effects of antagonist treatments on the numbers of events, bursts and SVP increases were 
compared both within animals (within the same drug dose, between testing trial 1: control trial 
and testing trial 2: drug trial) and between groups (between different doses within testing trial 1 
or 2: drug trial), separately for the 30 and 60 Hz stimulations, using two-way repeated Anova 
(factors: Testing trial and Drug dose) and Holm-Sidak post hoc tests. For the agonist 
experiments, numbers of events, bursts and SVP increases were compared within animals 
(between testing trial 1: control trial and testing trial 2: drug trial) and between treatment groups 
(between different doses within testing trial 1 or 2: drug trial), separately for each stimulation 
setting (following infusion without stimulation, 5, 10, 30, 60 Hz), using a two-way repeated 
Anova (factors: Testing trial and Drug Dose) and Holm-Sidak post hoc tests. A 95% confidence 
level was used for all tests.  
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3.2.4 Immunohistochemistry Experiments 
 
3.2.4.1 DPN Stimulation-induced pERK after intrathecal opioid receptor antagonist treatment 
 
To verify that mu opioid receptor antagonist CTOP and delta opioid receptor antagonist TIPP did 
not prevent the activation of LSt cells, expression of phosphorylation of ERK (pERK) in LSt 
cells was examined following stimulation of the DPN (Staudt et al., 2010; Kozyrev et al., 2012). 
Male rats (N = 9) were anesthetized and spinalized as described above. Two hours after 
spinalization, the DPN and BCM were exposed and vehicle (saline, N = 4) or drug (CTOP 3 
nmol; N =3, TIPP 40 nmol; N = 2, Bachem Americas, Inc. Torrance, CA, USA) were infused in 
a volume of 10 µL intrathecally as described above. Following a 25-minute infusion, the DPN 
was stimulated at 30 Hz and BCM EMG activity and SVP were recorded for 90 seconds. Five 
minutes following DPN stimulation, animals were perfused transcardially with 5 mL 0.9% saline 
solution and 500 mL of 4% paraformaldehyde in 0.1 M PB. Spinal cords were removed and 
postfixed for 1 hour in the same fixative and then transferred into a cryoprotective solution (20% 
sucrose in 0.1 PB with 0.01% sodium azide) until further processing for immunohistochemical 
visualization of pERK and galanin. The stimulation parameters and time of perfusion were 
previously shown to be optimal for detection of pERK expression in LSt cells (Staudt et al., 
2010; Kozyrev et al., 2012). Furthermore, previous experiments have shown that spinalization 
and the surgical exposure of the DPN and the BCM in the absence of electrical stimulation of the 
DPN do not induce pERK expression in LSt cells (Staudt et al., 2010), hence negative control 
groups were not included in this experiment. 
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3.2.5 Immunohistochemistry: Galanin/pERK dual fluorescence  
 
Spinal cords were cut using a freezing microtome (Thermo Fisher Scientific, Walldorf, 
Germany) into 12 parallel series of 35 um coronal sections in cryoprotectant solution (30% 
sucrose, 30% ethylene glycol in 0.1 M PB with 0.01% sodium azide) and stored at -20°C until 
further processing. Free floating sections of the lower thoracic, lumbar, and sacral spinal levels 
were thoroughly rinsed in 0.1 M saline buffered sodium phosphate (PBS) between incubations 
and blocked with 1% H2O2 for 10 minutes before incubation. All antibody incubations were 
performed in incubation solution containing 0.1% bovine serum albumin and 0.4% Triton X-100 
(BP151-500, Thermo Fisher Scientific Inc, Pittsburgh, PA, USA) in PBS at room temperature 
with gentle agitation. Spinal cord sections were incubated overnight with rabbit anti-pERK 
(1:1,000; overnight; Cell Signaling #26 L) and with biotinylated goat anti-rabbit for one hour 
(1:500; Vector Laboratories, Burlingame, CA, USA), avidin horseradish peroxidase complex 
(ABC-elite, 1:1,000 in PBS; 1 hour;Vector Laboratories), biotinylated tyramine (BT; 1:250 in 
PBS containing 1 uL/mL of 3% H2O2 for 10; NEL700/700A; PerkinElmer Life Sciences, 
Boston, MA, USA), and Alexa 488-conjugated streptavidin (1:100 in PBS, 30 minutes (Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA). Next, sections were incubated with 
rabbit anti-galanin (1:3,000; overnight, T-4334; Bachem, Torrance, CA, USA) and Alexa 555-
conjugated goat anti-rabbit for 30 minutes in PBS (1:100; Jackson Immuno-Research 
Laboratories) and mounted on plus charged slides, cover-slipped with gelvatol and stored in the 
dark at 4°C. For all immunohistochemistry procedures, the omission of primary antibodies 
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resulted in a complete loss of signal at specific wavelengths and all primary antibodies have been 
previously validated (Truitt et al., 2003; Staudt et al., 2010, 2011; Kozyrev et al., 2012) 
3.2.6 Data Analysis 
 
3.2.6.1 pERK Expression in LSt Cells 
 
pERK expression in LSt cells was analyzed on a DM5000B Leica fluorescent microscope (Leica 
Microsystems, Wetzlar, Germany). Specifically, all lumbar cells expressing galanin-ir were 
analyzed for expression of pERK, as cytopplasmic galanin-ir is exclusively expressed in LSt 
cells. Data are expressed as the mean percentages of LSt cells that display pERK for each 
animal. The group means were calculated and compared between animals that received an 
infusion of CTOP (3 nmol) or TIPP (40 nmol) and saline-treated controls, using Student t-tests 
with 95% confidence levels.  
 
3.3 Results 
 
3.3.1 Mu Opioid Receptor Antagonist CTOP Suppressed Ejaculatory Reflexes 
 
Mu opioid receptor antagonist CTOP significantly decreased DPN stimulation-induced 
ejaculatory reflexes at both 30 and 60 Hz stimulation frequencies as reflected in the reduced 
numbers of BCM events, bursts, and SVP increases. There were main effects of testing trial on 
 the numbers of BCM events for both 30 Hz (F(1, 29) = 88.436; 
Hz stimulation frequencies (F(1, 29) = 62.013; 
revealed that animals treated with either dose of CTOP during
significantly decreased BCM events in response to 30 or 60 Hz DPN stimulation compared to 
their DPN stimulation induced BCM events following saline treatment in their first control trial 
(trial 1; 60 Hz: P <0.001 (0.3 nmol); 
<0.001 (3 nmol); Figure 11A). There were no significant differences between the two groups 
treated with the lower and higher doses of CTOP for each stimulation frequency. 
 
 
P < 0.001; Figure 1
P < 0.001; Figure 11A). Post hoc analyses 
 the second, drug trial had 
P = 0.009 (3 nmol); 30 Hz: P = <0.001
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Figure 11 Effects of CTOP infusions on the numbers of BCM events and bursts induced by 
DPN stimulation in male rats. 
Quantitative analysis of BCM events (A) and bursts (B) in response to 30 and 60 Hz DPN 
stimulations following infusions of saline in trial 1 (control trial; white bars) or one of two doses 
of CTOP (0.4 or 4 nmol) in trial 2 (drug trial; filled bars). Data are presented as Mean SEM. * 
denotes significant differences from trial 1 within the same treatment group, while # indicates 
significant differences between treatment groups within the same testing trial. Representative 
EMG traces (90 seconds duration) following 60 Hz DPN stimulation (arrow) after an intrathecal 
infusion of saline (C: control trial) and CTOP (D: same animals as in C).  
 
Similarly, there were main effects of testing trial on the numbers of BCM bursts for both 
30 Hz (F(1, 29) = 108.732; P < 0.001; Figure 11B) and 60 Hz (F(1, 29) = 123.431; P < 0.001; 
Figure 11B) stimulation frequencies. In addition, there were significant interactions between 
testing trial and drug dosage for both stimulation frequencies (30Hz: F(1.29)=11.83;  P = 0.023; 
60 Hz: F(1,29) = 23.87; P = 0.016). CTOP during trial 2 (drug trial) significantly reduced BCM 
bursts compared to trial 1 (control trial) with saline treatment (30 Hz: P < 0.001 [0.3 nmol], 30 
Hz: P < 0.001 [3 nmol], 60 Hz: P < 0.001 [0.3 nmol] 60 Hz: P < 0.001 [3 nmol]; Figure 11B, C, 
D). There was an effect of dose on the numbers of BCM bursts in testing trial 2: drug trial. 
Specifically, there were significantly fewer BCM bursts following the higher dose compared to 
the lower dose of CTOP (30 Hz: P = 0.003 [3 nmol]; Figure 11B, 60 Hz: P = 0.006 [3 nmol]; 
Figure 11B).  Finally, during the first trial, there were no significant differences between groups 
in the numbers of BCM events or bursts.   
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In a separate group of males, CTOP (3 nmol) also severely impaired the emission 
component of ejaculation as indicated by significantly decreased numbers of SVP increases 
(Figure 12). There were main effects of testing trial on the numbers of SVP increases (F(1, 23) = 
120.143; P < 0.001; Figure 12C, D, E), as well as BCM events (F(1, 23) = 513.688; P < 0.001; 
Figure 12A, D, E), and BCM bursts (F(1, 23) = 118.433; P < 0.001; Figure 12B, D, E). Post hoc 
analyses revealed that CTOP (3 nmol) in trial 2 (drug trial), male rats displayed significantly 
fewer numbers of SVP increases, BCM events and bursts compared to control trial 1, for both 30 
Hz (events: P < 0.001; bursts: P < 0.001; SVP: P < 0.001; Figure 12A-E) and 60 Hz (events: P 
< 0.001; bursts: P < 0.001; SVP: P < 0.001; Figure 12A-E). Overall, these results confirm the 
hypothesis that intrathecal CTOP suppresses both the emission and expulsion components of 
ejaculation and that activation of mu opioid receptors in the lumbosacral spinal cord is required 
for ejaculatory reflexes in male rats.  
 Figure 12 Effects of CTOP on the numbers of BCM bursts and SVP increases induced by 
DPN stimulation in male rats. 
Quantitative analyses of BCM events 
and 60 Hz DPN stimulation following infusions of saline in trial 1 (control trial; white bars) or 
CTOP (4 nmol) in trial 2 (drug trial; filled bars). Data are presented as Mean SEM. * denotes 
significant differences from trial 1 (control
duration following 60 Hz DPN stimulation (arrow) after an intrathecal infusion of saline 
control trial) and CTOP (E same animal
 
(A) bursts, (B) and SVP increases (C) in response to 30 
 trial). EMG and concurrent SVP traces of 90 seconds 
 as in D).  
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3.3.2 Delta Opioid Receptor Antagonist TIPP Suppressed Ejaculatory Reflexes 
 
Delta opioid receptor antagonist TIPP significantly decreased DPN stimulation-induced 
ejaculatory reflexes at both 30 and 60 Hz stimulation frequencies as reflected in the reduced 
numbers of BCM events, BCM bursts, and SVP increases. There were main effects of testing 
trial on the numbers of BCM events for both 30 Hz (F(1,37) = 20.131; P < 0.001; Figure 13A) 
and 60 Hz stimulation frequencies (F(1, 37) = 26.666; P < 0.001; Figure 13A), main effect of 
drug dosage for 60 Hz (F(2,37)=6.18; P = 0.01) and significant interactions between testing trial 
and drug dosage for both 30 and 60 Hz (30 Hz: (F(2,37) = 5.861; P = 0.012; 60 Hz (F(2,37) = 
4.349; P = 0.031). Animals treated with the higher (4 nmol) and highest (40 nmol) but not the 
lower (0.4 nmol) dose of TIPP during the second, drug trial had significantly decreased BCM 
events in response to 30 Hz (P = 0.012: 4 nmol; P = <0.001: 40 nmol; Figure 13A) and 60 Hz  
(60 Hz: P = 0.014, 4 nmol; P <0.001, 40 nmol; Figure 13A) stimulation frequencies compared to 
saline treatment in trial 1 (control trial). In addition, there was an effect of dosage, as animals 
treated with the highest dose of TIPP (40 nmol) in the second trial (drug trial) displayed 
significantly fewer BCM events compared to those treated with the lower dose of TIPP (0.4 
nmol) for both the 30 Hz (P = 0.004, 40 nmol; Figure 13A) and 60 Hz (P < 0.001, 40 nmol; 
Figure 13A) stimulation frequencies and compared to animals treated with the middle dose of 
TIPP (4 nmol) in response to the 60 Hz (P = 0.003, 4 nmol; Figure 13A) stimulation (with a 
trend for the 30 Hz (P = 0.075, 4 nmol; Figure 13A)).  
Similarly, numbers of BCM bursts were reduced for both 30 Hz (F(1, 37) = 23.209; P < 
0.001; Figure 13B) and 60 Hz (F(1, 37) = 21.298; P < 0.001; Figure 13B) stimulation 
frequencies. Males treated with the middle (4 nmol) and the highest (40 nmol) but not the lower 
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(0.4 nmol) dose of TIPP during trial 2 (drug trial) had significantly fewer BCM bursts compared 
to trial 1 (control trial) with saline treatment (30 Hz: P = 0.004 [4 nmol]; Figure 13B, 30 Hz: P < 
0.001 [40 nmol]; Figure 13B, 60 Hz: P = 0.018 [4 nmol]; Figure 13B, 60 Hz: P < 0.001 [40 
nmol]; Figure 13B, D, E).  
Finally, TIPP reduced SVP increases and there were main effects of testing trial for both 
30 Hz (F(1, 37) = 19.041; P < 0.001; Figure 13C) and 60 Hz (F(1, 37) = 9.059; P = 0.008; Figure 
13C) stimulation frequencies. Males treated with the highest (40 nmol) but not the middle (4 
nmol) or lower (0.4 nmol) doses of TIPP during trial 2 (drug trial) had significantly fewer SVP 
increases compared to trial 1 (control trial) with saline treatment (30 Hz: P < 0.001 [40 nmol], 60 
Hz: P = 0.002 [40 nmol]; Figure 13C, D, E).  
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Figure 13 Effects of TIPP infusions on the numbers of BCM events, bursts and SVP 
increases triggered by DPN stimulation in male rats 
Quantitative analyses of BCM events (A), bursts (B) and SVP increases (C) in response to 30 
and 60 Hz DPN stimulation following infusions of saline in trial 1 (control trial; white bars) or 
one of three doses of TIPP (0.4, 4 or 40 nmol) in trial 2 (drug trial; filled bars). Data are 
presented as Mean SEM. * denotes significant differences from trial 1 within the same treatment 
group, while # indicates significant differences between treatment groups within the same testing 
trial. EMG traces of 90 seconds duration following 60 Hz DPN stimulation (arrow) after an 
intrathecal infusion of saline (D: control trial) and TIPP (E: same animal as in C).  
There were no significant differences for any of the parameters between the two groups 
of animals during trial 1 (control trial) when both groups received saline, indicating that group 
differences in trial 2 were caused by drug treatment.  
 
3.3.3 CTOP and TIPP did not affect DPN Stimulation-Induced pERK in LSt Cells 
In order to test that mu opioid receptor antagonist CTOP and delta opioid receptor antagonist 
TIPP suppressed BCM bursting and SV pressure via actions in LSt target areas rather than by 
preventing activation of LSt cells, DPN stimulation-induced activation of LSt cells was 
examined. In control treated males, DPN stimulation induced pERK in 95.4 ± 2.7 % of LSt cells, 
as reported previously (Staudt et al., 2010, 2011; Kozyrev et al., 2012). Neither CTOP nor TIPP 
infusions prior to DPN stimulation affected LSt activation (CTOP: 96.5 ± 3.5 % (Figure 14); 
TIPP: 100 ± 0 % of LSt cells).  
82 
 
 
Figure 14 CTOP infusions did not prevent the activation of LSt cells induced by DPN 
stimulation in male rats. 
Confocal images (1 µm optical sections) demonstating pERK expression in LSt cells induced by 
DPN stimulation following infusions of saline (A) and the mu opioid receptor antagonist CTOP 
(B). The pattern of pERK labeling is characteristic of all CTOP and saline-treated animals. Scale 
bar indicates 20 µm.  
 
3.3.4 Mu Opioid Receptor Agonist DAMGO Triggered and Facilitated Ejaculatory Reflex  
The mu opioid receptor agonist DAMGO triggered BCM events, bursts and SVP 
increases in the absence of DPN stimulation. In addition, DAMGO dose-dependently facilitated 
BCM events, bursts and SVP increases induced by subthreshold levels of DPN stimulation (5-10 
Hz). For the numbers of BCM events, there were main effects of testing trial for all stimulation 
frequencies (Infusion (0 Hz: (F(1, 29) = 6.400; P = 0.025); 5 Hz: (F(1, 29) = 11.407; P = 0.005); 
10 Hz: (F(1, 29) = 41.312; P < 0.001); 30 Hz (F(1, 29) = 42.443; P < 0.001); and 60 Hz (F(1, 29) 
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= 73.256; P < 0.001); Figure 15A). Moreover, there were effects of drug dosage (5 Hz: (F(1, 29) 
= 8.637; P = 0.012), 10 Hz: (F(1, 29) = 29.005; P < 0.001) and 30 Hz (F(1, 29) = 4.763; P = 
0.048) DAMGO-induced BCM events in the absence of DPN stimulation, but only following the 
higher dose (10 nmol) and in 100% of males (Infusion: P = 0.009 compared to saline in trail 1; P 
= 0.024 compared to lower dosage in trial 2; Figure 15A). DAMGO treatment also induced 
BCM events following subthreshold DPN stimulation; but this effect was only observed with the 
lower dosage (0.1 nmol) and not the higher dose (10 nmol) (5-10 Hz: P < 0.001; compared to 
saline treatment in trial 1; 5-10 Hz: P < 0.001 compared to higher dosage in trial 2; Figure 15A). 
In contrast, DAMGO reduced numbers of BCM events following 30 and 60 Hz DPN stimulation 
frequencies, which reliably triggered BCM activity following saline in trial 1 (Figure 15A; 30Hz: 
P < 0.001, 10 nmol compared to saline in trial 1 and compared to lower dosage in trial 2; 60 Hz: 
P < 0.001, 10 nmol; P < 0.001, 0.1 nmol; compared to saline in trial 1).  
 Figure 15 Effects of DAMGO infusions on the numbers of BCM events, bursts and
increases in male rats. 
Quantitative analyses of BCM events 
infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation following intrathecal infusions of 
saline in trial 1 (control trial; white bars) or one of two doses of DAMGO (0.1 or 10 nmol) in 
trial 2 (drug trial; filled bars). Data are presented a
infusions, 5, and 10 Hz, as these stimulation frequencies do not trigger BCM events, bursts, nor 
SVP increases in control conditions. * denotes significant differences from trial 1 within the 
(A), bursts (B) and SVP increases (C)
s Mean SEM. Note absence of white bars for 
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 SVP 
 in response to 
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same treatment group, while # indicates significant differences between treatment groups within 
the same testing trial. Representative EMG traces (180 seconds duration) following an 
intrathecal infusion of saline (D: control trial) and DAMGO (E: 10 nmol: Same animals as in 
D) in the absence of DPN stimulation. EMG and concurrent SVP traces (90 seconds duration) 
following 10 Hz DPN stimulation (arrow) after an intrathecal infusion of saline (F: control trial) 
and DAMGO (G: 0.1 nmol: same animal as in F).  
 
The effects of DAMGO on BCM bursts were nearly identical to those described above 
for BCM events with main effects of testing trial and drug dosage for all stimulation frequencies 
except 30 Hz (Figure 15B; Testing trial: Infusion, 0 Hz: (F(1, 29) = 10.726; P = 0.006; 5 Hz: 
(F(1, 29) = 16.136; P = 0.001; 10 Hz: (F(1, 29) = 80.755; P < 0.001; and 60 Hz (F(1, 29) = 
78.692; P < 0.001); Drug dosage:  and main effects of drug dosages: Infusion: F(1, 29) = 4.960; 
P = 0.044; 5 Hz: (F(1, 29) = 11.152; P = 0.005; 10 Hz: (F(1, 29) = 69.792; P < 0.001; and 60 Hz 
(F(1, 29) = 8.074; P = 0.014). Post hoc tests showed that DAMGO induced BCM bursts in the 
absence of DPN stimulation in males treated with the higher dose (10 nmol) but not the lower 
dose (0.1 nmol; Infusion: P = 0.001; compared to saline in trial 1; P = 0.001 compared to lower 
dosage in trail 2). DAMGO also facilitated BCM bursts following subthreshold DPN 
stimulations, but only with the lower (0.1 nmol) and not the higher (10 nmol) dose (5 Hz: P < 
0.001; 10 Hz P < 0.001; compared to saline in trial 1 or higher dose in trial 2). DAMGO reduced 
numbers of BCM bursts following 60 Hz DPN stimulation (lower dose (0.1 nmol): P < 0.001 
compared to saline in trial 1; higher dose (10 nmol): P < 0.001 compared to saline in trial 1 and 
P = 0.014 compared to lower dose in trial 2).  
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Finally, effects of DAMGO on SVP increases mirrored those on BCM activity (Figure 
15C). There were main effects of testing trial (Infusion (0 Hz: (F(1, 27) = 8.168; P = 0.014; 5 
Hz: (F(1, 27) = 28.106; P < 0.001; 10 Hz: (F(1, 27) = 63.157; P < 0.001; 30 Hz (F(1, 27) = 
6.866; P = 0.022; and 60 Hz (F(1, 27) = 16.471; P < 0.002; Figure 15C) and of drug dosage 
(Infusion: (F(1, 27) = 8.168; P = 0.014; 5 Hz: (F(1, 27) = 5.807; P = 0.033; 10 Hz: (F(1, 27) = 
31.383; P < 0.001; 30 Hz:(F(1, 27) = 18.103; P = 0.001; and 60 Hz:(F(1, 27) = 9.874; P = 
0.008). DAMGO infusions alone, in the absence of DPN stimulation, caused increases in SVP in 
males treated with the higher dose (10 nmol) but not the lower dose (0.1 nmol) (Infusion: P < 
0.001; compared to saline in trial 1 or to the lower dose in trial 2).  Furthermore, DAMGO 
increased SVP following subthreshold DPN stimulation (5 Hz: P < 0.001, 0.1 nmol; P = 0.047, 
10 nmol ; 10 Hz: P < 0.001; 0.1 nmol) compared to saline treatment in trial 1. The lower dosage 
of DAMGO was significantly more effective in causing SVP increases than the higher dosage (5 
Hz: P < 0.001; 10 Hz: P < 0.001). Lastly, the higher dose of DAMGO (10 nmol) decreased SVP 
increases induced by threshold DPN stimulation (30 Hz (P < 0.001) and 60 Hz (P < 0.001) 
compared to saline in trial 1 or to the lower dose in trial 2).  
During trail 1, there were no significant differences in BCM events, bursts, or SVP 
increases between groups, indicating that the differences observed in trial 2 were due to the 
effects of DAMGO.   
 
3.3.5 Delta Opioid Receptor Agonist Deltorphin Facilitated Ejaculatory reflexes 
In contrast to the effects of DAMGO, Deltorphin did not induce BCM activity or SVP 
increases in the absence of DPN stimulation (Figure 16). However, deltorphin enhanced the 
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emission and expulsion components of the ejaculatory reflex following subthreshold DPN 
stimulation (Figure 16). There were main effects of testing trial on BCM events (5 Hz: (F(1, 31) 
= 33.286; P < 0.001; 10 Hz: (F(1, 31) = 56.543; P < 0.001; 30 Hz (F(1, 31) = 6.059; P = 0.027; 
60 Hz (F(1, 31) = 5.710; P < 0.031; Figure 16A), BCM bursts (5 Hz: (F(1, 31) = 121.00; P < 
0.001; 10 Hz: (F(1, 31) = 108.432; P < 0.001; 60 Hz (F(1, 31) = 14.608; P < 0.002; Figure 16B), 
and SVP increases (5 Hz: (F(1, 31) = 52.417; P < 0.001; 10 Hz: (F(1, 31) = 54.000; P < 0.001; 
and 60 Hz (F(1, 31) = 8.590; P = 0.011; Figure 16C), and a significant interaction between 
testing trial and drug dosage on BCM bursts for 60 Hz (F(1, 31) = 5.020; P = 0.042) stimulation. 
Deltorphin II (1.3 nmol or 13 nmol) significantly increased numbers of BCM events, burst and 
SVP increases following 5 Hz (events: 1.3 nmol: P < 0.001; 13 nmol: P = 0.006; bursts: 1.3 
nmol: P < 0.001; 13 nmol: P < 0.001; SVP: 1.3 nmol: P < 0.001; 13 nmol: P < 0.001; Figure 16 
A-E) and 10 Hz (events: 1.3 nmol: P < 0.001; 13 nmol: P < 0.001; bursts: 1.3 nmol: P < 0.001; 
13 nmol: P < 0.001; SVP: 1.3 nmol: P < 0.001; 13 nmol: P < 0.001; Figure 16 C ) stimulation 
frequencies. Deltorphin did also slightly increase BCM events following 30 Hz, but only after 
the lower dosage, and without effects on BCM bursts or SVP increases   and 60 Hz stimulation 
frequencies (P = 0.012). Finally, the higher dose of deltorphin (13 nmol) reduced BCM activity 
and SVP increases following 60 Hz DPN stimulation (events: P = 0.011; bursts: P < 0.001; SVP 
increases: P = 0.011) compared to saline treatment in trial 1. As noted for each of the 
experiments presented above, there were again no differences in BCM or SVP parameters 
between groups during the saline control trial 1. 
 Figure 16 Effects of Deltorphin II on the numbers of BCM events, bursts and SVP 
increases in male rats. 
Quantitative analyses of BCM events 
Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation after intrathecal infusions of saline in trial 1 
(control trial; white bar) or deltorphin II (1.3 or 13
are presented as Mean SEM. Note absence of white bars for infusions, 5, and 10 Hz, as these 
stimulation frequencies do not trigger BCM events, bursts, nor SVP increases in control 
conditions.* denotes significant differences from trial 1 (control trial), while # indicates 
significant differences from lower dosage within the same testing trial. EMG and SVP traces (90 
seconds duration) following 5 Hz DPN stimulation (arrow) after an intrathecal infusion of sal
(D: control trial) and deltorphin II 
(A) bursts (B) and SVP increases (C) following infusion, 5 
 nmol) in trial 2 (drug trial; filled bars). Data 
(E: same animal as in D).  
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3.4 Discussion 
 
The results of these experiments support the hypothesis that enkephalin plays a critical role in the 
control of ejaculation by acting on mu and delta opioid receptors in LSt target areas in the 
lumbosacral spinal cord. Antagonist studies showed that activation of either MOR or DOR is 
critical for the emission and expulsion phases of ejaculation in response to sensory stimulation in 
male rats. In addition, activation of either MOR or DOR by agonist administration at lower 
dosages facilitated both the emission and expulsion phases of ejaculation following sub- 
threshold sensory stimulation. Finally, stimulation of MOR, but not DOR was sufficient to 
trigger ejaculatory reflexes in the absence of sensory stimulation in a large subset (75 %) of male 
rats.  
Together, these findings demonstrate that endogenous activation of MOR or DOR plays a 
facilitative role in the control of ejaculation. However, infusions of higher dosages receptor 
agonists for either the MOR or DOR disrupted ejaculation. This finding is in conformity with 
previous studies which showed that systemic and intravenous morphine exerts inhibitory effects 
on ejaculatory behavior (Myers and Baum, 1979; Szechtman et al., 1981; Wiesenfeld-Hallin and 
Sodersten, 1984) and reflexes in male rats (Myers and Baum, 1979; Carro-Juarez and Rodriguez-
Manzo, 2009). The effects of morphine have been proposed to be partially mediated via actions 
on peripheral tissues (Agmo et al., 1992). The current findings demonstrate that the inhibitory 
effects of high doses of opioid receptor agonists are mediated via central actions within the 
lumbosacral spinal cord. Noteworthy, our previous studies showed similar inhibitory effects of 
higher doses of GRP agonists on ejaculatory reflexes, while lower doses of GRP agonists 
triggered or facilitated ejaculation. Therefore, it is possible that high doses of GRP or opioid 
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receptor ligands cause mechanisms of desensitization of the G-protein coupled receptors at the 
LST target sites (Wess, 1997); thereby preventing the ability of DPN stimulation to trigger 
further action of endogenous ligands on receptor activation. It is also possible that infusion of the 
higher dose of mu and delta receptor agonists prevented DPN stimulation-induced ejaculatory 
reflexes by acting on the processing of the sensory inputs relayed via the DPN. The DPN is 
comprised of A δ and C-fibers (Johnson and Halata, 1991) but the specific contributions of A δ 
and C-fibers to ejaculation have not been investigated. Intrathecal infusions of opioid agonists 
inhibit A δ and C-fibers (Yeomans and Proudfit, 1996) raising the possibility that the disruption 
of ejaculatory reflexes to threshold sensory stimulation after the higher dose but not the lower 
dose of opioid agonists is mediated by inhibition of A δ and C-fibers in the dorsal horn of the 
lumbosacral spinal cord. In addition, A δ and C-fiber neurons have cell bodies in the dorsal root 
ganglia and express mu and delta opioid receptors (Ikoma et al., 2007) indicating that 
presynaptic inhibition of DPN synaptic transmission may have contributed to disruption of 
ejaculation. Finally, the primary excitatory neurotransmitter released from A δ and C-fibers is 
glutamate (Russell, 2007) which activates NMDA receptors in LSt cells to trigger ejaculatory 
reflexes in male rats (Staudt et al., 2011). Opioids in turn, can inhibit the release of glutamate 
(Russell, 2007) thereby blocking the activation of LSt cells in the lumbosacral spinal cord.  
One of the main findings of the current study was that infusion of the higher dose of 
DAMGO (10 nmol) was sufficient to trigger ejaculatory reflexes in the absence of sensory 
stimulation in a large proportion of male rats (75 %). Mu and delta opioid receptors are 
inhibitory G-protein coupled receptors (Russell, 2007); therefore, it is likely that the mechanism 
of action whereby endogenous opioids trigger or facilitate ejaculatory reflexes is by means of 
inhibition of inhibitory neurons in LSt target regions. However, at this time, the localization of 
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mu or delta opioid receptor in LSt target areas is unknown. Future studies identifying the exact 
pre- or postsynaptic localization of these receptors are critical to elucidate the mechanisms by 
which opioids influence ejaculatory function. For example, opioids can exert analgesia through 
inhibition of inhibitory GABA (γ – aminobuteric acid) neurons (Basbaum and Fields, 1984). 
Opioids inhibit GABA-mediated synaptic transmission by reducing the likelihood of presynaptic 
neurotransmitter release (Capogna et al., 1993; Vaughan et al., 1997) and this effect is mediated 
by voltage-dependent potassium conductance (Vaughan et al., 1997). Mu but not delta opioid 
receptors are specifically coupled to this potassium conductance (Vaughan et al., 1997) and the 
subsequent inhibition of GABAergic synaptic transmission; therefore we speculate that this may 
explain that intrathecal infusions of DAMGO, a selective MOR agonist, but not deltorphin, a 
selective DOR agonist, triggered ejaculatory reflexes in the absence of DPN stimulation. 
However, localization of presynaptic MOR on LSt axons has not been confirmed.   
 A second main finding of the current study was intrathecal infusions of mu or delta 
opioid antagonists CTOP or TIPP, severely disrupted ejaculatory reflex induced by DPN 
stimulation that reliably triggered ejaculation under control conditions. Conversely, facilitation 
of ejaculatory reflexes by infusions of mu or delta receptor agonists DAMGO or deltorphin, was 
observed after DPN stimulation at sub-threshold parameters that do not trigger ejaculation in 
control animals. Moreover, antagonist infusions did not disrupt activation of LSt cells, indicating 
that opioid antagonists acted on neurons downstream from LSt cells, rather than on inputs to LSt 
cells. These data support our hypothesis that endogenous opioids are primarily acting in LSt 
target areas to regulate ejaculatory reflexes. As mentioned above, a critical next step is detailed 
localization of the expression of mu and delta receptors within these LSt target areas.  The 
findings that both mu and delta receptors are involved in mediating ejaculation, indicates that 
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enkephalin may act on both receptors. Indeed, studies have shown that opioid receptors may 
form heterodimers (Gomes et al., 2000; Pfeiffer et al., 2003). In addition, activation of delta 
receptors influences subsequent activation of mu receptors. Indeed, mu and delta opioid 
receptors demonstrate a high degree of sequence homology and a common opioid receptor 
binding site within the helical transmembrane core has been proposed to account for the ligand-
directed signaling or biased agonism which occurs at opioid receptors (Pradhan et al., 2012).   
In addition to forming complex interaction between mu and delta receptors, opioid 
receptors also form complex interaction with other GPCR. We have previously shown that GRP 
regulates ejaculatory reflexes, showing findings similar to those described here. Thus, it is 
possible that a complicated interplay exists between the actions of co-expressed neuropeptides, 
including enkephalin and GRP (Kozyrev et al., 2012), in LSt cells and axons, such that co-
release of multiple neuropeptides may be required to induce ejaculation, but inhibition of each 
one alone may disrupt ejaculation.  
  In conclusion, these data support the hypothesis that activation of mu and delta opioid 
receptors in the lumbosacral spinal cord is required for sensory stimulation-induced emission and 
expulsion in anesthetized and spinalized male rats. The endogenous opioid ligand enkephalin 
may act through the activation of both mu and delta receptors in the outputs of the LSt cells. 
However, precise localization of mu and delta opioid receptor expression in the spinal 
ejaculation generator is currently unknown and needs to be elucidated in future studies. 
Furthermore, the roles of other neuropeptides expressed in the LSt cells and axons, including 
galanin and cholecystokinin, in the control of ejaculation remain an open question. Finally, these 
data indicate that mu and delta opioid antagonists may be useful for the treatment of ejaculatory 
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dysfunction, specifically to delay the onset of ejaculation in men afflicted with premature 
ejaculation.  
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Chapter 4: Activation of galanin and cholecystokinin 
receptors in the lumbosacral spinal cord is required for 
ejaculatory reflexes in male rats 
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4.1 Introduction 
 
Ejaculation refers to the forceful discharge of seminal contents from the urethral meatus 
(Marberger, 1974; McKenna, 1999) and consists of two phases: emission and expulsion. 
Emission refers to the secretion of seminal fluids from the prostate, seminal vesicles and vas 
deferens and these processes are under the control of parasympathetic preganglionic neurons in 
the sacral parasympathetic nucleus (SPN) in the upper sacral spinal cord (Hancock and Peveto, 
1979b; Nadelhaft and Booth, 1984; Coolen et al., 2004). In addition, emission involves the 
contraction of the ductus deferes and closure of the bladder neck, in order to prevent retrograde 
ejaculation, and these processes are under the control of sympathetic preganglionic neurons in 
the intermediolateral cell column (IML) and dorsal central autonomic nucleus (DCN) in the 
thoracolumbar spinal cord (Hancock and Peveto, 1979a; Nadelhaft and McKenna, 1987; Baron 
and Janig, 1991; Coolen et al., 2004). The expulsion component is characterized by rhythmic 
contractions of the striated perineal muscles, particularly the muscle of the bulbocavernosus 
(BCM), accompanied by the forceful expulsion of semen from the urethral meatus and is under 
sympathetic and motor control (Bohlen et al., 1980; Gerstenberg et al., 1990; Holmes et al., 
1991; Holmes and Sachs, 1991; Coolen et al., 2004). Motorneurons that control the rhythmic 
contraction of the BCM are located in the spinal nucleus of the bulbocavernosus (SNB) in the 
lumbosacral spinal cord in male rats (Schroder, 1980; McKenna and Nadelhaft, 1986; Ueyama et 
al., 1987). It well established that ejaculation is a spinal reflex and the essential components that 
control this reflex are localized to the lumbosacral spinal cord (Pescatori et al., 1993; McKenna, 
1999). This spinal control center is referred to as the spinal ejaculation generator (Marberger, 
1974; McKenna, 1999; Truitt and Coolen, 2002; Truitt et al., 2003; Staudt et al., 2010; Staudt, 
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2011; Staudt et al., 2011; Kozyrev et al., 2012; Kozyrev, 2013c) and contols ejaculation through 
a complex coordination of the sympathetic, parasympathetic, and motor components required to 
facilitate emission and expulsion (Coolen et al., 2004; Coolen, 2005; Staudt et al., 2010; Staudt, 
2011; Kozyrev et al., 2012; Kozyrev, 2013c) with sensory inputs during sexual activity. The 
latter are primarily relayed via the dorsal penile nerve (DPN) (Coolen et al., 2004; Coolen, 2005; 
Staudt et al., 2010; Staudt, 2011; Kozyrev et al., 2012; Kozyrev, 2013c) . The spinal ejaculation 
generator is composed of lumbar spinothalamic (LSt) cells, in lamina 10 and the medial portion 
of lamina 7 of lumbar segments 3 and 4, (L3-4). LSt cells are essential for ejaculation  
(McKenna, 1999; Truitt and Coolen, 2002) which they trigger via projections to DCN, IML, 
SPN, and SNB (Newton, 1993; McKenna, 1997; Truitt and Coolen, 2002; Coolen et al., 2004; 
Allard et al., 2005; Sakamoto et al., 2008; Sun et al., 2009; Young et al., 2009; Kozyrev et al., 
2012; Kozyrev, 2013c). The LSt cells express the neuropeptides galanin, cholecystokin (CCK), 
enkephalin and gastrin-releasing peptide (GRP) (Ju et al., 1987; Nicholas et al., 1999; Coolen et 
al., 2003; Sakamoto et al., 2008). It is hypothesized that LSt cells transform sensory signals 
conveyed by the DPN associated with the summation of coitus into motor or secretory outputs to 
trigger emission and expulsion (Truitt and Coolen, 2002). There is abundant evidence to support 
the notion that LSt cells are an integral component of the spinal ejaculation generator and are 
essential for ejaculation. Firstly, it has been shown that LSt cells express cFos (Truitt et al., 
2003) and phosphorylated extracellular signal-regulated kinases 1 and 2 (pERK) (Staudt et al., 
2010),  markers of  neural activation, exclusively with ejaculation but not with other components 
of male rat sexual behavior (Truitt et al., 2003). Secondly, acute transection of the spinal cord at 
the mid-thoracic spinal segments followed by electrical stimulation of the DPN triggers 
ejaculatory reflexes in male rats (Staudt et al., 2010; Staudt, 2011; Staudt et al., 2011; Kozyrev et 
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al., 2012; Kozyrev, 2013c). Thirdly, LSt cells display neural activation, specifically pERK 
(Staudt et al., 2010) and phosphorylated NMDA receptor subunit 1 (pNR1) (Staudt et al., 2011) 
following stimulation of the DPN, akin to mating animals. This neural activation is critical for 
ejaculation in male rats since blocking ERK and NMDA receptor activation with specific 
antagonists resulted in the absence of a coordinated pattern of BCM bursting, representative of 
ejaculation, after electrical stimulation of the DPN (Staudt et al., 2010, 2011). Similarly, targeted 
ablation of LSt cells completely abolished ejaculation but did not affect mounts or intromissions 
in male rats (Truitt and Coolen, 2002).  
LSt cells co-express several neuropeptides including gastrin releasing peptide (GRP), 
enkephalin, galanin and cholecystokin (CCK) (Ju et al., 1987; Nicholas et al., 1999; Coolen et 
al., 2003; Truitt et al., 2003; Sakamoto et al., 2008; Kozyrev et al., 2012). Therefore we 
hypothesized that these neuropeptides are released from LSt cell axon terminals onto receptors of 
preganglionic sympathetic (IML and CAN), parasympathetic (SPN) and motor (SNB) neurons to 
modulate ejaculatory reflexes. Indeed, our laboratory has recently revealed a critical role for the 
GRP and the mu and delta opioid receptors in the control of ejaculation in male rats (Kozyrev et 
al., 2012; Kozyrev, 2013c). It was discovered that intrathecal infusions of the GRP antagonist 
RC-3095, mu and delta opioid receptor antagonists CTOP and TIPP, respectively, severely 
disrupted ejaculatory reflexes in male rats. Conversely, intrathecal infusion of GRP agonist 
GRP2029 or the opioid receptor agonist DAMGO triggered ejaculatory reflexes in 43-66 % and 75 
% of male rats respectively. In addition, intrathecal infusion of GRP2029, the delta receptor 
agonist deltorphin II or DAMGO facilitated ejaculatory reflexes following subthreshold levels of 
DPN stimulation in 100 % of male rats (Kozyrev et al., 2012; Kozyrev, 2013c).  
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The purpose of the current study was to test the respective roles of galanin and CCK in the 
control of ejaculatory reflexes in male rats. It was hypothesized that LSt cells release galanin and 
CCK from their axon terminals onto their target regions, is critical for triggering the emission 
and expulsion components of ejaculation. The current study aimed to investigate the individual 
contributions of galanin and cholecystokin receptor activation in the control of emission and 
expulsion reflexes induced by electrical stimulation of the DPN in anesthetized and spinalized 
male rats, and simultaneously recordings of seminal vesicle (SV) pressure and concurrent 
rhythmic contractions of the BCM, markers of emission and expulsion respectively.  
 
4.2  Materials and Methods 
 
4.2.1 Animals 
 
For these experiments, adult male Sprague Dawley rats (225-250 grams) were obtained from 
Charles River (Wilmington, MA, USA) and housed in pairs in standard housing cages on a 
reverse 12-hour light/dark cycle with lights off at 9 a.m. Food and water were available ad 
libitum. All procedures were approved by the University Committee on Use and Care of Animals 
at the University of Michigan and conformed to the guidelines outlined by the National Institutes 
of Health. 
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4.2.2 Experimental Designs 
 
4.2.2.1 Intrathecal infusions of Galanin or Cholecystokinin antagonists  
 
Procedures were identical to our previously described studies(Brumovsky et al., 2006). Male rats 
were deeply anesthetized with urethane (1.5 g/kg, i.p.), a laminectomy was performed between 
the sixth and the eighth thoracic spinal segments and a complete transaction of the spinal cord 
was performed at the same spinal level. Next, the bulbocavernosus muscle (BCM) and the dorsal 
penile nerve (DPN) were surgically exposed and the surrounding connective tissue was removed. 
Subsequently, silver recording electrodes, attached to the PowerLab/7SP Data Acquisition 
System (AD Instruments, Inc., Colorado Springs, CO, USA) were inserted bilaterally into the 
BCM and a ground electrode was placed into the muscle of the right thigh in preparation for 
electromyographic (EMG) recordings. Additionally, the right seminal vesicle was exposed by 
coeliotomy for the purpose of measuring and recording seminal vesicle (SV) pressure, an marker 
of the emission component of ejaculation (Clement et al., 2008; Kozyrev et al., 2012; Kozyrev, 
2013c).  SV pressure (SVP) was measured with a pressure catheter (AD Instruments Inc., model 
number: SPR-671(1.4 F, Single, Straight, 15 cm, Ny) attached to a catheter interface cable (AD 
Instruments Inc., model number: AEC-IOD) and connected to a Bridge AMP (AD Instruments 
Inc.). The pressure catheter was carefully inserted into the lumen of the SV and secured in place 
prior to recording. In preparation for stimulation of the DPN, a bipolar stimulating electrode 
connected to the SD9 Square Pulse Stimulator (Grass Technologies, West Warwick, RI, USA) 
was positioned directly above the DPN. Initial stimulation of the DPN was performed 
immediately after spinal cord transection was in order to verify that the spinal cord transection is 
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complete, as evidenced by rhythmic bursting of the BCM and simultaneous SVP increases. 
Initial electrical stimulation of the DPN comprised square wave pulses of 1 ms duration, 4 V at 
60 Hz for 10 seconds. These established DPN stimulation parameters reliably trigger rhythmic 
bursting of the BCM, corresponding to the expulsion phase of ejaculation, in all saline-treated 
control animals (Staudt et al., 2010; Staudt, 2011; Staudt et al., 2011; Kozyrev et al., 2012; 
Kozyrev, 2013c). Pharmacological experiments began two hours after spinal cord transection in 
order to allow the acute effects of spinal cord transection to subside. Next, a small incision was 
made in the dura mater at the site of the laminectomy and a polyethylene catheter (Caly-Adams 
PE-10, Parsippany, NJ, USA) was carefully inserted into the subarachnoid space until the open 
end reached the 3rd lumbar-4th lumbar (L3-L4) spinal segments.  
In each animal, in trial 1, 10 µL of 0.9% sterile saline (or 0.9% sterile saline solution mixed with 
a small amount of dimethyl sulfoxide (DMSO) for animals subsequently treated with galantide) 
was infused through the polyethylene catheter to bath the entire lumbosacral spinal cord and 
BCM EMG activity was recorded for 25 minutes. Following the saline infusion, the DPN was 
stimulated at 30 Hz and 60 Hz in a counterbalanced order, with 5-minute rest periods between 
the stimulations (testing trial 1; control trial). Recordings of BCM EMG and SVP spanned a 
period of 90 seconds, corresponding to the duration of a representative ejaculatory reflex 
triggered by DPN stimulation in male rats (Staudt et al., 2010; Staudt, 2011; Kozyrev et al., 
2012; Kozyrev, 2013c). The entire procedure was repeated one hour later in the same animals, 
which now received a 10 µL infusion of one of two doses of the galanin antagonist galantide 
dissolved in a solution of 0.9 % sterile saline mixed with a small amount of DMSO (1 nmol, N = 
8; 10 nmol, N = 8; and N=6 in a second experiment [Phoenix Pharmaceuticals Inc. USA, 
Burlingame, CA, USA]), or one of two doses of the cholecystokinin (CCK) antagonist 
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proglumide (71 nmol, N = 6; 714 nmol, N = 6 [Sigma-Aldrich Corp. St. Louis, MO, USA]). 
After drug infusion, BCM EMG and SVP were recorded for 25 minutes, followed by stimulation 
of the DPN at 30 Hz and 60 Hz in a counterbalanced order, and concurrent recordings of BCM 
EMG and SVP (testing trial 2; drug trial). Our previous experiments have demonstrated that 
saline infusions or repeated DPN stimulations do not affect parameters of ejaculatory reflex 
(Kozyrev et al., 2012; Kozyrev, 2013c). 
 
4.2.2.2 Intrathecal infusions of galanin or cholecystokinin   
 
Three separate groups of male rats were anesthetized, spinalized, and prepared as described 
above. In testing trial 1: control trial, male rats received 10 µL intrathecal infusions of 0.9% 
saline (N = 20) or 0.9% saline mixed with DMSO (N = 8; CCK group) and BCM EMG and SVP 
were recorded for 10 minutes after infusion. Next, the DPN was stimulated at 5 HZ, 10 HZ, 30 
HZ and 60 HZ in a randomized and counterbalanced order, and BCM EMG and SVP were 
recorded for the duration of 90 seconds following stimulation (testing trial 1; control trial). One 
hour following the final DPN stimulation, the procedure was repeated in the same groups of 
animals, which now received 10 µL intrathecal infusions of one of two doses of galanin (0.16 
nmol, N = 6 and N = 7 in a second experiment; 0.32 nmol, N = 7 (Bachem Americas, Inc. 
Torrance, CA, USA)] or CCK dissolved in 0.9% sterile saline and DMSO solution [CCK (26-33) 
(sulfated), 4.35 nmol; N = 8] (Phoenix Pharmaceuticals Inc. USA, Burlingame, CA, USA) and 
BCM EMG and SVP were recorded for 10 minutes after infusion. Following each drug infusion, 
the DPN was stimulated at 5, 10, 30, and 60 HZ in a counterbalanced order as described 
102 
 
previously (testing trial 2 and 3; drug trials) (Kozyrev et al., 2012). Our previous studies have 
demonstrated that saline infusions or repeated DPN stimulations do not affect parameters of 
ejaculatory reflex (Kozyrev et al., 2012; Kozyrev, 2013c). 
 
4.2.3 BCM EMG and SVP Analysis  
 
Analyses were performed as described in or previous studies (Staudt et al., 2010; Kozyrev et al., 
2012; Kozyrev, 2013c). Analysis of BCM EMG and SVP recordings spanned 25 minutes or 10 
minutes after infusion of the antagonist or agonist, respectively, and 90 seconds after every DPN 
stimulation. The numbers of BCM events, bursts, and SVP increases were analyzed. The analysis 
of numbers of BCM events was carried out using LabChart 7.35 (AD Instruments Inc.), and all 
events that were above baseline activity were included in the analysis (Staudt et al., 2010; Staudt, 
2011; Staudt et al., 2011; Kozyrev et al., 2012; Kozyrev, 2013c). Additionally, the numbers of 
bursts and SVP increases were analyzed. The antagonist experiments were analyzed such that the 
effects of antagonist treatments on the numbers of events, bursts and SVP increases were 
compared within animals (within the same drug dose, between testing trial 1: control trial and 
testing trial 2: drug trial) and between groups (between different doses within testing trial 1: 
control trial and testing trial 2: drug trial), for the 30 and 60 Hz stimulations separately, using 
two-way repeated anova (factors: Testing trial and Drug dose) and Holm-Sidak post hoc tests. 
The galanin infusion experiments were analyzed such that the effects of neuropeptide treatment 
on the numbers of events, bursts and SVP increases were compared within animals (within the 
same drug dose, between testing trial 1: control trial and testing trial 2: drug trial) and between 
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treatment groups (separately for each stimulation setting: Infusion, 5 Hz, 10 Hz, 30 Hz, and 60 
Hz), and separately for each of the two testing trials, using a two-way repeated anova (factors: 
Testing trial and DPN stimulation) and Holm-Sidak post hoc tests. A 95% confidence level was 
utilized for all tests. The cholecystokinin experiment was analyzed using a two-way repeated 
anova and the effects of CCK treatment on the numbers of events, bursts and SVP increases were 
compared within testing trials (with the saline and drug trials) and between stimulation settings 
(Infusion, 5 Hz, 10 Hz, 30 Hz, and 60 Hz) as well as between the two testing trials within each 
stimulation setting using a two-way repeated anova (factors: Testing trial and DPN stimulation) 
and Holm-Sidak post hoc tests.  
 
4.2.4 Immunohistochemistry Experiments 
 
4.2.4.1 DPN Stimulation-induced pERK after intrathecal opioid receptor antagonist treatment 
 
To confirm that the galanin antagonist galantide and the CCK antagonist proglumide disrupted 
ejaculatory reflexes by acting on LSt target regions and not by preventing the activation of LSt 
cells, the expression of pERK in LSt cells was examined following intrathecal infusions of 
galantide or proglumide and stimulation of the DPN (Staudt et al., 2010; Kozyrev et al., 2012; 
Kozyrev, 2013c). Male rats (N = 9) were anesthetized and spinalized as described above. Two 
hours after spinalization, the DPN and BCM were exposed and galantide (10 nmol, N =4) or 
proglumide (714 nmol, N = 2) were infused in a volume of 10 µL intrathecally as described 
previously. Following a 25-minute infusion, the DPN was stimulated at 30 Hz and BCM EMG 
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and SVP were recorded for 90 seconds. Five minutes following DPN stimulation, animals were 
perfused transcardially with 5 mL 0.9% saline solution and 500 mL of 4% paraformaldehyde in 
0.1 M PB. Spinal cords were removed and postfixed for 1 hour in the same fixative and then 
transferred into a cryoprotective solution (20% sucrose in 0.1 PB with 0.01% sodium azide) until 
further processing for immunohistochemical visualization of pERK and galanin. The stimulation 
parameters and time of perfusion were previously shown to be optimal for detection of pERK 
expression in LSt cells (Staudt et al., 2010; Kozyrev et al., 2012; Kozyrev, 2013c). In addition, it 
was previously shown that intrathecal infusions of saline do not prevent DPN stimulation 
induced pERK experession in LSt cells (Kozyrev et al., 2012; Kozyrev, 2013c). Furthermore, 
previous experiments have shown that spinal cord transection and the surgical exposure of the 
DPN and the BCM without electrical stimulation of the DPN does not lead to pERK expression 
in LSt cells (Staudt et al., 2010), hence negative control groups were not included in this 
experiment. 
 
4.2.5 Immunohistochemistry: Galanin/pERK dual fluorescence  
 
Spinal cords were sliced with a freezing microtome (Thermo Fisher Scientific, Walldorf, 
Germany) into 12 parallel series of 35 um coronal sections, placed into a cryoprotectant solution 
(30% sucrose, 30% ethylene glycol in 0.1 M PB with 0.01% sodium azide) and stored at -20°C 
until further processing. Free floating sections of the lower thoracic, lumbar, and sacral spinal 
cord were thoroughly rinsed in 0.1 M saline buffered sodium phosphate (PBS) between 
incubations and blocked with 1% H2O2 for 10 minutes prior to incubation. All antibody 
incubations were performed in incubation solution containing 0.1% bovine serum albumin and 
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0.4% Triton X-100 (BP151-500, Thermo Fisher Scientific Inc, Pittsburgh, PA, USA) in PBS at 
room temperature with gentle agitation. Spinal cord sections were incubated overnight with 
rabbit anti-pERK (1:1,000; overnight; Cell Signaling #26 L) and with biotinylated goat anti-
rabbit for one hour (1:500; Vector Laboratories, Burlingame, CA, USA), avidin horseradish 
peroxidase complex (ABC-elite, 1:1,000 in PBS; 1 hour;Vector Laboratories), biotinylated 
tyramine (BT; 1:250 in PBS containing 1 uL/mL of 3% H2O2 for 10; NEL700/700A; 
PerkinElmer Life Sciences, Boston, MA, USA), and Alexa 488-conjugated streptavidin (1:100 in 
PBS, 30 minutes (Jackson ImmunoResearch Laboratories, West Grove, PA, USA). Next, 
sections were incubated with rabbit anti-galanin (1:3,000; overnight, T-4334; Bachem, Torrance, 
CA, USA) and Alexa 555-conjugated goat anti-rabbit for 30 minutes in PBS (1:100; Jackson 
Immuno-Research Laboratories) and mounted on plus charged slides, cover-slipped with 
gelvatol and stored in the dark at 4°C. For all immunohistochemistry procedures, the omission of 
primary antibodies resulted in a complete loss of signal at specific wavelengths and all primary 
antibodies have been previously characterized (Truitt et al., 2003; Staudt et al., 2010, 2011; 
Kozyrev et al., 2012; Kozyrev, 2013c).  
 
4.2.6 Data Analysis 
 
4.2.6.1  pERK Expression in LSt Cells 
 
pERK expression in LSt cells was analyzed using a DM5000B Leica fluorescent microscope 
(Leica Microsystems, Wetzlar, Germany). Essentially, all neurons in the lumbar spinal cord 
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expressing galanin-ir were analyzed for expression of pERK and percentages of galanin-ir cells 
co-expressing pERK were calculated for each animal. Differences between groups were analyzed 
using ANOVA and Holms-Sidak post hoc tests. 
 
4.3  Results 
 
4.3.1 Galantide Suppressed Ejaculatory Reflexes  
 
The galanin antagonist galantide significantly suppressed DPN stimulation-induced ejaculatory 
reflexes at both 30 and 60 Hz stimulation frequencies as evidenced in the reduced numbers of 
BCM events, and bursts. There were main effects of testing trial on the numbers of BCM events 
for both 30 Hz (F (1, 29) = 50.905; P < 0.001; Figure 16A) and 60 Hz stimulation frequencies (F 
(1, 29) = 30.213; P < 0.001; Figure 17A). Post hoc analyses revealed that animals treated with 
either dose of galantide during the second trial (drug trial) had significantly decreased BCM 
events in response to 30 and 60 Hz DPN stimulations compared to saline treatment in their first 
control trial (trial 1; 30 Hz: P = 0.003 (1 nmol); P < 0.001 (10 nmol); 60 Hz: P = 0.008 (1 nmol); 
P <0.001 (10 nmol); Figure 17A, C, D). In addition, animals treated with the higher dose of 
galantide during trial 2 displayed significantly fewer BCM events in response to 60 Hz (trial 1; P 
= 0.022 [10 nmol]) DPN stimulation frequency compared to saline treatment in trial 1 (Figure 17 
A, C, D). None of these effects were attributable to pre-existing group differences, as in control 
trial 1, when all animals received saline there were no significant differences in the numbers of 
107 
 
BCM events in response to either 30 or 60 Hz DPN stimulations between groups (control trial; 
Figure 17 A, C).  
The effects of galantide on BCM bursts paralleled the effects on BCM events. There were 
main effects of testing trial on the numbers of BCM bursts for both 30 Hz (F(1, 29) = 100.213; P 
< 0.001) and 60 Hz (F(1, 29) = 218.400; P < 0.001) stimulation frequencies (Figure 17 B). 
Specifically, male rats treated with either dose of galantide during trial 2 (drug trial) 
demonstrated significantly fewer BCM bursts compared to trial 1 (control trial) with saline 
treatment (trial 1; 30 Hz: P < 0.001 [1 nmol]; P < 0.001 [10 nmol]; 60 Hz: P < 0.001 [1 nmol]; P 
< 0.001 [10 nmol]; Figure 17 B, C, D). In addition, there were significant interactions between 
factors of testing trial and drug dosage on the number of BCM bursts for both 30 Hz (F(1, 29) = 
4.916; P = 0.045) and 60 Hz (F(1, 29) = 6.067; P = 0.029) stimulation frequencies. Post hoc 
analyses demonstrated that male rats treated with the higher dose of galantide during trial 2 (drug 
trial) had significantly fewer BCM bursts in response to 60 Hz (trial 2: P = 0.041 [10 nmol]) 
DPN stimulation frequency compared to trial 1 (Figure 17 B, C, D). There were no significant 
differences in the numbers of BCM bursts after 30Hz or 60 Hz DPN stimulation within testing 
trial 1, control trial, indicating that differences in dosage in trial 2 (drug trial) were due to the 
effects of galantide (Figure 17 B, C).  
 
  
 
 
Figure 17 Effects of galantide on numbers of BCM events and bursts in male rats.
Quantitative analyses and accompanying EMG traces of BCM events and bursts 
intrathecal infusions of galantide. Quantitative analysis of BCM events (
response to 30 and 60 Hz DPN stimulation following infusions of saline in trial 1 (control trial) 
or one of two doses of galantide (1 or 10 nmol) in tri
duration following 60 Hz DPN stimulation (arrow) after an intrathecal infusion of saline (
control trial) and galantide (D: same animals as in 
1 within the same treatment group, while # indicates significant differences between treatment 
groups within the same testing trial.
 
A) and bursts (
al 2 (drug trial). EMG traces of 90 seconds 
C). * denotes significant differences from trial 
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The effects of galantide on SVP increases, a marker of the emission component of 
ejaculation, was tested in a separate group of animals in which BCM EMG and SVP were 
recorded simultaneously following intrathecal infusion of the higher dose of galantide (10 nmol)  
(N = 6). The effects on BCM events and bursts were completely replicated, and moreover were 
paralleled by significant decreases in numbers of SVP increases. There were main effects of 
testing trial on the numbers of BCM events (F(1, 23) = 30.227; P =  0.003), BCM bursts (F(1, 
23) = 53.382; P < 0.001) and SVP increases (F(1, 23) = 110.401; P < 0.001). Post hoc analyses 
revealed that male rats treated with galantide in trial 2 showed significantly fewer numbers of 
BCM events, bursts and SVP increases for both 30 Hz (events: P = 0.004; bursts: P < 0.001 
(Figure 18A); SVP: P < 0.001; Figure 18B) and 60 Hz (events: P = 0.001; bursts: P < 
0.001(Figure 18A); SVP: P < 0.001; Figure 18B, C, D) stimulation frequencies compared to 
saline treatment in trial 1. Overall, these results confirm that intrathecal galantide suppresses 
both the emission and expulsion components of ejaculation, indicating that activation of galanin 
receptors in the lumbosacral spinal cord is required for ejaculatory reflexes in male rats.  
 Figure 18 Effects of galantide on the numbers of BCM bursts and SVP increases in male 
rats. 
Quantitative analyses and accompanying EMG traces of BCM bursts and SVP increases 
following intrathecal infusions of galantide. Quantitative analysis of BCM bursts (
increases (B) in response to 30 and 60 Hz DPN stimulation following infusions of saline in tria
1 (control trial) or galantide (10 nmol) in trial 2 (drug trial). EMG and concurrent SVP traces of 
90 seconds duration following 60 Hz DPN stimulation (arrow) after an intrathecal infusion of 
saline (C: control trial) and galantide (
from trial 1 (control trial). 
 
 
D: same animals as in C). * denotes significant differences 
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4.3.2 Proglumide Dose-Dependently Suppresses Ejaculatory Reflexes  
 
The CCK antagonist proglumide dose-dependently disrupted DPN stimulation-induced 
ejaculatory reflexes in response to 30 and 60 Hz stimulation frequencies as reflected in the 
reduced numbers of BCM events, bursts, and SVP increases. There were main effects of testing 
trial on the numbers of BCM events for both 30 Hz (F(1, 23) = 23.289; P < 0.001) and 60 Hz 
(F(1, 23) = 5.446; P = 0.042) stimulation frequencies. Post hoc analyses revealed that animals 
treated with the higher but not the lower dose of proglumide during the second trial (drug trial) 
had significantly decreased BCM events in response to 30 and 60 Hz DPN stimulation compared 
to saline treatment in the first control trial (30 Hz: P < 0.001 (714 nmol); 60 Hz: P = 0.020 (714 
nmol); Figure 19A).  
There was also a main effect of drug dosage on the numbers of BCM events following 60 
Hz DPN stimulation (F(1, 23) = 5.025; P = 0.049) and a significant interaction between factors 
of drug dosage and testing trial on the numbers of BCM events following 30 Hz DPN stimulation 
(F(1, 23) = 9.846; P = 0.011). Post hoc analyses revealed that male rats treated with the higher 
dose of proglumide (714 nmol) during trial 2 (drug trial) displayed significantly fewer BCM 
events following 30 Hz (P = 0.015) and 60 Hz DPN stimulation frequencies (P = 0.018) 
compared to animals that received the lower dose of proglumide (71 nmol); Figure 19A. There 
were no significant differences in the numbers of BCM events in response to 30 or 60 Hz DPN 
stimulation frequencies between the groups during trial 1 (control trial) when both groups of 
animals received infusions of saline (Figure 19A).   
 Figure 19 Effects of proglumide on the numbers of BCM events, bursts and SVP increases 
in male rats. 
Quantitative analyses and accompanying EMG traces of BCM events, bursts and SVP increases 
following intrathecal infusions of proglumide. Quantitative analysis of BCM events (A)
(B) and SVP increases (C) in response to 30 and 60 Hz DPN stimulation following infusio
saline in trial 1 (control trial) or one of two doses of proglumide (71 or 714 nmol) in trial 2 (drug 
trial). EMG traces of 90 seconds duration following 60 Hz DPN stimulation (arrow) after an 
intrathecal infusion of saline (D: control trial) and gal
significant differences from trial 1 within the same treatment group, while # indicates significant 
differences between treatment groups within the same testing trial.
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Similarly, there were main effects of testing trial on the numbers of BCM bursts for 60 
Hz (F(1, 23) = 6.680; P = 0.027) stimulation frequency, and for drug dosage on the numbers of 
BCM bursts for 30 Hz (F(1, 23) = 8.007; P = 0.018) DPN stimulation frequency. Post hoc 
analyses revealed that male rats that received infusions of the higher dose (714 nmol) of 
proglumide during testing trial 2 (drug trial) displayed significantly fewer BCM bursts following 
30 Hz (P = 0.022; Figure 19B) and 60 Hz (P = 0.014; Figure 19B, D, E) DPN stimulation 
frequencies. Furthermore, male rats treated with the higher dose (714 nmol) of proglumide 
showed a significant reduction in the numbers of BCM bursts following 30 Hz (P = 0.003) with 
a trend towards significance following 60 Hz (P = 0.062) DPN stimulation frequency compared 
to male rats treated with the lower dose of proglumide (71 nmol; Figure 19B). There were no 
significant differences between the groups in the numbers of BCM bursts following 30 or 60 Hz 
DPN stimulations during trial 1 (control trial; Figure 19B).  
In addition, intrathecal infusions of proglumide dose-dependently suppressed SVP 
increases. There were main effects of testing trial on the numbers of SVP increases following 30 
Hz (F(1, 23) = 10.565; P = 0.009) and 60 Hz (F(1, 23) =  6.288; P = 0.031) stimulation 
frequencies. Post hoc analyses demonstrated that the higher dose (714 nmol) of proglumide 
significantly reduced numbers of SVP increases following 30 Hz (P = 0.012; 714 nmol; Figure 
19C) and 60 Hz (P = 0.014; 714 nmol; Figure 19C) stimulation frequencies. Furthermore, there 
was an effect of dosage during trial 2 (drug trial) whereby animals receiving the higher dose of 
proglumide (714 nmol) displayed significantly fewer SVP increases in response to 30 Hz (P = 
0.039; Figure 19C) and 60 Hz (P = 0.021; Figure 19C, D, E) stimulation frequencies. Finally, 
there were no differences between groups during trial 1 (control trial; Figure 19C). 
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4.3.3 Galantide and Proglumide Did Not Prevent DPN Stimulation-Induced pERK in LSt 
Cells 
 
In order to test that the galanin antagonist galantide and the CCK antagonist proglumide 
suppressed BCM bursting and SV pressure by acting in LSt target areas instead of acting directly 
on LSt cells, DPN stimulation-induced neural activation of LSt cells was examined following 
intrathecal infusions of each antagonist. It has previously been shown that in control treated 
animals, DPN stimulation induced pERK in 97 ± 0.03 % of LSt cells (Kozyrev et al., 2012). 
Similarly, intrathecal infusions of galantide and proglumide did not prevent DPN stimulation-
induced activation of LSt cells. Indeed, DPN stimulation induced pERK in 94.05 ± 0.03% and 
87.93 ± 0.07 % of LSt cells in galantide (10 nmol) and proglumide (714 nmol) treated male rats, 
respectively. These results indicate that galantide and proglumide are primarily acting in LSt 
target regions to suppress the emission and expulsion components of ejaculation, and not directly 
on LSt cells.    
 
4.3.4 Galanin Facilitated BCM Events, Bursts and SVPs 
 
In control trial 1, it was confirmed that 30 and 60 Hz DPN stimulation triggered BCM 
events and burst, while saline infusion or DPN stimulation at 5 and 10 Hz did not trigger BCM 
activity. In Trial 2, galanin facilitated BCM events, bursts and SVP increases. There were main 
effects of testing trial on the numbers of BCM events for Infusion: (F(1, 25) = 17.937; P = 
0.001); 5 Hz: (F(1, 25) = 17.853; P = 0.001; 10 Hz: (F(1, 31) = 54.000; P < 0.001) stimulation 
 frequencies. Post hoc tests demonstrated that infusions of the lower dose of galanin, in the 
absence of DPN stimulation, during trial 2 (drug trial) increased number of BCM e
nmol P = 0.003; 0.3 nmol; P=0.051) compared to 
galanin facilitated BCM events after sub threshold DPN stimulation in male rats treated with 
either dose of galanin demonstrated significantly greater
Hz (0.15 nmol: P < 0.001; 0.3 nmol: 
effect of dosage for the 5 Hz stimulation frequency during trial 2 (drug trial). Specifically, 
animals treated with the higher dose
BCM events following 5 Hz DPN stimulation compared to animals treated with the lower dose 
of galanin (0.3 nmol: P = 0.014; Figure 20
 
trial 1 (control trial; Figure 20
 numbers of BCM events following 10 
P < 0.001; Figure 20A) DPN stimulation. There was an 
 of galanin demonstrated significantly greater numbers of 
A).  
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Figure 20 Effects of galanin on numbers of BCM events and bursts in male rats 
Quantitative analyses and accompanying EMG traces of BCM events and bursts following 
intrathecal infusions of galanin. Quantitative analysis of BCM events (A) and bursts (B) in 
response to infusion and DPN stimulation at 5 Hz, 10 Hz, 30 Hz and 60 Hz (counterbalanced) 
following infusions of saline in trial 1 (control trial) or one of two doses of galanin (0.15 or 0.3 
nmol) in trial 2 (drug trial). EMG traces of 90 seconds duration following 10 Hz DPN 
stimulation (arrow) after an intrathecal infusion of saline (C: control trial) and galanin (D: same 
animals as in C). * denotes significant differences from trial 1 within the same treatment group, 
while # indicates significant differences between treatment groups within the same testing trial. 
The effects of galanin on BCM bursts were similar to the effects on BCM events, except 
that galanin infusions in the absence of DPN stimulation did not trigger BCM bursting activity. 
However, galanin did facilitate BCM bursts induced by DPN stimulation. There were main 
effects of testing trial on the numbers of BCM bursts for 5 Hz: (F(1, 25) = 31.406; P < 0.001 and 
10 Hz: (F(1, 25) = 30.305; P < 0.001) stimulation frequencies. There were also main effects of 
drug dosage for 5 Hz (F(1, 25) = 17.453; P = 0.002; 10 Hz: (F(1, 25) = 16.183; P = 0.002) and 
60 Hz (F(1, 25) = 9.739; P = 0.010) stimulation frequencies. and significant interactions between 
the factors for 5 Hz (F(1, 25) = 17.453; P = 0.002; 10 Hz: (F(1, 25) = 16.183; P = 0.002 and 30 
Hz (F(2, 25) = 6.119; P = 0.018). Post hoc tests revealed that the higher dose (0.3 nmol) of 
galanin during trial 2 (drug trial) significantly increased numbers of BCM bursts following 5 Hz 
(P < 0.001), 10 Hz (P < 0.001), 30 Hz (P < 0.001), and 60 Hz (P=0.049) stimulation frequencies 
compared to trial 1 (control trial) (Figure 20B, C, D). Post hoc analyses demonstrated that male 
rats treated with the higher dose of galanin in trial 2 (drug trial: 0.3 nmol) had significantly more 
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BCM bursts compared to the lower dose of agalnin (0.15 nmol) (5 Hz: P < 0.001; 10 Hz: P < 
0.001; 30 Hz: P = 0.004; and 60 Hz: P = 0.006; Figure 20B).  
Effects of galanin (0.3 nmol) in SVP increases were tested in a separate group of male 
rats (N = 7) with simulatenous recordings of SVP and BCM EMG. In this group of animals, 
intrathecal infusions of galanin (0.3 nmol) facilitated both the emission and expulsion 
components of ejaculation as evidenced in the increased numbers of BCM events, bursts and 
SVP increases following subthreshold levels (5-10 Hz) of DPN stimulation. First, there were 
main effects of stimulation frequency on the numbers of BCM events (F (4, 69) = 36.451; P < 
0.001), bursts (F(4, 69) = 37.889; P < 0.001) and SVP increases (F(4, 69) = 18.603; P < 0.001). 
In saline-treated males, in trial 1 (saline trial), only 30 and 60 Hz DPN stimulation frequencies 
increased NCM events, bursts, and SVP increases as expected (all P < 0.001 compared to saline 
infusion) (Figure 21A, B). There were also significant interactions between main factors of 
testing trial and stimulation frequency on the numbers of BCM events (F (4, 69) = 11.633; P < 
0.001), bursts (F(4, 69) = 10.774; P < 0.001) and SVP increases (F(4, 69) = 8.779; P < 0.001).  
Post hoc analyses demonstrated that male rats treated with galanin in trial 2 had 
significantly greater numbers of BCM events, bursts and SVP following 5 Hz (events: P < 
0.001; bursts: P < 0.001; Figure 21A, C, D; SVP: P < 0.001; Figure 21B, C, D) and 10 Hz 
(events: P = 0.008; bursts: P = 0.003; Figure 21A; SVP: P = 0.003; Figure 21B) DPN 
stimulation frequencies compared to control trial 1. Overall, these results indicate that intrathecal 
galanin facilitates but does not trigger the emission and expulsion components of ejaculation. 
However, contrary to the first galanin experiment where it was found that intrathecal galanin 
facilitated numbers of BCM events and bursts not only in response to subthreshold (5-10 Hz) but 
also following threshold (30-60 Hz) levels of DPN stimulation, in this second experiment, 
 threshold levels of DPN stimulation (60 Hz) significantly decreased the numbers of BCM bursts 
and SVP increases following galanin infusions in trial 2 (bursts: 
= 0.036; Figure 21B).  
Figure 21 Effects of galanin on numbers of BCM bursts and SVP increases in male rats.
Quantitative analyses and accompanying EMG traces of BCM bursts and SVP increases 
following intrathecal infusions of galanin.
increases(B) in response to infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation 
(counterbalanced) following intrathecal infusions of saline in trial 1 (control trial) or galanin (0.3 
nmol) in trial 2 (drug trial). EMG traces of 90 seconds duration following 10 Hz DPN 
stimulation (arrow) after an intrathecal infusion of saline (C: control trial) and galanin (D: same 
P = 0.041; Figure 21
 Quantitative analysis of BCM bursts (A) and SVP 
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animals as in C). * denotes significant differences from trial 1 (control trial), while # indicates 
significant differences from infusion, 5Hz and 10 Hz within the same testing trial. 
 
4.3.5 Cholecystokinin (CCK) Facilitated BCM Events, Bursts and SVPs  
  
CCK (26-33) facilitated both the emission and expulsion components of ejaculation as 
evidenced by the increased numbers of BCM events, bursts and SVP increases following 
subthreshold levels of DPN stimulation. There were main effects of stimulation frequency on the 
numbers of BCM events (F(4, 59) = 51.540; P < 0.001), bursts (F(4, 59) = 56.316; P < 0.001) 
and SVP increases (F(4,59) = 38.292; P < 0.001).  As expected, during trial 1 (saline trial) 30 
and 60 Hz DPN stimulation increased numbers of BCM events, bursts and SVP increases 
compared to saline infusion, 5 or 10 Hz stimulation (all P < 0.001; Figure 22A-B). . There were 
also significant interactions between main factors of testing trial and stimulation frequency on 
the numbers of BCM events (F(4, 59) = 4.897; P = 0.006) and bursts (F(4, 59) = 5.493; P = 
0.004). Post hoc analyses revealed that following CCK in trial 2 there were significantly greater 
numbers of BCM events, bursts and SVP increases following 10 Hz (events: P = 0.040; Figure 
22A; bursts: P = 0.005; Figure 22B; SVP: P = 0.013; Figure 22C) DPN stimulation in trial 2 
(drug trial) compared to trial 1 (saline trial). CCK did not significantly affect SVP increased 
following 5 Hz DPN stimulation during trial 2 compared to trial 1, even though BCM bursts and 
events were increased (P = 0,05 and 0.001; Figure 22B). Taken together, the results indicate that 
intrathecal infusions of CCK facilitate both the emission and expulsion components of 
ejaculatory reflexes following subthreshold levels of DPN stimulation (10 Hz) in male rats.  
 Figure 22 Effects of CCK on the numbers
male rats. 
Quantitative analyses and accompanying EMG traces of BCM events, bursts and SVP increases 
following intrathecal infusions of 
SVP increases (C) in response to infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz DPN stimulation 
(counterbalanced) following intrathecal infusions of saline in trial 1 (control trial) or CCK (4.35 
nmol) in trial 2 (drug trial). EMG traces of 90 seco
(arrow) after an intrathecal infusion of saline (D: control trial) and CCK (E: same animals as in 
D). * denotes significant differences from trial 1 (control trial), while # indicates significant 
differences from infusion, 5 Hz and 10 Hz within the same testing trial.
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4.4  Discussion 
 
These data support the hypothesis that galanin and CCK receptor activation in LSt target areas is 
critical for ejaculatory reflexes in male rats by acting on galanin and CCK receptors in LSt target 
areas in the lumbosacral spinal cord. As predicted, intrathecal infusions of galanin or CCK 
receptor antagonists, galantide and proglumide respectively, prevented both the emission and 
expulsion phases of ejaculation in response to sensory stimulation of the DPN in male rats.  
Conversely, galanin and CCK agonists facilitated ejaculatory reflexes following sub- threshold 
sensory stimulation (5–10 Hz) in 100% of male rats. In contrast, galanin or CCK infusions in the 
absence of DPN stimulation were not sufficient to trigger ejaculatory reflexes. This finding is in 
contrast with our previous observations that agonists for GRP or mu opioid receptors do trigger 
ejaculatory reflexes (Kozyrev et al., 2012; Kozyrev, 2013c). It is therefore possible that galanin 
and CCK act synergistically with the endogenous release of neuropeptides from LSt axon 
terminals, including galanin (Newton, 1992a, 1993), CCK (Phan and Newton, 1999), GRP 
(Sakamoto et al., 2008; Kozyrev et al., 2012) and enkephalin (Nicholas et al., 1999; Kozyrev, 
2013c), upon sensory stimulation of the DPN.  
Even though the group data presented in the results shows a lack of significant induction by 
galanin or CCK of ejaculation in the absence of sensory stimulation, intrathecal infusions of 
galanin and CCK triggered ejaculatory reflexes in 15 % (3/20) and 16 % (1/6) of male rats 
respectively. Perhaps the ability of intrathecal infusions of galanin or CCK to trigger ejaculatory 
reflexes in the absence of sensory stimulation in a minority of male rats may be explained by the 
presence of individual differences in galanin and CCK receptor densities in the lumbosacral 
spinal cord. It is possible that male rat ‘responders’ in the current study have a lower threshold to 
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ejaculation and are more likely to exhibit the characteristic aspects of ‘premature ejaculation’. 
Indeed, a previous study observed inherent differences in the spinal command of ejaculation 
between rats classified as ‘rapid ejaculators’ as compared to ‘sluggish ejaculators’ and ‘normal 
ejaculators’ based on their ejaculation frequency in a set of mating tests (Borgdorff et al., 2009). 
Specifically, BCM contractions following microstimulation of the spinal ejaculation generator, 
corresponding to the expulsion phase of ejaculation, were significantly accelerated in ‘rapid 
ejaculators’ compared with ‘sluggish ejaculators’ and ‘normal ejaculators’(Borgdorff et al., 
2009). Overall, the agonist experiments indicate that activation of galanin and CCK receptors in 
the lumbosacral spinal cord facilitates ejaculatory reflexes following subthreshold levels of DPN 
stimulation (5-10 Hz) but is not sufficient to trigger ejaculatory reflexes in the majority of male 
rats in the absence of sensory stimulation of the DPN.   
LSt cells and axons co-express galanin and CCK and the expression of both 
neuropeptides has been shown to be sexually dimorphic (Newton, 1992a, 1993; Phan and 
Newton, 1999). Specifically, male rats have a significantly greater number of both galanin and 
CCK-ir neurons and greater optical densities for both galanin and CCK than female rats and 
males with a testicular feminization mutation (Tfm) that lack functional androgen receptors 
(Newton and Phan, 2006). Therefore, androgens and functional androgen receptors regulate the 
expression of galanin and CCK in LSt cells. In addition, the expression of GRP, another 
neuropeptide expressed in LSt cells and axons, has been shown to be androgen-dependent since 
castration significantly reduced the intensity of GRP-ir fibers in the lumbar spinal cord in male 
rats and this reduction was prevented by androgen replacement (Sakamoto et al., 2008).  
Galanin is a 29/30 amino acid long neuropeptide encoded by the GAL gene (Evans et al., 
1993) that is widely distributed in the brain, spinal cord and gastrointestinal tract of mammals 
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(Kask et al., 1997; Hokfelt et al., 1999) and is involved in a variety of physiological functions 
including feeding, nociception, cognition, regulation of blood pressure and mood (Mechenthaler, 
2008) . Galanin-ir is expressed in dorsal root ganglion cells (DRG) (Hokfelt et al., 1993; Kask et 
al., 1997; Landry et al., 2005), but in the lumbosacral spinal cord, is expressed exclusively in LSt 
cells (Truitt and Coolen, 2002; Truitt et al., 2003; Staudt, 2011). Furthermore, galanin-ir axon 
terminals exclusively deriving from LSt cells are in close proximity to cell bodies and proximal 
dendrites of autonomic preganglionic and motor neurons (Newton, 1992b; Ohmachi et al., 1996). 
A predominately inhibitory, hyperpolarizing neuropeptide (Ito, 2009), galanin mediates its 
effects through its receptors: GALR1, GALR2 and GALR3. Galanin receptors are inhibitory G-
protein-coupled receptors that are associated with G-protein coupled inwardly-rectifying K+ 
(GIRK) channels (Kask et al., 1997; Wang et al., 1998) and GALR1 receptors have the highest 
densities postsynaptically compared to the other two receptor types (Brumovsky et al., 2006; 
Landry et al., 2006). In the lumbosacral spinal cord, GalR1 receptors have been observed in 
dorsal and ventral horns, lateral spinal nuclei (Brumovsky et al., 2006) and numerous GALR1 
positive mRNA neurons were detected in lamina X, presumably in the vicinity of the LSt cells 
(Brumovsky et al., 2006).  GALR2 mRNA expression is considerably diminished compared to 
GALR1 mRNA expression and is confined primarily to the dorsal horn (Brumovsky et al., 
2006). However, the most intensely labeled neurons are observed in the ventral horn, likely on 
motorneurons, and a few GALR2 positive mRNA neurons are detected in the sympathetic and 
parasympathetic lateral cell columns, in the locations of the  IML and SPN (Brumovsky et al., 
2006). In light of these findings, it is likely that galanin facilitates emission and expulsion by 
acting on GALR1 and GALR2 receptors in LSt target regions, specifically on autonomic 
preganglionic neurons in the lateral cell columns and on motoneurons in the ventral horns of the 
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lumbosacral spinal cord in male rats. As previously mentioned, GALR1 receptors have been also 
observed in lamina X, in the region of LSt cells. However, it remains to be tested whether these 
receptors are expressed on LSt cells or other types of neurons in the lumbosacral spinal cord. If 
GALR1 receptors are indeed expressed on LSt cells, this suggests the possibility of autoreceptor 
interactions or reciprocal connections. However, intrathecal pretreatment with galantide in the 
current study did not prevent the activation of LSt cells following DPN stimulation suggesting 
that autoreceptors are not the primary targets of galanin released from the axon terminals of LSt 
cells. Alternatively, galantide did not diffuse deeply into the spinal cord to the location of the LSt 
cells.  
Similarly to galanin, CCK is one of the first peptide hormones to be isolated from the 
gastrointestinal tract and is widely distributed in the nervous system of mammals 
(Vanderhaeghen et al., 1975). CCK is involved in many physiological processes including 
digestion, satiety, and is known to induce anxiety and drug tolerance to opioids (Bradwejn, 1993; 
Greenough et al., 1998; Fukazawa et al., 2007). The actions of CCK are mediated by two classes 
of receptors: CCKA and CCKB subtypes (Oz et al., 2007) which belong to a family of G-
protein-coupled receptors (Oz et al., 2007). As galanin, CCK is expressed in DRG cells and 
involved in the maintenance of neuropathic pain following nerve injury (Brewer et al., 2003; 
Kim et al., 2009) reflected in substantial increases in CCK mRNA following injuries to the CNS 
(Xu et al., 1993; Brewer et al., 2003). In the spinal cord, CCK is expressed in LSt cells and LSt 
axons. CCK receptor expression has been described in motor neurons (Cortes et al., 1990; 
Schiffmann et al., 1991; Truitt et al., 2003). In addition, CCK depolarized neurons in lamina X in 
the lumbar spinal cord (Phelan and Newton, 2000), the precise location of LSt cells. Bath 
application of CCK has also been shown to depolarize isolated, hemisected lumbar spinal cord 
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ventral horn neurons and motorneurons in neonatal rats (Suzue et al., 1981) and this depolarizing 
action was mediated by CCKB type receptors (Oz et al., 2007).  Activation of postsynaptic 
CCKB receptors can enhance the excitability of motoneurons and other types of neurons in 
ventral spinal cord of rats (Oz et al., 2007). This may also be the mechanism by which CCK 
facilitated BCM bursting.  
CCK is an antagonist of endogenous opioids in the brain and spinal cord (Cesselin, 1995; 
Wiesenfeld-Hallin et al., 1999). It appears that CCK mediates its noxious effects through CCKB 
type receptors. The systemic administration of the CCKB receptor antagonist but not opioids 
successfully reduced mechanical allodynia in an ischemic model of SCI (Xu et al., 1994). The 
tendency of CCK to antagonize opioids may explain why the effect of CCK infusions on 
ejaculatory reflexes following subthreshold sensory stimulation (5-10 Hz) was somewhat 
dampened compared to galanin infusions in this study (Figures 4 – 6). LSt cells are hypothesized 
to release their co-expressed neuropeptides, including enkephalin, onto neurons in their target 
regions, thereby triggering ejaculation. Indeed, our laboratory recently found that intrathecal 
infusions of the mu opioid receptor agonist DAMGO consistently triggered ejaculatory reflexes 
in the absence of sensory stimulation in 75 % of male rats (Kozyrev, 2013c). Thus, activation of 
mu opioid receptors in the lumbosacral spinal cord was sufficient in a large majority of animals 
to trigger ejaculatory reflexes in male rats. Infusions of CCK in the current study may have 
suppressed the facilitative effects of opioids on ejaculatory reflexes in male rats by antagonizing 
endogenous opioids released from the LSt cells onto target regions following stimulation of the 
DPN. Although data from the two neuropeptide experiments were not directly compared, it is 
evident that the numbers of events, bursts and SVP increases following infusions of galanin 
(Figures 20 – 21) are somewhat higher compared to the numbers of events, bursts and SVP 
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increases following infusions of CCK (Figure 22). Furthermore, infusions of galanin produced a 
coordinated bursting pattern of the BCM and a robust increase in the numbers of BCM bursts 
and concurrent SVP increases (Figure 20D and 21D) while infusions of CCK resulted in a 
modest increase in BCM bursts and simultaneous SVP increases but not a full coordinated 
bursting pattern characteristic of ejaculation (Figure 22E).  
In the first set of experiments, the higher dose of galanin (0.3 nmol; Figure 20) facilitated 
ejaculatory reflexes not only in response to subthreshold levels of DPN stimulation (5-10 Hz) but 
also following threshold stimulation frequencies (30-60 Hz). However, in the subsequent group 
of male rats, intrathecal infusion of the same dose of galanin (0.3 nmol; Figure 21) significantly 
decreased numbers of BCM events, bursts and SVP increases following 60 Hz DPN stimulation. 
In these animals, galanin (0.3 nmol) still facilitated numbers of BCM events, bursts and SVP 
increases in response to subthreshold levels of DPN stimulation (5-10 Hz). However, the 
discrepancies in ejaculatory responses between the two groups of male rats suggest that galanin 
consistently facilitates ejaculatory reflexes to subthreshold (5-10 Hz) but not to threshold (30-60 
Hz) levels of DPN stimulation.  
Since the activation of galanin or CCK receptors was not sufficient to trigger ejaculatory 
reflexes in the majority of male rats tested, the activation of galanin or CCK receptors may be 
required in combination with activation of other receptors in LSt target areas in order to trigger 
ejaculation. One candidate is the GRP receptor. Indeed, it was recently shown by our laboratory 
that activation of GRP receptors is required to trigger ejaculation and that intrathecal infusions of 
GRP triggered ejaculatory reflexes in up to 66% of male rats (Kozyrev et al., 2012). Other 
candidates include the mu and delta opioid receptors, whose ligand enkephalin is co-localized in 
LSt cells and axons (Nicholas et al., 1999) along with galanin (Newton, 1993; Newton and Phan, 
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2006), CCK (Newton, 1993; Newton and Phan, 2006) and GRP (Sakamoto et al., 2008; Kozyrev 
et al., 2012).  
Infusions of galanin significantly reduced the numbers of BCM events, bursts and SVP 
increases following threshold DPN stimulation (60 Hz). This finding is in agreement with 
previous reports of intrathecal infusions of  GRP, DAMGO and deltorphin II that have all 
significantly reduced the numbers of BCM events, bursts and SVP increases following 60 Hz 
DPN stimulation (Kozyrev et al., 2012; Kozyrev, 2013c). This consistent suppression of 
ejaculatory reflexes to threshold DPN stimulation (60 Hz) may be due to the effects of 
intrathecal infusions of neuropeptides combined with the endogenous release of opioids 
following DPN stimulation that cumulatively act to inhibit or desensitize the G-protein coupled 
receptors in autonomic and motor regions involved in ejaculation and suppress the transmission 
of sensory inputs to the LSt cells which are required to trigger ejaculation.   
 In conclusion, these data support the hypothesis that activation of galanin and CCK 
receptors in the lumbosacral spinal cord is required for sensory stimulation-induced emission and 
expulsion in anesthetized and spinalized male rats. Galanin and CCK likely act on receptors in 
LSt cell target regions, including motoneurons in the SNB, and autonomic preganglioninc 
neurons in the IML, CAN and SPN in the lumbosacral spinal cord. Overall, these data suggest 
that the co-release of neuropeptides from LSt cell axon terminals including galanin, CCK, 
enkephalin and GRP, triggers ejaculatory reflexes in male rats. Conversely, the release of only 
one of these neuropeptides is not sufficient to trigger ejaculatory reflexes in all animals in the 
absence of added sensory stimulation.  Finally, these data suggest that galanin and CCK 
antagonists may be promising pharmacological agents in the treatment of ejaculatory disorders, 
particularly for the purpose of delaying the onset of emission and expulsion in men suffering 
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from premature ejaculation.  
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Chapter 5: Activation of mu opioid and GRP 
receptors in the lumbosacral spinal cord can 
improve ejaculatory reflexes in male rats with 
chronic contusion spinal cord injury 
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5.1 Introduction  
 
Ejaculatory function is severely impaired in men with spinal cord injuries (SCI) (Brackett et al., 
1998). A great majority of these patients are men with 85% between the ages of 18 - 45 years 
(Ohl et al., 1989). Of these SCI men, just 12 – 15 % are able to ejaculate but only with the aid of 
intense vibratory stimulation or electro-ejaculation (Elliott, 2006). Among paraplegic men, 
regaining sexual function is of the utmost importance, and is even ranked higher than regaining 
locomotor function (Anderson, 2004). However, the mechanisms whereby chronic SCI so 
dramatically disrupts ejaculation in men with SCI are currently unknown.   
Male sexual behavior is a complex and highly rewarding behavior which includes several 
components including the pursuit and investigation of a female, mounts and intromissions, 
finally culminating in ejaculation (Coolen et al., 2004; Allard et al., 2005; Coolen, 2005) In men, 
ejaculation occurs concurrently with the pleasurable experience of orgasm (Bohlen et al., 1980; 
Elliott, 2002). Similarly, male rats associate ejaculation with reward (Tenk et al., 2009) 
Therefore, ejaculation is an exceptionally rewarding and complex physiological process which 
terminates in the expulsion of seminal contents from the urethral meatus (Giuliano and Clement, 
2005; Clement P, 2011) and comprises two phases: emission and expulsion. The emission phase 
involves the secretion of seminal fluids from the prostate, seminal vesicles and vas deferens and 
closure of the bladder neck and external urethral sphincter. The expulsion phase comprises 
rhythmic contractions of the striated perineal muscles, particularly the bulbocavernosus muscle 
(BCM), to forcefully expel seminal contents from the urethral meatus (Bohlen et al., 1980; 
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Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and Sachs, 1991). Ejaculation is a reflex 
under the control of the spinal ejaculation generator, located in the lumbosacral spinal cord 
(Pescatori et al., 1993; McKenna, 1999; Coolen et al., 2004; Allard et al., 2005; Coolen, 2005). 
The spinal ejaculation generator is comprised of interneurons in lamina 10 and the medial 
portion of lamina 7 of lumbar segments 3 and 4 (L3-4). These lumbar interneurons are known as 
lumbar spinothalamic (LSt) cells because of their anatomical location in the lumbar spinal cord 
and direct projections to the subparafascicular parvocellular thalamic nucleus (Coolen et al., 
2003; Truitt et al., 2003; Giuliano and Clement, 2005; Clement P, 2011). Moreover, they are 
pivotal in the control of ejaculatory behavior (Truitt et al., 2003) and reflexes (Staudt, 2011) in 
male rats. The spinal ejaculation generator is thought to regulate ejaculation by coordinating 
sympathetic, parasympathetic, and motor ouflow required to stimulate emission and expulsion 
(Coolen et al., 2004; Coolen, 2005) and by integrating the sensory inputs, conveyed by the dorsal 
penile nerve (DPN) during sexual activity, with autonomic and motor ouflow to produce 
ejaculation (Coolen et al., 2004; Allard et al., 2005; Coolen, 2005; Giuliano and Clement, 2005; 
Clement P, 2011). The  LSt cells, which form an integral component of the spinal ejaculation 
generator, are hypothesized to transform sensory signals associated with copulation into motor or 
secretory outputs (Truitt and Coolen, 2002). In support of this notion, LSt cells are activated 
specifically with ejaculation but not with other components of male sexual behavior (Truitt et al., 
2003). In addition, LSt cells express neural activation,  including cFos (Truitt et al., 2003) and 
phosphorylated extracellular signal-regulated kinases 1 and 2 (pERK) (Staudt et al., 2010) 
following ejaculation triggered by mating  or electrical stimulation of the dorsal penile nerve 
(DPN) in male rats (Sachs and Garinello, 1979; Pescatori et al., 1993; McKenna, 1997; Coolen et 
al., 2004). Moreover, activation of the  MAP kinase pathway is required for ejaculation 
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following mating in intact animals or DPN stimulation in anesthetized and spinalized male rats  
(Staudt et al., 2010). Finally, LSt cells control ejaculation via their axon projections to numerous 
target regions involved in ejaculation (Newton, 1993; Allard et al., 2005; Xu et al., 2006) 
including preganglionic sympathetic, parasympathetic and motor neurons in the thoracolumbar 
and lumbosacral spinal cord (Newton, 1993; McKenna, 1997; Sakamoto et al., 2008). LSt cells 
and axons co-express various neuropeptides including enkephalin, galanin, cholecystokinin  and 
gastrin releasing peptide (GRP) (Ju et al., 1987; Nicholas et al., 1999; Coolen et al., 2003; Truitt 
et al., 2003; Sakamoto et al., 2008). Thus, it was predicted that these neuropeptides modulate 
ejaculatory reflexes by acting in the LSt target areas. Indeed, our laboratory utilized a 
physiological paradigm to test that hypothesis, using stimulation of the DPN in spinalized, 
anestitized male rats. This DPN stimulation model is a physiologically relevant model of 
ejaculation (Clement P, 2011) which utilizes anesthetized and spinalized animals and 
consistently triggers ejaculatory reflexes in male rats (Pescatori et al., 1993), primates (Herbert, 
1973), and men (Wieder et al., 2000).  It has been demonstrated that antagonism of each of the 
neuropeptides receptors in LSt target areas abolish ejaculatory reflexes (Kozyrev et al., 2012; 
Kozyrev, 2013c, 2013b). Moreover, infusions of agonists for the receptors these neuropeptides 
triggered ejaculatory reflexes in the absence of sensory stimulation (Kozyrev et al., 2012; 
Kozyrev, 2013c, 2013b) or facilitated ejaculation following subthreshold sensory stimulation 
incapable of triggering ejaculation in control conditions.  
The purpose of the present study was to test whether intrathecal infusions of receptor 
agonists for the neuropeptides enkephalin, galanin, and GRP, individually and in combination, 
can restore ejaculatory reflexes in a chronic model of contusion SCI in anesthetized and 
spinalized male rats.  Specifically, it was tested whether infusion of each agonist individually or 
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infusions of a cocktail of these agonists is sufficient to trigger ejaculatory reflexes in male rats in 
the absence of sensory stimulation or followed by electrical stimulation of the DPN. Parameters 
of emission and expulsion were analyzed during neuropeptide infusions and following DPN 
stimulation.  
 
5.2 Materials and Methods 
 
5.2.1 Animals 
 
Adult male Sprague Dawley rats (225-250 grams) were acquired from Charles River 
(Wilmington, MA, USA) and pair housed in standard housing cages on a reverse 12-hour 
light/dark cycle with lights off at 9 a.m. Food and water were available ad libitum. All 
procedures were approved by the University Committee on Use and Care of Animals at the 
University of Michigan and conformed to the guidelines outlined by the National Institutes of 
Health. 
 
5.2.2 Spinal Cord Surgeries 
 
Male rats were randomly assigned to either the spinal cord injury (SCI) group (N = 16) or 
the sham group (N = 17) for these experiments. All surgical procedures were performed under 
ketamine (87 mg/ml) / xylazine (13 mg/ml) anesthesia (1 ml/kg i.p. injection). Backs were 
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shaved and thoroughly cleaned with betadine, iodine and 70 % alcohol solution. Lacrilube 
opthalamic ointment (Allergen, Irevine, CA) was applied to the eyes in order to avoid drying. In 
both SCI and sham animals, a laminectomy was performed between the 6th and 7th thoracic 
spinal segments (T6-T7) and was made large enough in order to ensure accessibility of the spinal 
cord during the impact injury. Only the SCI group of male rats was subjected to the contusion 
spinal cord injury, performed with the IH-400 impactor (Precision Systems and Instrumentation, 
LLC, Lexington, KY), positioned 3 mm above the cord and a force of 200-216 kdyn was applied 
directly to the intact dura of the exposed spinal cord at the T6/7 segments. After the contusion, 
the layers of muscle and skin were sutured separately, the muscle was sutured with absorbable 
sutures and the skin was closed using wound clips. Subcutaneous injections of the analgesic 
ketoprofen (5 mg/ml/kg s.c.), and the antibiotic Baytril (5 mg/ml/kg s.c.), were administered 
immediately following the surgery and for up to three days thereafter in order to alleviate pain 
and prevent infection. The sham animals were injected with ketoprofen and Baytril in the same 
manner and for the same period of time as the SCI animals. Bladders of SCI males were 
expressed twice daily until bladder function returned (typically after 7-10 days).  
 
5.2.3 Locomotor testing 
 
Locomotor testing was conducted three times beginning one week following the 
contusion/sham surgeries and each week thereafter in order to assess locomotor recovery 
following spinal cord contusion. Locomotor activity was measured during the first half of the 
light phase, for 15 minutes, in a large area and using 16 × 16 photobeam array (Med Associates 
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Inc, Vermont). Locomotor activity was expressed as the time animals spent ambulatory in the 
horizontal position, or rearing in a vertical position. Locomotor activity was analyzed using a 
two-way repeated anova (factors: SCI and time) and Holm-Sidak post-hoc tests to compare 
locomotor activity two, three and four weeks following spinal cord contusion (or sham) surgery 
within each group of animals and between sham and SCI animals, separately for ambulatory and 
vertical time.  
 
5.3 Experimental Designs 
 
5.3.1 Intrathecal infusions of neuropeptides  
 
Four to five weeks following the spinal cord contusion surgeries, ejaculatory reflexes 
were measured as described before (Kozyrev et al., 2012; Kozyrev, 2013b, 2013a). Male rats 
were deeply anesthetized with urethane (1.5 g/kg, i.p.), backs were shaved and a laminectomy 
was made between the seventh and the eighth thoracic spinal segments, immediately caudal to 
the injury site, and a complete transaction of the spinal cord was performed at the same spinal 
level. Next, animals were positioned supine and the skin, fat, connective tissues and ligaments 
surrounding the reproductive organs were removed to expose the muscle of the bulbocavernosus 
(BCM) and the dorsal penile nerve (DPN). Then, silver recording electrodes, attached to the 
PowerLab/7SP Data Acquisition System (AD Instruments, Inc., Colorado Springs, CO, USA) 
were bilaterally implanted into the BCM and a ground electrode was inserted into the muscle of 
the right thigh prior to the start of electromyographic (EMG) recordings. In addition, a small 
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incision was made in the abdomen and the right seminal vesicle was located for the purpose of 
measuring and recording seminal vesicle (SV) pressure, a marker of the emission phase of 
ejaculation (Clement et al., 2008; Kozyrev et al., 2012; Kozyrev, 2013c, 2013b). SV pressure 
(SVP) was measured with a pressure catheter (AD Instruments Inc., model number: SPR-671(1.4 
F, Single, Straight, 15 cm, Ny) connected to a catheter interface cable (AD Instruments Inc., 
model number: AEC-IOD) and attached to a Bridge AMP (AD Instruments Inc.). The pressure 
catheter was carefully guided into the lumen of the SV and fixed in place before recording 
commenced. Lastly, a bipolar stimulating electrode connected to the SD9 Square Pulse 
Stimulator (Grass Technologies, West Warwick, RI, USA) was arranged directly on top of the 
DPN, in preparation for stimulation. Immediately following spinal cord transection, the DPN 
was stimulated in order to verify the completeness of the spinal transection, reflected in the 
release of supraspinal inhibition and the corresponding rhythmic bursting of the BCM and 
concurrent increases in SVP. The initial electrical stimulation of the DPN was composed of 
square wave pulses of 1 ms duration, 4 V at 60 Hz for 10 seconds. These DPN stimulation 
parameters have been well established to reliably trigger increases in SVP and concurrent 
rhythmic bursting of the BCM, corresponding to the emission and expulsion components of 
ejaculation, in all saline-treated control animals (Staudt et al., 2010; Staudt, 2011; Kozyrev et al., 
2012; Kozyrev, 2013c, 2013b). 
Pharmacological experiments were conducted as described previously (Kozyrev et al., 
2012; Kozyrev, 2013a, 2013b)  and began two hours after spinal cord transection in order to 
allow the acute effects of spinal cord transection to subside. In preparation for neuropeptide 
infusions, a small opening was made in the dura mater in the location of the laminectomy and a 
polyethylene catheter (Caly-Adams PE-10, Parsippany, NJ, USA) was gently guided into the 
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subarachnoid space until the open end reached the 3rd lumbar-4th lumbar (L3-L4) spinal 
segments.  
In the first testing trial (saline trial; Figure 23A), 10 µL of 0.9 % saline was intrathecally 
infused with a polyethylene catheter to bathe the entire lumbosacral spinal cord. The catheter 
was left in place for 10 minutes after injection in order to let the contents diffuse in the 
lumbosacral spinal cord and SVP and BCM EMG activity were recorded for the entire duration. 
After the saline infusion, the DPN was stimulated at 5, 10, 30 Hz and 60 Hz in a counterbalanced 
manner, with 5-minute intervals between the stimulations. We have previously established that  
saline infusions and repeated stimulations do not affect ejaculatory reflexes (Kozyrev et al., 
2012) . Moreover, we established that 5 and 10 Hz DPN stimulations in control conditions do not 
trigger ejaculation, while 30 and 60 Hz DPN stimulations under control conditions reliably 
trigger ejaculatory reflexes in all control animals. SVP and BCM EMG were recorded for at least 
90 seconds following nerve stimulation, corresponding to the duration of a characteristic 
ejaculatory reflex triggered by DPN stimulation in male rats (Staudt et al., 2010; Staudt, 2011; 
Kozyrev et al., 2012; Kozyrev, 2013b, 2013c). One hour later, this procedure was repeated twice 
in the same animals, but using neuropeptide receptor agonists (Trials 2 and 3). Half the animals 
received a 10 µL infusion of galanin (0.3 nmol [Bachem Americas, Inc. Torrence, CA, USA]; 
Figure 23B) and a 10 µL infusion of the delta opioid receptor agonist [DAla2] Deltorphin II (13 
nmol ; [American Peptide Co, Sunnyvale CA, USA]; N (SCI) = 5; N (sham) = 6; Figure 23B: 
Trial 3. The other half of the animals received 10 µL infusion of gastrin releasing peptide (GRP 
20-29; 0.2 nmol; [Phoenix Pharmaceuticals Inc. Burlingame, CA, USA]; Figure 23B: Trial 2) and 
a 10 µL infusion of the mu opioid receptor agonist (D-Ala2, N-Me-Phe4, glycinol5) – 
Enkephalin (DAMGO; [Bachem Americas, Inc. Torrence, CA, USA]; 1 nmol; N (SCI) = 11, N 
 (sham) = 11; Figure 23). Each pair of drugs was delivered in a counterbalanced order of infusion 
and there was a rest period of 2
effects of the previous neuropeptide on ejaculatory reflexes to subside. Recordings of SVP and 
BCM EMG were obtained during and following drug infusion for a total period of 10 minutes. 
Next, the DPN was stimulated at 5, 10, 30 and 60 Hz in a 
concurrent recordings of SVP and BCM EMG were obtained for 90 seconds following DPN 
stimulation (Testing trial 2 and 3; drug trials). 
Figure 23 Timeline of experimental manipulations.
In trial 1, all male rats received intrathecal infusions of saline (A; Arrow) followed by intrathecal 
infusions of DAMGO (1 nmol) and GRP (0.2 nmol) or galanin (0.3 nmol) and deltrophin II (13 
nmol) in trials 2 and 3 (B: Arrow [in a counterbalanced order])
following infusion of the last neuropeptide, male rats received intrathecal infusions of a cocktail 
of neuropeptides (C: Arrow). Following each infusion, BCM EMG and SVP activity was 
recorded for 15 minutes. Next, the DPN 
counterbalanced manner (A – C) and SVP and BCM EMG activity was recorded for 90 seconds 
following each DPN stimulation. 
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5.3.2 Intrathecal infusions of a cocktail of neuropeptides  
 
Three hours following the last neuropeptide infusion, male rats (N (SCI) = 11; N (sham) 
= 7) received 10 µL intrathecal infusion of a cocktail of neuropeptides composed of galanin (0.3 
nmol), deltorphin (13 nmol,), DAMGO (1 nmol) and GRP (0.2 nmol) and recordings of SVP and 
BCM EMG were obtained for 15 minutes (Figure 23C: Trial 4). After the infusion, the DPN was 
stimulated at 5, 10, 30, and 60 Hz in a counterbalanced manner with five minute intervals 
between stimulations.  
 
5.3.3 BCM EMG and SVP Analysis  
 
SVP and BCM EMG recordings were analyzed for 10 minutes following infusion of each 
neuropeptide, and for 90 seconds each time the DPN was stimulated. The numbers of SVP 
increases and concurrent BCM events and bursts were analyzed. Analysis of the numbers of 
BCM events was performed with LabChart 7.35 (AD Instruments Inc.) software and all events 
that were above baseline activity were included in the analysis (Kozyrev et al., 2012; Kozyrev, 
2013b, 2013a). The numbers of SVP increases and BCM bursts were analyzed as previously 
described (Kozyrev et al., 2012; Kozyrev, 2013b, 2013a). Briefly, 8 or more consecutive BCM 
events above baseline were considered a ‘burst’ and all concurrent increases in SVP above 
baseline were included in the analysis.  
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5.3.4 Statistical analyses  
 
Statistical analyses of the neuropeptide experiments involved comparing the effects of 
each neuropeptide on the numbers of SVP increases, BCM events and bursts within animals 
(within the same drug, between testing trial 1: control trial and testing trial 2 and 3: drug trials) 
and between SCI and sham groups of animals (separately for each stimulation setting: Infusion, 5 
Hz, 10 Hz, 30 Hz, and 60 Hz), and separately for each of the three testing trials, using a two-way 
repeated anova (factors: drug and SCI) and Holm-Sidak post hoc tests. A 95% confidence level 
was utilized for all tests. In a separate analysis, the effects of the order of drug delivery were 
tested for Trials 2 and 3. One way ANOVA was conducted to determine differences in the 
effects of each drug between the half the animals receiving the drug in the second and in the third 
trial. Only if no differences were detected were all animals included in the analysis. Similarly, 
the cocktail infusion experiment was analyzed by comparing the effects of the cocktail on the 
numbers of SVP increases, BCM events and bursts within animals (between different stimulation 
settings: Infusion, 5 Hz, 10 Hz, 30 Hz and 60 Hz) as well as between sham and SCI male rats 
using a two-way repeated anova (factors: DPN stimulations and SCI) and Holm-Sidak post hoc 
tests.  
 
5.4 Results 
 
5.4.1 Locomotor activity was impaired in SCI male rats  
 
 There was no evidence of recovery in either ambulatory or vertical time in the SCI group 
of male rats. Moreover, SCI males did not differ in activity at 4 weeks compared 
post-injury. In addition, both ambulatory (horizontal) and vertical time were significantly 
reduced in SCI male rats compared to sham male rats following surgery (contusion or sham 
spinal cord trauma). There were main effects of SCI on ambulator
0.031; Figure 24A) and vertical time (F(1, 68) = 11.537; 
analyses demonstrated that sham males spent significantly more ambulatory time exploring their 
chamber compared to SCI males three weeks
addition, sham males spent significantly greater vertical time in the chamber compared to SCI 
males two weeks (P = 0.004), 3 weeks (
surgery (Figure 24B).   
 
 
 
y time (F(1, 68) = 5.360; 
P = 0.003; Figure 2
 following surgery (P = 0.007; Figure 2
P = 0.002) and four weeks (P = 0.010) following 
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Figure 24 Locomotor activity in sham and SCI male rats 2, 3 and 4 weeks after surgery. 
Locomotor acitivity expressed as the mean combined time (ms) sham and SCI male rats spent in 
ambulatory (A) and vertical (B) locomotion during three 15-minute trials, two, three and four 
weeks following spinal cord contusion injury (or sham surgery).   
 
5.4.2 Experiment 1: Ejaculatory reflexes were absent in SCI males  
 
In the first experiment, ejaculatory reflexes were examined in sham and SCI males 
following saline (control Trial 1), and subsequently following GRP or DAMGO (Trials 2 and 3). 
First, under control saline conditions, in trial 1, SCI male rats demonstrated severely disrupted 
BCM events, bursts, and SVP increases following 30 and 60 HZ DPN stimulation, parameters 
that reliable trigger ejaculation in control animals (Figures 25D, 25E, 25D, 26E, 27D, 27E).  For 
both stimulation parameters, there were main effects of SCI on BCM events (F(1,59) = 31.25; P 
< 0.001 and F(1,59) = 33.53; P < 0.001), BCM bursts (F(1,59) = 48.94; P < 0.001 and F(1,59) = 
83.55; P < 0.001), and SVP increases (F(1,59) = 39.38; P < 0.001 and F(1,59) = 72.98; P < 
0.001). Specifically, whereas sham animals (following saline infusions), display increased BCM 
events, bursts and SVP increases following either 30 or 60 Hz (all  P < 0.001); SCI animals 
display no BCM activity nor SVP changes at all and were significantly different from sham 
controls in all parameters (all P < 0.001).  Hence, SCI severely disrupted the ability of DPN 
stimulation to trigger ejaculatory reflexes. 
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Figure 25 Effects of DAMGO and GRP infusions on the numbers of BCM events in sham 
and SCI male rats. 
Quantitative analysis of BCM events following intrathecal infusions of saline (A: trial 1[ control 
trial]) and DAMGO and GRP (A: trials 2 and 3 [ drug trials]), followed by 5 Hz (B), 10 Hz (C), 
30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI male 
rats. * denotes significant differences from saline (trial 1: control trial) within sham or SCI; # 
denotes significant differences between treatment groups (sham vs. SCI) within the same testing 
trial.   
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Figure 26 Effects of GRP and DAMGO infusions on the numbers of BCM bursts in sham 
and SCI male rats. 
Quantitative analysis of BCM bursts following intrathecal infusions of saline (A: trial 1[ control 
trial]) and DAMGO and GRP (A: trials 2 and 3 [ drug trials]), followed by 5 Hz (B), 10 Hz (C), 
30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI male 
rats. * denotes significant differences from saline (trial 1: control trial) within the same treatment 
group. # denotes significant differences between treatment groups (sham vs. SCI) within the 
same testing trial.   
 
  
 
 
 
147 
 
148 
 
Figure 27 Effects of GRP and DAMGO infusions on the numbers of SVP increases in sham 
and SCI male rats. 
Quantitative analysis of  SVP increases following intrathecal infusions of saline (A: trial 1[ 
control trial]) and DAMGO and GRP (A: trials 2 and 3 [ drug trials]), followed by 5 Hz (B), 10 
Hz (C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and 
SCI male rats. * denotes significant differences from saline (trial 1: control trial) within the same 
treatment group. # denotes significant differences between treatment groups (sham vs. SCI) 
within the same testing trial.   
 
5.4.3 Infusions of GRP and DAMGO in sham and SCI male rats  
 
Following the saline trial (Trial 1), animals received GRP and DAMGO infusions in 
counter balanced order during Trials 2 and 3. However, preliminary data showed that DAMGO 
infusions prevented the facilitatory effects of the subsequent GRP infusions, although this effect 
was not significant because of the small numbers of animals tested. In contrast, GRP infusions 
did not affect the facilitatory effects of subsequent DAMGO infusions. Therefore, data for GRP 
in Trial 3 were not included in the analysis, and analysis was based on effects of GRP in Trial 2 
and DAMGO in Trails 2 and 3.  
 There were main effects of drug treatment (GRP and DAMGO in Trials 2 and 3) on all 
three parameters of ejaculatory reflex: numbers of BCM events (infusion: (F(2,59) = 11.578; P < 
0.001; Figure 25A); 5 Hz: (F(2, 59) = 11.637; P < 0.001; Figure 25B); 10 Hz: (F(2, 59) = 14.755; 
P < 0.001; Figure 25C); 30 Hz: (F(2, 59) = 22.937; P < 0.001; Figure 25D); 60 Hz: (F(2, 59) = 
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20.186; P < 0.001; Figure 25E), BCM bursts (infusion: (F(2, 59) = 12.987; P < 0.001; Figure 
26A), 5 Hz: (F(2, 59) = 17.113; P < 0.001; Figure 26B), 10 Hz: (F(2, 59) = 13.326; P < 0.001; 
Figure 26C), 30 Hz: (F(2, 59) = 26.569; P < 0.001; Figure 26D), 60 Hz: (F(2, 59) = 42.239; P < 
0.001; Figure 26E), and SVP increases (infusion: (F(2, 59) = 9.086; P < 0.001; Figure 27A), 5 
Hz: (F(2, 59) = 15.422; P < 0.001; Figure 27B), 10 Hz: (F(2, 59) = 13.295; P < 0.001; Figure 
27C), 30 Hz: (F(2, 59) = 19.958; P < 0.001; Figure 27D), 60 Hz (F(2, 59) = 35.523; P < 0.001; 
Figure 27E).  In addition, there were main effects of SCI on the numbers of SVP increases, BCM 
events and bursts for 30 and 60 Hz (30 HZ: SVP increases: (F(1, 59) = 39.381; P < 0.001); BCM 
events: (F(1, 59) = 31.248; P < 0.001); BCM bursts: (F(1, 59) = 48.942; P < 0.001; 60 Hz: SVP 
increases: (F(1, 59) = 72.984; P < 0.001); BCM events: (F(1, 59) = 33.530; P < 0.001); BCM 
bursts: F(1, 59) = 83.552; P < 0.001), and on numbers of SVP increases for 10 Hz (F(1, 59) = 
5.681; P = 0.026) . Furthermore, there were significant interactions between SCI and drug 
treatment on the numbers of SVP increases, BCM events and bursts for 30 and 60 Hz (30 Hz: 
SVP increases: (F(2, 59) = 18.420; P < 0.001); BCM events (F(2, 59) = 17.185; P < 0.001); 
BCM bursts: (F(2, 59) = 19.344; P < 0.001;  and 60 Hz: SVP increases: (F(2, 59) = 40.377; P < 
0.001); (BCM events: (F(2, 59) = 23.978; P < 0.001); BCM bursts: (F(2, 59) = 47.729; P < 
0.001), and on the numbers of SVP increases and BCM bursts for 10 Hz (SVP increases: (F(2, 
59) = 4.491; P = 0.019; Figure 27C); BCM bursts: F(2, 59) = 3.413; P = 0.045; Figure 26C). 
 
5.4.4 Infusions of GRP triggered and facilitated ejaculatory reflexes in male SCI rats  
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Intrathecal infusions of the gastrin-releasing peptide (GRP) agonist GRP2029 improved 
ejaculatory reflexes in male rats with SCI, following drug infusion alone and in response to 
subthreshold (5 – 10 Hz) levels of DPN stimulation (Figures 25 – 27, 28C, 28D, 29A-29D). 
First, in sham control males, GRP infusions in trial 2, in the absence of DPN stimulation 
triggered ejaculatory reflexes and increased numbers BCM events (P = 0.001), bursts (P < 
0.001), and SVP (P = 0.001) compared to saline infusions in trial 1, replicating our previous 
findings (Kozyrev et al., 2012). Moreover, GRP infusions facilitated ejaculatory reflexes 
following 5 and 10 Hz DPN stimulation, evidenced by significant increases in numbers of BCM 
events (P = 0.002 and P < 0.001), BCM bursts (P < 0.001 both), and SVP increases (P < 0.001 
both), and again confirming our previous findings (Kozyrev et al., 2012). Moreover, in SCI 
males, GRP infusions alone, and in conjunction with subthreshold DPN stimulation triggered and 
facilitated ejaculatory reflexes. In SCI males, GRP infusions increased numbers of BCM events 
(P = 0.006), BCM bursts (P = 0.002), and SVP increases (P = 0.003) compared to saline in trial 
1. Also, in SCI males GRP increased these parameters following 5 Hz (BCM events: P = 0.005; 
BCM bursts: P = 0.004; SVP increases: P = 0.004) and 10 Hz (BCM events: P = 0.014) 
compared to saline infusions and DPN stimulation. Furthermore, ejaculatory reflexes in SCI 
males treated with GRP were identical to those of sham males. 
 Figure 28 Representative BCM EMG and SVP recording traces showing SV
and concurrent BCM activity induced by intrathecal infusions of GRP and DAMGO in 
sham and SCI male rats. 
Infusions of saline did not trigger SVP increases or BCM activity in sham 
rats. In contrast, intrathecal infusions of G
same animal as in A], F: SCI [ same animal as in B])
BCM bursts in the absence of DPN stimulation in a subset of sham and SCI male rats. Each trace 
represents 200 seconds of recordings. 
 
 
(A) 
RP (C: Sham, D: SCI) and DAMGO 
 induced SVP increases and simultaneous 
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Figure 29 Representative BCM EMG and SVP recording traces depicting SVP and 
concurrent BCM EMG activity triggered by subthreshold (5 Hz) and threshold (30 Hz) 
levels of DPN stimulation following infusions of saline and GRP in sham and SCI male rats 
Representative BCM EMG and SVP recording traces depicting SVP and concurrent BCM EMG 
activity triggered by subthreshold (5 Hz) and threshold (30 Hz) levels of DPN stimulation in 
sham and SCI male rats. Subthreshold DPN stimulation (5 Hz) following saline infusions did not 
induce BCM EMG or SVP activity in sham (A) or SCI (C) male rats. Conversely, subthreshold 
DPN stimulation (5 Hz) following infusions of GRP triggered emission (SVP) and explusion 
(EMG) reflexes in both sham (B [same animal as in A]) and SCI (D [same animal as in C]) 
male rats. Next, threshold DPN stimulation (30 Hz) triggered BCM EMG and SVP activity in 
sham (E) but not in SCI (G) males. Intrathecal infusions of GRP followed by threshold DPN 
stimulation (30 Hz) triggered BCM EMG and SVP increases in sham males (F [same animal as 
in E]) and rescued ejaculatory reflexes in SCI males (H [same animal as in G]).    
 
Finally, in sham males, numbers of BCM events, bursts and SVP increases were 
significantly lower compared to those following 30 or 60 Hz stimulation after saline treatment in 
Trail 1 (all P < 0.001), but still appeared increased compared to subthreshold or no stimulation 
(statistical comparisons were not conducted). Hence, although GRP inhibited ejaculatory 
reflexes, they were still triggered by DPN stimulation. However, SCI males were even more 
affected by these inhibitory effects of GRP, and numbers of BCM bursts and SVP increases were 
significantly lower compared to sham males under the same GRP and DPN stimulation 
conditions (BCM bursts: 30 Hz: P < 0.001and 60 Hz: P = 0.036; SVP increases: 30 Hz P = 
0.01). 
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5.4.5 Infusions of DAMGO triggered ejaculatory reflexes in male SCI rats  
 
In sham animals, DAMGO (1 nmol) triggered ejaculatory reflexes (BCM events: P = 
0.001; BCM bursts: P < 0.001; SVP increases: P = 0.011). Moreover, DAMGO infusions 
triggered ejaculatory reflexes in SCI males, even though this only reached statistical significance 
for SVP increases (P = 0.028), with strong trends for BCM events (P = 0.053) and bursts (P = 
0.07). There were no differences between sham and SCI males in these parameters. In sham 
males, DAMGO did not facilitate ejaculatory reflexes following sub threshold DPN stimulation. 
Moreover, DAMGO completely ablated the ability of 30 and 60 Hz DPN stimulation to trigger 
ejaculation. These findings replicate our previous findings (Kozyrev, 2013b: Chapter 3) and 
indicate that once DAMGO is infused to stimulate ejaculation, subsequent ejaculatory reflexes 
can no longer be triggered by DPN stimulation. DAMGO infusions in SCI animals had the same 
lack of effect on DPN stimulation-induced ejaculatory reflexes. 
 
5.4.6 Experiment 2: SCI disrupts ejaculatory reflexes, but deltorphin or galanin do not 
improve function. 
 
First, the effects of SCI observed in the first experiment, were again observed in this 
second experiment. Whereas, 30 and 60 Hz DPN stimulation following saline infusions (control 
Trial 1) reliably triggered ejaculatory reflexes in sham males; SCI males showed no ejaculatory 
reflexes under any conditions (Figures 30, 31, 32). 
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Figure 30 Effects of galanin and deltorphin II infusions on the numbers of BCM events in 
sham and SCI male rats. 
Quantitative analysis of BCM events following intrathecal infusions of saline (A: trial 1[ control 
trial]) and galanin and deltorphin II (A: trials 2 and 3 [drug trials]), followed by 5 Hz (B), 10 Hz 
(C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI 
male rats. * denotes significant differences from saline (trial 1: control trial) within the same 
treatment group. # denotes significant differences between treatment groups (sham vs. SCI) 
within the same testing trial.   
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Figure 31 Effects of galanin and deltorphin infusions on the numbers of BCM bursts in 
sham and SCI male rats 
Quantitative analysis of BCM bursts following intrathecal infusions of saline (A: trial 1[control 
trial]) and galanin and deltorphin II (A: trials 2 and 3 [drug trials]), followed by 5 Hz (B), 10 Hz 
(C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and SCI 
male rats. * denotes significant differences from saline (trial 1: control trial) within the same 
treatment group. # denotes significant differences between treatment groups (sham vs. SCI) 
within the same testing trial.   
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Figure 32 Effects of galanin and deltorphin infusions on the numbers of SVP increases in 
sham and SCI male rats 
Quantitative analysis of SVP increases following intrathecal infusions of saline (A: trial 1[ 
control trial]) and galanin and deltorphin II (A: trials 2 and 3 [drug trials]), followed by 5 Hz (B), 
10 Hz (C), 30 Hz (D), and 60 Hz (E) DPN stimulations (in a counterbalanced order) in sham and 
SCI male rats. * denotes significant differences from saline (trial 1: control trial) within the same 
treatment group & denotes significant differences between treatment groups (sham vs. SCI) 
within the same testing trial.   
 
There were main effects of SCI on the numbers of BCM events and bursts, and SVP 
increases for all stimulation parameters (Infusions: Events: (F(1,32) = 12.685; P = 0.006; 5 Hz 
BCM events: F(1, 32) = 12.685; P = 0.006; BCM bursts: F(1, 32) = 54.144; P < 0.001; SVP 
increases: F(1, 32) = 47.903; P < 0.001; 10 Hz: BCM events: F(1, 32) = 38.976; P < 0.001; BCM 
bursts: F(1, 32) = 36.113; P < 0.001; SVP increases: F(1, 32) = 36.113; P < 0.001; Figure 32C; 
30 Hz: BCM events: F(1, 32) = 41.255; P < 0.001; BCM bursts: F(1, 32) = 229.685; P < 0.001; 
SVP increases: F(1, 32) = 95.582; P < 0.001; and 60 Hz BCM events: F(1, 32) = 31.001; P < 
0.001; BCM bursts: F(1, 32) = 29.730; P < 0.001; SVP increases: F(1, 32) = 20.089; P = 0.002). 
There were main effects of drug on the numbers of BCM events, bursts and SVP increases for 5, 
10, and 60 Hz DPN stimulation frequencies (5 Hz: BCM events: F(2, 32) = 7.942; P = 0.003; 
BCM bursts: F(2, 32) = 19.753; P < 0.001; SVP increases: F(2, 32) = 5.395; P = 0.015; 10 Hz: 
BCM events: F(2, 32) = 5.984; P = 0.010; BCM bursts: F(2, 32) = 4.547; P = 0.025; SVP 
increases: F(2, 32) = 7.409; P = 0.004; 60 Hz: BCM bursts: F(2, 32) = 4.054; P = 0.035). 
Additionally, there were significant interactions between main factors of SCI and drug on the 
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numbers of SVP increases, BCM events and bursts for 5, 10, and 60 Hz (5 Hz: BCM events: F(2, 
32) = 7.942; P = 0.003; BCM bursts: F(2, 32) = 19.753; P < 0.001; SVP increases: F(2, 32) = 
5.395; P = 0.015; 10 Hz: BCM events: F(2, 32) = 5.671; P = 0.012; BCM bursts: F(2, 32) = 
4.547; P = 0.025; SVP increases: F(2, 32) = 7.409; P = 0.004; 60 Hz: BCM bursts: F(2, 32) = 
4.054; P = 0.035). 
Post hoc tests showed that infusion of galanin and deltorphin facilitated ejaculatory 
reflexes in 100 % of sham males but did not affect ejaculatory reflexes in SCI males (Figures 
30B, 30C, 31B, 31C, 32B, 32C, and 33A-33F). In sham males, both galanin and deltorphin 
facilitated ejaculatory reflexes following subthreshold DPN stimulation, evidenced by 
significantly greater numbers of BCM events and bursts, and SVP increases (all P < 0.001), 
confirming our previous findings (Kozyrev, 2013b) (Chapter 4). Also, as we reported previously, 
galanin and deltorphin infusions had a slight dampening effect on ejaculatory reflexes induced 
by 30 (galanin: BCM bursts: P = 0.024) or 60 Hz (galanin: BCM bursts: P < 0.001 and SVP 
increases: P = 0.009; deltorphin: BCM bursts: P = 0.006) DPN stimulation in sham males, 
compared to saline conditions in Trial 1. In contrast, galanin and deltorphin had no effect on 
ejaculatory reflexes in SCI males (Figure 30, 31, 32, 33, 34). 
 Figure 33 Representative BCM EMG and SVP recording traces depicting SVP and 
concurrent BCM EMG activity triggered by subthreshold (5 Hz) DPN stimulation 
following infusions of saline, galanin and deltorphin in sham and SC
Subthreshold DPN stimulation (5 Hz) following saline infusions did not induce BCM EMG or 
SVP activity in sham (A) or SCI 
following infusions of galanin and deltrophin II triggered emission (SVP) and explusion (EMG) 
reflexes in sham (C [galanin]; E
male rats. Each trace shown represents 90 seconds of recordings.   
I male rats.
(B) male rats. Next, subthreshold DPN stimulation (5 Hz) 
 [deltorphin II]) but not in SCI (D [galanin]; F [deltorphin II]) 
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 Figure 34 Representative BCM EMG and SVP recording traces depicting SVP and 
concurrent BCM EMG activity induced by threshold (30 Hz) DPN stimulation following 
infusions of saline, galanin and deltorphin in sham and SCI male rats.
30 Hz DPN stimulations following saline infusions induced BCM EMG and SVP activity in 
sham (A) but not in SCI (B) male rats. Next, 30 Hz DPN stimulation following infusions of 
galanin and deltrophin II triggered SVP increases and concurrent BCM bursts  in sham (
[galanin]; E [deltorphin II]) but not in SCI (
shown represents 90 seconds of recordings.   
 
 
D [galanin]; F [deltorphin II]) male rats. Each trace 
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5.4.7 Experiment 3: Cocktail infusions triggered ejaculatory reflexes in a subset of SCI 
males 
 
In the final intrathecal infusion experiment, all sham and SCI animals received intrathecal 
infusions of a cocktail of all four receptor agonists (10 µl of 0.3 nmol galanin, 1 nmol DAMGO, 
13 nmol deltrophin II and 0.2 nmol GRP). There were main effects of DPN stimulation 
parameters on the numbers of BCM events (F(4, 89) = 4.862; P = 0.002) and bursts (F(4, 89) = 
2.930; P = 0.027), but only a trend on SVP increases (P = 0.074). Post hoc tests showed that in 
sham males, cocktail infusions did not trigger or facilitate ejaculatory reflexes. However, in 
contrast, in SCI males, cocktail infusions did trigger ejaculatory reflexes in the absence of DPN 
stimulation; but cocktail infusions did not facilitate ejaculatory reflexes following DPN 
stimulation. In SCI males infused with the cocktail, numbers of BCM events and bursts were 
higher compared to all DPN stimulation frequencies (compared to 5 Hz: BCM events: P < 0.001; 
BCM bursts: P = 0.002; 10 Hz: BCM events: P < 0.001; BCM bursts: P = 0.008; 30 Hz: BCM 
events: P < 0.001; BCM bursts: P = 0.01; 60 Hz: BCM events: P < 0.001; BCM bursts: P = 
0.003; Figure 35).  
 Figure 35 Effects of cocktail infusion on BCM EMG and SVP in sham and SCI male rats
Quantitative analysis of BCM events 
infusions of a cocktail of neuropeptides (galanin, deltorphin, GRP and DAMGO) and subsequent 
DPN stimulations (5 – 60 Hz counterbalanced) and representative BCM EMG and SVP traces in 
sham (D: Cocktail infusion) and SCI (
differences from 5, 10, 30 and 60 Hz DPN stimulations within the same treatment group. # 
denotes significant differences between treatment groups (sham vs. SCI) within the same DPN 
stimulation frequency.  Each trace shown represents 10 minutes of recordings.   
 
(A), bursts (B) and SVP increases (C) following intrathecal 
E: Cocktail infusion) male rats. * represents significant 
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5.5  Discussion 
 
The current study demonstrated that SCI following contusion injury severely disrupted 
ejaculatory reflexes in male rats. Moreover, the current study sought to determine if intrathecal 
infusions of four receptor ligands known to be expressed in LSt cells, were able to improve 
ejaculatory function in SCI males. We had previously shown facilitative effects of these four 
receptor ligands on ejaculatory reflexes in control animals (Kozyrev et al., 2012; Kozyrev, 
2013b, 2013c). Indeed, GRP and DAMGO, but not galanin and deltoprhin had a beneficial 
impact on ejaculatory function.  
 
Infusions of GRP rescued ejaculatory reflexes in a large subset of male rats with chronic SCI. 
GRP infusions were most effective in triggering emission and expulsion following drug infusion 
alone or in combination with subthreshold levels of DPN stimulation (5 – 10 Hz) in both sham 
and SCI males. Similarly, intrathecal infusions of the MOR agonist DAMGO restored emission 
in male rats with chronic SCI. Although the effects of DAMGO on expulsion, including the 
numbers of BCM events and bursts were not statistically significant across the group of SCI 
males, DAMGO infusions restored expulsion reflexes in a large percentage of SCI males (54 %). 
Future studies are required to investigate whether lower doses of DAMGO can restore 
ejaculatory reflexes in response to subthreshold levels of DPN stimulation in male rats with 
chronic SCI.  
In contrast, intrathecal infusions of galanin and deltorphin significantly enhanced ejaculatory 
reflexes following subthreshold DPN stimulation (5 – 10 Hz) in sham males but had no effect on 
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emission or expulsion in SCI male rats. One possible explanation for the inefficacy of galanin 
and deltrophin in the recovery of ejaculatory reflexes in male rats with chronic SCI may be a 
substantial reduction in delta opioid receptor and galanin receptor expression in the lumbosacral 
spinal cord as a result of the chronic SCI.  Since infusions of GRP and DAMGO, but not galanin 
or deltorphin were sufficient in restoring ejaculatory reflexes in a subset of SCI males, this 
suggests that the densities of mu opioid receptors and GRP receptors may remain relatively 
unchanged in male rats with chronic SCI. Our laboratory has previously observed that galanin 
immunoreactivity in LSt cells and axons in male rats with chronic SCI was not changed 
(unpublished observations), but a detailed investigation of neuropeptide or receptor expression 
has not yet been conducted.   
 
The disruption of descending pathways to the lumbosacral spinal cord following chronic SCI 
may constitute another reason why DPN stimulation may be ineffective in triggering ejaculation 
in SCI males (de Groat, 2010). This disruption of descending pathways can result in the 
denervation of spinal neurons triggering the release of neurotrophic factors which in turn trigger 
spinal cord plasticity and remodeling, including altered properties of afferent neurons, afferent 
nerve sprouting and changes in the synaptic connections between these neurons (de Groat, 2010). 
Indeed, SCI male rats exhibited profoundly impaired DPN-stimulation induced ejaculatory 
reflexes compared to sham males. The inability to trigger ejaculatory reflexes in response to 
sensory stimulation in SCI males may be due to a number of factors including neuroplasticity of 
the sensory pathways to the spinal ejaculation generator as a consequence of the chronic SCI 
which presumably may alter the sensitivity and/or the efficiency of the DPN to transmit sensory 
signals to the LSt cells. Electrophysiological studies in cats demonstrated the presence of 
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alterations in the afferent limb of the micturition reflex pathway as well as remodeling of 
synaptic connections in the spinal cord associated with the recovery of bladder function after 
chronic SCI (de Groat et al., 1981; de Groat et al., 1990; Araki and de Groat, 1997; Cheng et al., 
1999). Reorganization of the micturition reflex pathway after chronic SCI suggests the 
possibility of reorganization of the spinal ejaculation generator as well. This reorganization 
likely involves A δ and C-fibers in the DPN. Both types of fibers have been previously 
characterized in the DPN (Johnson and Halata, 1991).  However, the contribution of each type of 
fiber to ejaculation is currently unclear. Interestingly, alterations in morphology, neuropeptide 
expression and function of C-fiber afferents have been observed in the rat after chronic SCI. 
These changes include increased soma size of bladder afferent neurons in the L6-S1 dorsal root 
ganglion, (Yoshimura et al., 1998) the precise point of entry into the spinal cord of the DPN, 
after joining the pudendal nerve (Nunez et al., 1986), as well as increased neuropeptide 
expression and considerable afferent axonal expansion in the lumbosacral spinal cord (Zvarova 
et al., 2005; Vizzard, 2006). Based on these observations, it appears that C-fiber bladder 
afferents contribute to the synaptic remodeling in the lumbosacral spinal cord after chronic SCI. 
Moreover, the inability to trigger DPN stimulation-induced ejaculatory reflexes in SCI males in 
the current study suggests that the C-fiber mediated synaptic remodeling in the lumbosacral 
spinal cord may be the culprit. Future studies will be required to test the hypothesis that selective 
degeneration of C-fibers in the DPN will restore DPN-stimulation induced ejaculatory reflexes in 
male rats with chronic SCI.  
 
It is likely that the neuroplasticity resulting after chronic SCI considerably alters the sensory 
pathways to the spinal ejaculation generator, including the DPN, thereby rendering sensory 
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stimulation of the DPN an ineffective means of triggering ejaculatory reflexes in male rats with 
chronic SCI. A future experiment may utilize DPN stimulation to induce activation of the MAP 
kinase pathway in LSt cells in SCI and sham control animals. A finding that LSt cells in SCI 
males do not express pERK (Staudt et al., 2010; Kozyrev et al., 2012) or cFos (Truitt et al., 
2003) may be indicative of reduced sensory inputs to the LSt cells. 
Taken together, the results of the current study demonstrated that infusions of both GRP and 
DAMGO improved ejaculatory reflexes in a subset of chronic SCI male rats, with greater effects 
of GRP. However, it should be noted that in the current study, all animals received an acute 
transection of the mid thoracic spinal cord prior to the intrathecal infusions of the drugs. The 
rationale for this procedural decision is that ejaculatory reflexes in sham control animals can only 
be triggered upon removal of the supraspinal influences on the spinal ejaculation generator. 
Hence, it is currently unknown if GRP or DAMGO treatments will be effective in triggering 
ejaculatory reflexes in male rats with chronic SCI, but otherwise intact remaining suprasinal 
connections. Thus, additional preclinical studies will be required before GRP may be considered 
for its potential therapeutic properties in the treatment of ejaculatory dysfunction in SCI men.  
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Chapter 6: Systemic infusions of 7-OH-DPAT rescued 
ejaculatory reflexes in male rats with chronic contusion 
spinal cord injury  
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6.1 Introduction 
 
Ejaculation is a complex physiological process, that is composed of two successive 
phases: emission and expulsion (Marberger, 1974; McKenna, 1999). During the emission phase, 
seminal fluids are secreted from the accessory sexual organs, including the prostate, seminal 
vesicles and vas deferens, and moved through the urethra, while the bladder neck and external 
urethral sphincter shut to deter retrograde ejaculation. During the expulsion phase, the striated 
perineal muscles, including the bulbocavernosus muscle (BCM), undergo coordinated, rhythmic 
contractions and in this way vigorously eject seminal contents from the urethral meatus (Bohlen 
et al., 1980; Gerstenberg et al., 1990; Holmes et al., 1991; Holmes and Sachs, 1991). Ejaculation 
is radically altered in men with chronic spinal cord injuries (SCI) (Brackett et al., 1998) the 
majority of whom ( 85%) are men between the ages of 18-45 (Ohl et al., 1989). Of all SCI men, 
only 12 – 15 % are able to ejaculate by means of intense vibratory stimulation or electro-
ejaculation (Elliott, 2006). Recovery of normal sexual function is the highest priority for 
paraplegic men, followed by bladder function (Anderson, 2004). However, the neural 
mechanisms that alter ejaculation following chronic SCI are currently unknown.   
Ejaculation is a reflex (Pescatori et al., 1993; McKenna, 1999) controlled by a spinal 
ejaculation generator, comprised of a set of interneurons located in lamina 10 and the medial 
aspect of lamina 7 in lumbar segments 3 and 4 (L3-4) in the lumbosacral spinal cord and their 
projections to spinal autonomic and motor neurons (Truitt and Coolen, 2002). The interneurons, 
known as lumbar spinothalamic (LSt) cells due to their anatomical positioning in the lumbar 
spinal cord and thalamic projections (Ju et al., 1987; McKenna, 1997; Coolen et al., 2003; Truitt 
et al., 2003), are critical for ejaculation. Previous studies from our laboratory have shown that 
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targeted lesion of these interneurons completely ablates ejaculation while sparing all other 
components of male sexual behavior in freely-moving male rats during coitus (Truitt and Coolen, 
2002; Staudt, 2011) and abolishes ejaculatory reflexes induced by stimulation of sensory inputs 
from the dorsal penile nerve (DPN) or urethra, or triggered by infusion of the selective dopamine 
D3 receptor agonist 7-hydroxy-2-(di-N-propylamino) tetralin (7OHDPAT) in anesthetized and 
spinalized male rats (Staudt, 2011). The mechanisms whereby the spinal ejaculation generator 
controls ejaculation involve the coordination of sympathetic, parasympathetic, and motor ouflow 
necessary to trigger emission and expulsion (Carro-Juarez et al., 2003; Coolen et al., 2004; 
Coolen, 2005; Carro-Juarez and Rodriguez-Manzo, 2007) as well as the integration of the DPN-
transmitted sensory signals during mating with this autonomic and motor ouflow to initiate 
ejaculation (Coolen et al., 2004; Coolen, 2005). Specifically, the LSt cells are postulated to 
convert sensory signals associated with mating into motor or secretory outputs (Staudt et al.; 
Truitt and Coolen, 2002; Coolen et al., 2004; Coolen, 2005; Staudt, 2011). LSt cell axons 
directly project to sympathetic, parasympathetic and motor spinal nuclei in the thoracolumbar 
and lumbosacral spinal cord implicated in emission and expulsion components of ejaculation 
(Newton, 1993; Allard et al., 2005; Xu et al., 2006; Sakamoto et al., 2008; Kozyrev et al., 2012; 
Kozyrev, 2013c, 2013b). LSt cells and axons co-contain the neuropeptides enkephalin, galanin, 
cholecystokinin  and gastrin releasing peptide (GRP) (Ju et al., 1987; Newton, 1993; Nicholas et 
al., 1999; Coolen et al., 2003; Truitt et al., 2003; Sakamoto et al., 2008; Kozyrev et al., 2012). 
Release of these neuropeptides is critical for ejaculation, as blockade of each of the neuropeptide 
receptors in the lumbosacral spinal cord prevents ejaculatory reflexes triggered by DPN 
stimulation (Kozyrev et al., 2012; Kozyrev, 2013c, 2013b). 
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Moreover, the neurotransmitter dopamine, has also been shown to play a critical role in 
ejaculation (Hull et al., 2004; Peeters and Giuliano, 2008). In evidence of this, 
intracerebroventricular (i.c.v)  or systemic infusions of the selective dopamine D3 receptor 
agonist 7-hydroxy-2-(di-N-propylamino) tetralin (7OHDPAT) dramatically reduces the number 
of intromissions prior to ejaculation as well as the latency to ejaculation in freely mating male 
rats (Ahlenius and Larsson, 1995; Ferrari and Giuliani, 1996).  In addition, i.c.v administration of 
7OHDPAT consistently triggers coordinated, rhythmic contractions of the BCM and concurrent 
increases in SVP in anesthetized spinal intact male rats (Clement et al., 2007; Kitrey et al., 2007; 
Clement et al., 2008; Clement et al., 2009a; Staudt, 2011). 7OHDPAT can also trigger 
ejaculatory reflexes in spinalized anesthetized male rats, demonstrating that it acts on D3 
receptors in the lumbosacral spinal cord to mediate ejaculation (Staudt, 2011). Moreover, effects 
of 7OHDPAT are dependent on intact LSt cells, suggesting that this D3 agonist acts either on 
LSt cells or on D3 receptor-containing neurons that provide inputs to LSt cells.  
Given the facilitatory effects of 7OHDPAT on ejaculatory reflexes, the current study 
aimed to test whether subcutaneous infusions of the D3 receptor agonist 7OHDPAT can rescue 
ejaculatory reflexes in anesthetized and spinalized male rats with chronic SCI. It was predicted 
that subcutaneous infusion of 7OHDPAT will restore ejaculatory reflexes in chronic SCI male 
rats without added sensory stimulation by acting on D3 receptors in the lumbosacral spinal cord. 
Additionally, it was predicted that subcutaneous infusions of 7OHDPAT will rescue emission 
and expulsion reflexes in SCI males following threshold levels of DPN stimulation (30 – 60 Hz). 
The DPN stimulation model was utilized for these experiments  because it is a physiologically 
relevant model of ejaculation (Clement P, 2011). The DPN stimulation model reliably triggers 
ejaculatory reflexes in rodents (Pescatori et al., 1993; Staudt et al., 2010; Kozyrev et al., 2012; 
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Kozyrev, 2013b, 2013c), primates (Herbert, 1973), and men (Wieder et al., 2000) and all 
experiments are performed on anesthetized male rats.   
 
6.2 Materials and Methods 
 
6.2.1 Animals 
Adult male Sprague Dawley rats (225-250 grams) were obtained from Charles River 
(Wilmington, MA, USA) and pair housed in standard housing cages on a reverse 12-hour 
light/dark cycle with lights off at 9 a.m. Food and water were available at all times. All 
procedures were approved by the Use and Care of Animals at the University of Michigan and 
conformed to the guidelines outlined by the National Institutes of Health. 
 
6.2.2 Spinal Cord Surgeries 
Male rats were divided in a spinal cord injury (SCI) group or sham group. All surgical 
procedures were performed under ketamine (87 mg/ml) / xylazine (13 mg/ml) anesthesia (I 
ml/kg i.p. injection), and as described in Chapter 5. The entire back of the males was shaved and 
cleaned with betadine, iodine and 70 % alcohol solution. Eyes were covered with Lacrilube 
opthalamic ointment (Allergen, Irevine, CA) to prevent them from drying. All animals received a 
laminectomy between the 6th and 7th thoracic spinal segments (T6-T7) and SCI male rats 
received a contusion injury of the spinal cord, performed with the IH-400 impactor (Precision 
Systems and Instrumentation, LLC, Lexington, KY). The impactor was positioned 1.5 inches 
above the cord and a force of 200 kdyn was applied to the dura of the exposed spinal cord. 
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Afterwards, the layers of muscle and skin were sutured separately, with absorbable sutures and 
wound clips respectively. In order to alleviate pain and prevent bacterial infection animals 
received subcutaneous injections of the analgesic ketoprofen (5 mg/ml/kg), and the antibiotic 
Baytril (5 mg/ml/kg), immediately following surgery and for three days thereafter. The sham 
animals underwent all procedures, including ketoprofen and Baytril treatment, except for the 
contusion injury. In SCI animals, bladders were expressed twice per day until bladder function 
returned (typically 7-10 days after injury). Sham animals were handled, but bladders were not 
expressed. 
 
6.2.3 Locomotor testing 
Locomotor activity was measured as described in Chapter 5, at 2, 3, and 4 weeks after contusion 
injury or sham procedures, sham (N= 7) and SCI (N = 13) males were placed in an Open Field 
Apparatus (Med Associates Inc, Vermont) surrounded by two 16x16 photobeam arays, during 
the first half of the dark phase. Locomotor activity was measured and expressed ambulatory time 
in the horizontal plane, and vertical rearing. Both measures of locomotor activity were analyzed 
using a two-way repeated anova (factors: SCI and time) and Holm-Sidak post-hoc tests.  
 
6.3 Experimental Designs 
 
6.3.1 General Methods: 
Recording parameters of expulsion and emission: All experiments started four to five weeks 
following the spinal cord contusion surgeries.  Male rats were deeply anesthetized with urethane 
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(1.5 g/kg, i.p.) and procedures for recordings are identical as we described previously (Staudt et 
al., 2010; Kozyrev et al., 2012; Kozyrev, 2013b, 2013c). Connective tissues and ligaments 
enclosing the reproductive organs were carefully removed to expose the muscle of the 
bulbocavernosus (BCM) and the dorsal penile nerve (DPN). In preparation for 
electromyographic (EMG) recordings, silver recording electrodes connected to the 
PowerLab/7SP Data Acquisition System (AD Instruments, Inc., Colorado Springs, CO, USA) 
were inserted bilaterally into the BCM and a ground electrode was implanted into the muscle of 
the right thigh. For simultaneous recordings of seminal vesicle (SV) pressure, a marker of the 
emission component of ejaculation (Clement et al., 2008; Kozyrev et al., 2012; Kozyrev, 2013b, 
2013c; Kozyrev, 2013a), a small abdominal incision was performed and the right seminal vesicle 
was located. SV pressure (SVP) was recorded using a pressure catheter (AD Instruments Inc., 
model number: SPR-671(1.4 F, Single, Straight, 15 cm, Ny) coupled to a catheter interface cable 
(AD Instruments Inc., model number: AEC-IOD) and connected to a Bridge AMP (AD 
Instruments Inc.). The pressure catheter was gently inserted into the lumen of the SV and fixed in 
place before the start of recordings. The initial electrical stimulation of the DPN comprised 
square wave pulses of 1 ms duration, 4 V at 30 or 60 Hz for 10 seconds. These established DPN 
stimulation parameters consistently induce emission and expulsion reflexes in all saline-treated 
control male rats, reflected in rhythmic increases in SVP and concurrent bursting of the BCM 
respectively (Staudt et al., 2010; Staudt, 2011; Staudt et al., 2011; Kozyrev et al., 2012; Kozyrev, 
2013c, 2013b; Kozyrev, 2013a).  
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6.3.2 BCM EMG and SVP Analysis  
For these experiments, SVP and BCM EMG recordings were analyzed for 15 minutes following 
infusions of saline and 7OHDPAT, and for 90 seconds following each DPN stimulation. 
Specifically, the numbers of SVP increases and concurrent BCM events and bursts were 
analyzed following DPN stimulation and subcutaneous infusion of saline and 7OHDPAT. The 
numbers of BCM events were analyzed using LabChart 7.35 (AD Instruments Inc.) software and 
all events above baseline activity were incorporated in the analysis (Staudt et al., 2010; Kozyrev 
et al., 2012). The numbers of BCM bursts and SVP increases were analyzed as previously 
described (Kozyrev et al., 2012; Kozyrev, 2013b; Kozyrev, 2013a; Kozyrev, 2013c). 
Specifically, 8 or more successive BCM events above baseline activity were counted as a ‘burst’ 
and all simultaneous increases in SVP (greater than baseline) were incorporated in the analysis.  
 
Acute spinal transection: Depending on the experimental design (see below), animals received a 
complete acute spinal transection before and after 7OHDPAT infusions. A laminectomy was 
performed at the eighth thoracic segment (T8), caudal to the injury site, and the spinal cord was 
completely transected.  
 
Drug infusions: 7-Hydroxy-2-(di-n-propylamino) tetralin hydrobromide (7OHDPAT; Sigma 
Alderich Co. LLC) was dissolved in sterile saline (0.9%) and injected s.c. at dose 1 mg/ml/kg. 
This dose was previously shown to trigger ejaculatory reflexes in anesthetized, spinalized male 
rats (Staudt, 2011). 
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6.3.3 Experiment 1: 7OHDPAT or saline infusions after acute spinal transection 
 
This second experiment was a partial repeat of the first experiment, but without the high 
stimulation frequencies prior to 7OHDPAT infusions. Moreover, each animal received both 
saline and 7OHDPAT infusions to allow for within animal comparisons. Anesthetized and 
spinally-transected sham (N = 6) and SCI (N = 6) male rats received DPN stimulation at 30 and 
60 Hz in a counterbalanced manner and SVP and BCM EMG were recorded for 90 seconds 
following each stimulation (trial 1). Next, sterile saline was infused subcutaneously and SVP and 
BCM EMG were recorded for a 15 minutes. Afterwards, 7OHDPAT was infused subcutaneously 
and once again SVP and BCM EMG were recorded for 15 minutes following drug infusion. 
Following drug infusion, the DPN was stimulated at 30 and 60 Hz in a counterbalanced manner 
and SVP and BCM EMG were recorded for 90 seconds after each stimulation (trial 2; Figure 
36A).  
 Figure 36 7-OH-DPAT experiments: Timeline of experimental manipulations.
A) In the first experiment, spinalized sham and SCI male rats received 30 and 60 Hz DPN 
stimulations (indicated by empty bolt arrows) in a counterbalanced manner with five
intervals between stimulations and recordings of BCM EMNG and SVP, in Trial 1. 
animals received saline (arrow) and subsequently 7OHDPAT (arrow), each followed by 15 
minutes recording of BCM EMG and SVP, in Trial 2. Next, animals received 30 and 60 Hz DPN 
stimulations in a counterbalanced order (filled bolt arrows) and BCM EMG a
recorded for 90 seconds following each DPN stimulation, in Trial 3. 
experiment, sham and SCI male rats received 60 Hz DPN stimulation (bolt arrow), followed by 
consecutive saline and 7OHDPAT infusions (arrows: Trial 1) and BCM 
recorded for 15 minutes following each infusion. Next, animals received acute spinal transection 
and DPN stimulation at 60 Hz (bolt arrow)
infusions of saline and 7OHDPAT (arrows: Trial 2) and BC
recorded for 15 minutes each. Finally, males received DPN stimulation at 30 and 60 Hz 
B)
EMG and SVP were 
. Subsequently, animals received consecutive 
M EMG and SVP were again 
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Next, 
nd SVP were 
 In the second 
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(counterbalanced: Bolt arrows) and BCM EMG and SVP were recorded for 90 seconds 
following each DPN stimulation.     
 
Statistical analysis: The effects of SCI (Factor: SCI versus sham) on numbers of BCM 
events and bursts, and SVP increases were compared between saline and 7OHDPAT infusion 
trials (Factor: drug versus saline) using two-way repeated ANOVA. In separate two way 
repeated ANOVAs, effects of SCI (factor: SCI versus sham) on responses to each 30 or 60 Hz 
DPN stimulation were compared for before and after spinal cord transection (factor: spinal 
transection). Holms Sidak tests were used for all post hoc analyses. 95% confidence level was set 
for all tests.  
 
6.3.4 Experiment 2: 7OHDPAT infusions before and after acute spinal transection  
In this experiment, anesthetized and spinally-intact sham (N = 7) and SCI (N = 8) male 
rats received initial DPN stimulation at 60 Hz to confirm lack of ejaculatory reflexes. Next, all 
animals received subcutaneous infusion of sterile saline (1ml/kg; 0.9%) and SVP and BCM 
EMG were recorded for 15 minutes after saline infusion (trial 1: Saline trial). Again, no reflexes 
are expected under these circumstances. Next, male rats received subcutaneous injections of 
7OHDPAT (1mg/ml/kg) and SVP and BCM EMG were recorded for 15 minutes immediately 
following drug infusion (trial 2: Drug trial). After a rest period of 3 hours, selected to allow the 
effects of the 7OHDPAT on ejaculatory reflexes to subside, the spinal cord was completely 
transected at T8. Next, the DPN was stimulated at 60 Hzand SVP and BCM EMG were recorded 
for 90 seconds following stimulation, in order to verify the completeness of the spinal cord 
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transection. Next, sterile saline was infused subcutaneously and SVP and BCM EMG were 
recorded for 15 minutes following saline injection (trial 1: Saline trial). Subsequently, 
7OHDPAT was infused subcutaneously and SVP and BCM EMG were recorded for another 15 
minutes following drug infusion (trial 2: Drug trial). Finally, the DPN was stimulated at 30 and 
60 Hz (in a counterbalanced manner) and SVP and BCM EMG were recorded for 90 seconds 
after each DPN stimulation with a 5 minute rest period between stimulations (Figure 36B).  
 
Statistical analysis:  Numbers of SVP increases, BCM events and bursts were compared within 
animals between saline or 7OHDPAT treatment, and between SCI and sham groups within saline 
or 7OHDPAT using a two-way repeated anova (factors: drug and SCI). Data were analyzed 
separately for before and after spinal transection.  
 
6.4 Results  
 
6.4.1 Locomotor activity was impaired in SCI male rats  
 
Locomotor activity was impaired in SCI rats, but not completely absent. Animals 
displayed comparable levels of ambulatory activity, as there were no significant differences 
between sham and SCI male rats in time spent in horizontal activity (Figure 37A). However, SCI 
males had impaired ability to rear and thus time spent on vertical activity (Figure 37B). There 
were main effects of SCI on vertical activity (F(1, 59) = 9.361; P = 0.007; Figure 37B). Vertical 
 activity was significantly reduced in SCI male rat
0.006; Figure 37B) and four weeks (
trend towards significance 2 weeks following surgery (
 
Figure 37 7-OH-DPAT experiments: Locomotor activity in sham and SCI male rats 2, 3, 
and 4 weeks after surgery. 
Locomotor acitivity expressed as the mean time (ms) sham and SCI male rats spent in 
ambulatory (A) and vertical (B)
weeks following spinal cord contusion injury (or sham surgery).  
 
s compared to sham male rats three weeks (
P = 0.005; Figure 37B) following contusion injury, with a 
P = 0.081; 2 tailed test).  
 locomotion during three 15-minute tests, two, three and four 
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6.4.2 7OHDPAT infusions improved ejaculatory reflexes in chronic SCI male rats after 
acute spinal transection 
First, DPN stimulation did not trigger ejaculatory reflexes in SCI males, confirming the 
detrimental effects of SCI we reported previously (Kozyrev, 2013a). The initial 60 Hz DPN 
stimulation increased numbers of BCM events, bursts, and SVP increases in sham, but not SCI 
males (Table 2). 
 
Table 2 Initial 60 Hz DPN stimulation facilitates BCM events, bursts and SVP increases in 
sham but not in SCI male rats. 
60 Hz SHAM (N=6) SCI (N=6) 
EVENTS  411.5 ± 61.956 27.5 ± 15.718* 
BURSTS 5.833 ± 0.801 0.666 ± 0.422* 
SVP 2.006 ± 0.571 0.666 ± 0.422* 
Data are presented as mean and standard error of the mean for numbers of BCM events, bursts 
and SVP increases in sham (N=6) and SCI (N=6) male rats. * indicates significant differences 
between groups (events: P < 0.001; Bursts: P < 0.001; SVP: P = 0.005).  
 
However, 7OHDPAT infusions (Trial 2) triggered both emission and expulsion reflexes 
in SCI male rats, similar to the effects in sham males (Figure 38). In addition, 7OHDPAT 
amplified ejaculatory reflexes following 30 and 60 Hz DPN stimulation in SCI males compared 
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to DPN stimulation without drug infusion delivered following spinal cord transection in trial 1 
(Figure 39).  Of all sham males tested, 83% responded to 7OHDPAT infusion alone, compared 
to 100% of SCI males. ‘Responders’ had at least one SVP increase and accompanying BCM 
burst following 7OHDPAT treatment. Moreover, 100 % of SCI and sham male rats responded to 
30 and 60 HZ DPN stimulation following infusions of 7OHDPAT (Figures 39B, 39D). 
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Figure 38 Single-infusion 7-OH-DPAT experiment: Effects of 30 and 60 Hz DPN 
stimulations on the numbers of BCM events, bursts and SVP increases in sham and SCI 
male rats. 
Representative BCM EMG and SVP traces in response to 30 Hz DPN stimulation after spinal 
cord transection (A) and following 7OHDPAT infusion (B – same animal as in A) in a sham 
male and corresponding traces triggered by 30 Hz DPN stimulation after spinal transection (C) 
and after 7OHDPAT infusion (D – same animal as in C) in an SCI male. Quantitative analysis of 
BCM events (E) bursts (F) and SVP (G) triggered by 30 and 60 Hz DPN stimulations following 
spinal transection and infusions of 1mg/kg 7OHDPAT.  # indicates significant differences from 
transection (trial 1: control trial) within the same treatment group. * denotes significant 
differences between treatment groups (sham and SCI) within the same testing trial and 
stimulation. 
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Figure 39 Single-infusion 7-OH-DPAT experiment: Effects of subcutaneous 7-OH-DPAT 
infusions on the numbers of BCM events, bursts and SVP increases in sham and SCI male 
rats 
Single-infusion 7OHDPAT experiment: Effects of subcutaneous 7OHDPAT infusion on the 
numbers of BCM events, bursts and SVP increases in sham and SCI male rats. Representative 
BCM EMG and SVP traces in response to saline (A) and 7OHDPAT (B – same animal as in A) 
infusion in a sham male and corresponding saline (C) and 7OHDPAT (D – same animal as in C) 
infusion traces in a SCI male rat. Quantitative analysis of BCM events (E) bursts (F) and SVP 
(G) in sham and SCI male rats triggered by infusions of 1mg/kg 7OHDPAT.  # indicates 
significant differences from saline (trial 1: control trial) within the same treatment group.  
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There were main effects of saline versus 7OHDPAT treatment on the numbers of BCM 
events and bursts (events: F(1,23) = 14.851; P = 0.003; bursts: (F(1,23) = 17.163; P = 0.002;) 
and numbers of SVP increases (F(1, 23) = 12.484; P = 0.005), but there were no main effects of 
SCI on any parameter of ejaculatory behavior. Post hoc analyses revealed that both sham and 
SCI males had significantly greater numbers of BCM events (sham: P = 0.014; SCI: P = 0.033) 
and bursts (sham: P = 0.013; SCI: P = 0.018) and SVP increases (sham: P = 0.043; SCI: P = 
0.023) following infusions of 7OHDPAT compared to saline infusions; Figure 38). There were 
no differences between sham and SCI groups in their responses to 7OHDPAT, indicating the D3 
agonist fully triggered ejaculatory reflexes in SCI males.  
 
However, only SCI males had significantly greater numbers of SVP increases following 
30 Hz DPN stimulation in trial 2 (7OHDPAT infusion; P = 0.005; Figure 39G). In addition, 
there were main effects of trauma on the numbers of SVP increases, BCM events and bursts 
following 30 Hz (SVP: F(1,23) = 19.912; P = 0.001; Figure 39G; Events: F(1,23) = 46.677; P < 
0.001; Figure 39E); Bursts: F (1,23) = 23.100; P < 0.001; Figure 39F) and 60 Hz (SVP: F(1,23) 
= 29.091; P < 0.001; Figure 39G; Events: F(1,23) = 29.748; P < 0.001; Figure 39E; Bursts: 
F(1,23) = 47.451; P < 0.001; Figure 39F) DPN stimulation frequencies. Moreover, there were 
significant interactions between factors of testing trial and trauma on the numbers of SVP 
increases, BCM events and bursts following 30 Hz DPN stimulations (SVP: F(1,23) = 7.168; P 
= 0.023; Events: F(2,23) = 5.900; P = 0.036; Bursts: F(2,23) = 12.484; P = 0.005; Figures 39E, 
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39F, 39G). Post hoc analyses demonstrated that sham male rats had significantly more BCM 
bursts following 60 Hz DPN stimulation after spinal cord transection in trial 1 compared to 
infusion of 7OHDPAT in trial 2 (P = 0.031; Figure 39A, 39B, 39F). In contrast, SCI males had 
significantly greater numbers of SVP increases, BCM events and bursts following 30 Hz DPN 
stimulation and with a trend for numbers of BCM events following 60 Hz DPN stimulation after 
7OHDPAT treatment, in trial 2, than after spinal cord transection, in trial 1 (SVP: 30 Hz:  P = 
0.005; Events: 30 Hz:  P = 0.014; Bursts: 30 Hz: P = 0.004; Events: 60 Hz:  P = 0.055; Figures 
39C, 39D, 39E, 39F, 39G). Following spinal cord transection in trial 1, sham males had 
significantly greater numbers of SVP increases, BCM events and bursts following 30 Hz DPN 
compared to SCI males (SVP: P < 0.001; Events: P < 0.001; Bursts: P < 0.001; Figures 39A, 
39C, 39E, 39F, 39G). In addition, sham males had significantly greater numbers of BCM events 
following 30 Hz DPN stimulation in trial 2, after 7OHDPAT infusions, compared to SCI males 
(BCM events: P = 0.002; Figure 39B, 39D, 39E). Similarly, sham males had significantly 
greater numbers of SVP increases, BCM events and bursts following 60 Hz DPN stimulation in 
both trials 1 and 2 after transection and 7OHDPAT treatment respectively, compared to SCI 
males (SVP (trial 1): P = 0.001; (trial 2): P = 0.020; Figure 39G; Events (trial 1): P < 0.001; 
(trial 2): P = 0.002; Figure 39E; and Bursts: (trial 1): P < 0.001; (trial 2): P = 0.001; Figure 
39F).  
 
6.4.3 7OHDPAT double infusion experiment: Results 
Prior to spinal cord transection in trial 1, subcutaneous injections of 7OHDPAT triggered 
ejaculatory reflexes in 2/7 sham (29%) and 1/8 SCI (13%) males with intact spinal cords in the 
absence of DPN stimulation (Figures 40A, 40B, 40C, 40D, 40I, 40J, 40K). Conversely, infusions 
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of 7OHDPAT after spinal cord transection triggered ejaculatory reflexes in 100% of sham and 
88% of SCI male rats (Figures 40G, 40H, 40I, 40J, 40K). There were main effects of infusion on 
the numbers of BCM events in sham male rats (F (1, 29) = 5.112; P = 0.042). Post hoc tests 
demonstrated that infusions of 7OHDPAT (trial 2) in anesthetized, intact sham males 
significantly increased the numbers of BCM events compared to saline treatment (trial 1: P = 
0.033; Figures 40A, 40B, 40I). In addition, there was a significant interaction between factors of 
infusion and trauma on the numbers of SVP increases prior to spinal cord transection (F (2, 29) = 
4.718; P = 0.049). Specifically, sham males with intact spinal cords (prior to transection) 
demonstrated significantly enhanced numbers of SVP increases after 7OHDPAT infusions in 
trial 2 compared to saline infusion in trial 1(P = 0.023; Figures 40A, 40B, 40K). There were also 
main effects of infusion on the numbers of SVP increases, BCM events and bursts in 
anesthetized and spinalized sham and SCI male rats (SVP: (F (1, 29) = 16.136; P = 0.001; Figure 
40K); Events: (F (1, 29) = 14.498; P = 0.002; Figure 40I); Bursts: (F (1, 29) = 16.136; P = 
0.001; Figure 40J). Post hoc tests revealed that spinally-transected sham and SCI males 
demonstrated significantly greater numbers of SVP increases and BCM bursts following 
infusions of 7OHDPAT in trial 2 compared to saline infusions in trial 1 (SVP: (sham): P = 
0.042; (SCI): P = 0.004); (Bursts: (sham): P = 0.042; (SCI): P = 0.004; Figures 40E, 40F, 40G, 
40H, 40J, 40K). However, only spinalized SCI males demonstrated significantly greater numbers 
of BCM events following 7OHDPAT infusions in trial 2 compared to saline injections in trial 1 
(P = 0.004; Figures 40G, 40H, 40I) while there was a trend towards significance for sham males 
(P = 0.071; Figures 40E, 40F).   
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Figure 40 Double-infusion 7-OH-DPAT experiment: Effects of 7-OH-DPAT infusions on 
the numbers of BCM events, bursts and SVP increases in spinally-intact and transected 
sham and SCI male rats. 
Representative BCM EMG and SVP traces in response to saline (A) and 7OHDPAT (B – same 
animal as in A) infusions in an intact sham male and corresponding saline (C) and 7OHDPAT 
(D – same animal as in C) infusions in an intact SCI male rat. Representative BCM EMG and 
SVP traces triggered by saline (E) and 7OHDPAT (F – same animal as in E) infusions in a 
transected sham and corresponding saline (G) and 7OHDPAT (H – same animal as in H) traces 
in a transected SCI male rat. Quantitative analysis of BCM events (I) bursts (J) and SVP (K) 
triggered by infusions of 1mg/kg 7OHDPAT in intact and subsequently spinally-transected sham 
and SCI male rats.  # indicates significant differences from saline (trial 1: control trial) within the 
same treatment group.  
 
6.5 Discussion 
 
These studies demonstrate that systemic administration of the dopamine D3 receptor agonist 
7OHDPAT improved ejaculatory reflexes in anesthetized and spinalized SCI male rats. 
Specifically, 7OHDPAT infusions triggered emission and expulsion reflexes in both sham and 
SCI male rats in the absence of sensory stimulation. However, an acute spinal transection is 
required for this effect of the D3 agonist. These results suggest that supraspinal influences inhibit 
the mechanisms by which D3 receptor agonist 7OHDPAT facilitates ejaculation. In addition, 
infusions of 7OHDPAT facilitated ejaculatory reflexes in SCI males following threshold (30 – 
60 Hz) levels of DPN stimulation. In all experiments, sham males demonstrated considerably 
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more robust ejaculatory reflexes prior to 7OHDPAT treatment. However, there were no 
significant differences between sham and SCI males in the numbers of SVP increases, BCM 
events or bursts triggered by infusions of 7OHDPAT with one exception.  
In the single-infusion experiment, SCI males clearly showed severe impairment in 
ejaculatory reflexes compared to sham males prior to 7-OH-DPAT treatment, as evidenced by 
the dramatically reduced numbers of SVP increases, BCM events and bursts following DPN 
stimulation (30 – 60 Hz) in SCI males compared to sham males in trial 1, following spinal cord 
transection. Undoubtedly, 7-OH-DPAT treatment restored ejaculatory reflexes in SCI males. 
However, even after 7-OH-DPAT infusions, SCI males still had reduced numbers of SVP 
increases, BCM events and bursts following DPN stimulation compared to sham males 
suggesting the presence of an underlying problem with the transmission of sensory information 
to the spinal ejaculation generator required to activate the LSt cells, and in turn, trigger emission 
and expulsion. One reason for the altered transmission of sensory information to the lumbosacral 
spinal cord in SCI males might be the disruption of descending pathways to the lumbosacral 
spinal cord following chronic SCI (de Groat, 2010). Impaired descending pathways can lead to 
the denervation of spinal neurons promoting the release of neurotrophic factors leading to 
synaptic remodeling and plasticity of afferent neurons, marked changes in the properties of these 
neurons and their connections (de Groat, 2010).  Another reason for the impaired DPN-
stimulation induced ejaculatory reflexes in SCI males may be the reorganization of sensory 
pathways, particularly the DPN, resulting in reduced transmission of sensory information from 
the sexual organs to the dorsal horn of the lumbosacral spinal cord.  Indeed, previous studies 
reported reorganization of sensory fibers of the micturition reflex pathway in cats following 
chronic SCI (de Groat et al., 1981; de Groat et al., 1990; Araki and de Groat, 1997; Cheng et al., 
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1999) indicating that reorganization of afferent fibers may also occur in other reflex pathways in 
the spinal cord, namely in the spinal ejaculation generator. The DPN is composed of A δ and C-
fibers (Johnson and Halata, 1991) but the role of each fiber type in ejaculation is presently 
unknown. However, previous studies reported changes in soma size, neuropeptide expression 
and function of C-fiber afferents (Yoshimura et al., 1998) as well as neuroplasticity of sensory 
fibers in the lumbosacral spinal cord in rats with chronic SCI (Zvarova et al., 2005; Vizzard, 
2006). Therefore, C-fiber bladder afferents undergo synaptic remodeling and reorganization 
following chronic SCI and the inefficacy of DPN stimulation to trigger ejaculatory reflexes in 
chronic SCI males may be the result of synaptic remodeling of C-fibers in the DPN.  
The DPN represents the sensory branch of the pudendal nerve that conveys sensory 
information associated with copulation to the spinal ejaculation generator and in turn, leads to 
the activation of LSt cells with ejaculation (Hart, 1968; McKenna and Nadelhaft, 1986; Staudt et 
al., 2010; Staudt, 2011; Kozyrev et al., 2012). Moreover, stimulation of the DPN produces 
coordinated and rhythmic contractions of the BCM akin to those observed in male rats during 
mating (Pescatori et al., 1993) and bilateral lesion of the DPN completely ablates ejaculation in 
copulating rats (Lodder and Zeilmaker, 1976). Direct stimulation of the DPN results in the neural 
activation of LSt cells, in anesthetized and spinalized male rats (Staudt et al., 2010; Kozyrev et 
al., 2012). Specifically, DPN stimulation activates the LSt cells through map kinase signaling 
(Staudt et al., 2010) and the activation of NMDA receptors (Staudt et al., 2011) and 
pharmacologically blocking either of these components  inhibits ejaculatory reflexes triggered by 
DPN stimulation in male rats (Staudt et al., 2010, 2011). Anatomically, it is known that fibers of 
the DPN innervate the dorsal horn and the dorsal central grey (DCG) in lumbosacral spinal cord, 
in the vicinity of the LSt cells (McKenna and Nadelhaft, 1986; Ueyama et al., 1987; Tang et al., 
196 
 
1999). However, precisely how sensory information associated with mating or DPN stimulation 
is transmitted to the LSt cells and more importantly, any direct functional connections between 
the DPN and LSt cells are presently unknown. Clearly, spinal cord trauma appears to alter the 
functional properties of the DPN, since DPN stimulation (30 – 180 Hz) alone was ineffective in 
triggering ejaculatory reflexes in SCI males. However, it is likely that other intraspinal 
connections, acting through D3 receptors, remain intact after chronic spinal trauma, since 
systemic infusions of 7-OH-DPAT successfully induced ejaculatory reflexes in 100% of 
anesthetized and spinally-transected chronic SCI male rats without added sensory stimulation. It 
is known from previous studies that systemic treatment with 7-OH-DPAT enhances mating by 
lowering the latency to ejaculation and the number of intromissions required to ejaculate in male 
rats (Ahlenius and Larsson, 1995). In addition, i.c.v infusions of 7-OH-DPAT have been shown 
to trigger coordinated BCM bursting (Clement et al., 2007). Furthermore, i.c.v administration of 
a D2/D3 or a specific D3 antagonist prevented BCM bursting following infusions of 7-OH-
DPAT (Clement et al., 2007) indicating that ejaculatory reflexes are triggered by activation of 
D3 receptors. The medial preoptic area has been shown to play an important role in ejaculation 
through the activation of D3 receptors since targeted injections of 7-OH-DPAT into this brain 
region induced ejaculatory reflexes in anesthetized male rats (Kitrey et al., 2007). Finally, 
previous studies from our laboratory have clearly shown that subcutaneous infusions of 7-OH-
DPAT in anesthetized and spinally-transected male rats triggered ejaculatory reflexes (Staudt, 
2011). Moreover, LSt lesions blocked ejaculatory reflexes induced by 7-OH-DPAT injections 
suggesting that D3 receptors are also expressed in the spinal ejaculation generator and that 7-
OH-DPAT activates these receptors to induce ejaculatory reflexes (Staudt, 2011). Although the 
expression of D3 receptors in the spinal ejaculation generator is currently unknown, it has been 
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suggested that because intact LSt cells are critical for the effects of 7-OH-DPAT on ejaculatory 
reflexes, D3 receptors may be expressed directly on LSt neurons as well as/or on neurons in the 
spinal cord that convey sensory signals associated with mating or DPN stimulation to the LSt 
cells (Staudt, 2011).  
Unexpectedly, very few anesthetized but spinally-intact sham and SCI animals responded to 
systemic infusions of 7OHDPAT with enhanced emission and expulsion reflexes compared to 
saline infusions (29% of sham and 13% of SCI males). In contrast, 7OHDPAT infusions 
triggered ejaculatory reflexes in 100% of sham and 88% of SCI males (in the same animals) after 
complete spinal cord transection. This finding provides further evidence for the presence of D3 
receptors in the spinal ejaculation generator since transection of the cord would have limited 
activation of D3 receptors in supraspinal regions. Although a previous study has demonstrated 
high densities of D3 receptor binding in the dorsal horn and around the central canal in the 
lumbar spinal cord (Levant and McCarson, 2001), the expression of D3 receptors in the spinal 
ejaculation generator is still unclear. Therefore, future studies are required to localize and 
determine the densities of dopamine D3 receptors in the spinal ejaculation generator of sham and 
chronic SCI male rats.  
In the current study, all SCI males clearly showed evidence of hindpaw paralysis as reflected 
in the significantly reduced time SCI males engaged in vertical locomotion. In addition, prior to 
7OHDPAT treatment, all SCI animals had profoundly diminished BCM events, bursts and SVP 
increases in response to 30 and 60 Hz DPN stimulations compared to sham males. The current 
study clearly demonstrated that systemic infusions of 7OHDPAT consistently triggered 
ejaculatory reflexes as indicated in the coordinated pattern of BCM bursting and concurrent 
increases in SVP observed in anesthetized and spinalized chronic SCI males. Therefore, 
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7OHDPAT treatment restored ejaculatory reflexes in SCI males. Indeed, ejaculatory reflexes 
were significantly enhanced in SCI males following 7OHDPAT infusions compared to saline 
treatment. However, sham males still showed significantly greater numbers of BCM events, 
bursts and SVP increases, particularly following 60 Hz DPN stimulation, compared to SCI males 
suggesting that transmission of sensory information by the DPN is severely altered following 
chronic SCI and cannot be completely restored by activation of dopamine D3 receptors. Perhaps 
future anatomical tract tracing studies can reveal the specific changes to the reflex pathways of 
the spinal ejaculation generator following chronic SCI in male rats.  
 In conclusion, these data established that systemic administration of the dopamine D3 
receptor agonist 7-OH-DPAT restored ejaculatory reflexes in anesthetized and spinalized male 
rats with chronic SCI. It should be emphasized that 7-OH-DPAT likely triggered ejaculatory 
reflexes through the activation of D3 receptors in the lumbosacral spinal cord since complete 
transection of the cord resulted in a robust increase in the percentages of sham and SCI males 
that responded to 7-OH-DPAT infusions with coordinated, rhythmic bursting of the BCM and 
concurrent increases in SVP, compared to 7-OH-DPAT treatment prior to spinal transection in 
the same animals. Furthermore, 7-OH-DPAT infusions facilitated emission and expulsion 
reflexes in anesthetized and spinalized SCI males. However, even after 7-OH-DPAT treatment, 
SCI males had significantly reduced ejaculatory reflexes following DPN stimulation compared to 
sham males indicating that the transmission of sensory information via the DPN is hindered in 
chronic SCI animals, likely due to the reorganization and plasticity of the DPN following chronic 
spinal trauma.  Finally, the current data suggest that 7OHDPAT may be utilized in the treatment 
of ejaculatory dysfunction in men with chronic SCI.   
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Chapter 7: General Discussion 
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7.1 Summary of Results and Conclusions 
 
Taken together, the findings of these studies determined that activation of GRP, DOR, MOR, 
galanin, and CCK receptors in the lumbosacral spinal cord is required for ejaculatory reflexes in 
anesthetized and spinalized male rats. However, the activation of only one of these receptors was 
not sufficient to trigger ejaculatory reflexes in all male rats in the absence of sensory stimulation 
suggesting that the co-release of multiple neuropeptides may be required to elicit emission and 
expulsion reflexes without added sensory stimulation in male rats. Furthermore, these studies 
demonstrated that activation of MOR and GRP receptors in the lumbosacral spinal cord can 
rescue ejaculatory reflexes in male rats with chronic contusion SCI. Conversely, the activation of 
DOR and galanin receptors in the lumbosacral spinal cord failed to restore ejaculatory reflexes in 
SCI males. These findings suggest that the densities of DOR and galanin, but not MOR and GRP 
receptors in are severely reduced in the lumbosacral spinal cord following chronic SCI. Lastly, 
systemic infusions of 7-OH-DPAT significantly improved ejaculatory reflexes in SCI males. 
However, DPN-induced ejaculatory reflexes remained impaired in SCI males even after 
treatment with GRP and D3 receptor agonists indicating that the transmission of sensory 
information via the DPN to the spinal ejaculation generator is severely disrupted following 
chronic SCI. In conclusion, GRP, MOR, DOR, galanin and CCK receptor antagonists can be 
used in the treatment of premature ejaculation to delay ejaculation in afflicted individuals. 
Finally, GRP and the D3 agonist 7-OH-DPAT can be useful in the treatment of ejaculatory 
dysfunction, specifically to restore anterograde ejaculation, perhaps in conjunction with intense 
penile vibratory stimulation or electro-ejaculation, in men with chronic SCI.   
 
201 
 
7.1.1  Chapter 2: Activation of gastrin-releasing peptide receptors in the lumbosacral 
spinal is required for ejaculation in male rats 
 
The main finding of Chapter 2 is that GRP is critically involved in the control of ejaculation in 
anesthetized and spinalized male rats (Kozyrev et al., 2012). This finding is consistent with a 
previous report that spinal GRP is involved in the control of male sexual reflexes (Sakamoto et 
al., 2008). GRP acts on the outputs of LSt cells, specifically on autonomic and motor areas in the 
lumbosacral spinal cord. Indeed, the expression of GRP was observed in 100% of LSt cells and 
LSt axons projecting to autonomic nuclei including the IML, CAN and SPN and to motor 
neurons in the SNB. Furthermore, intrathecal infusions of the GPR receptor antagonist RC-3095 
dramatically impaired ejaculatory reflexes induced by DPN stimulation in male rats. This 
reduction in ejaculatory reflexes was reflected in the significant decrease in numbers of BCM 
events, bursts and SVP increases following electrical stimulation of the DPN. In contrast, 
infusions of the GRP receptor agonist GRP 20-29 enhanced both emission and expulsion reflexes 
as evidenced by the amplified numbers of SVP increases and concurrent BCM events and bursts 
respectively. GRP was particularly enhancing for ejaculation when accompanied by subthreshold 
levels of DPN stimulation (5 – 10 Hz). These subtle levels of DPN stimulation are normally not 
sufficient to trigger ejaculatory reflexes in male rats. However, this mild intensity of electrical 
stimulation was sufficient to trigger emission and expulsion reflexes in conjunction with 
intrathecal infusion of GRP 20-29. This finding indicates the presence of combined effects of 
endogenous neuropeptide release following sensory DPN stimulation and intrathecal infusions of 
GRP 20-29 that cumulatively trigger activation of GRP receptors in the lumbosacral spinal cord to 
induce ejaculatory reflexes in male rats. GRP receptor activation is pivotal for DPN stimulation-
induced ejaculatory reflexes in anesthetized and spinalized male rats. Indeed, RC-2095 did not 
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prevent activation of LSt cells induced by stimulation of the DPN. Instead, the GRP receptor 
antagonist likely blocked GRP receptors in LSt target regions including autonomic and motor 
areas of the lumbosacral spinal cord. Future studies will be necessary to elucidate the expression 
and distribution of GRP receptors particularly in autonomic and motor nuclei of the lumbosacral 
spinal cord that contain axonal projections from the LSt cells.  
 
7.1.2  Chapter 3: Activation of Mu and Delta Opioid Receptors in the Lumbosacral Spinal 
Cord is required for Ejaculatory Reflexes in Male Rats  
 
The primary finding of Chapter 3 is that enkephalin is essential in the control of ejaculatory 
reflexes in anesthetized and spinalized male rats and acts through the activation of MOR and 
DOR in LSt cell target areas in the lumbosacral spinal cord. Enkephalin has been previously 
shown to be expressed by LSt cells and axons (Nicholas et al., 1999). Pharmacological blockade 
of MOR or DOR in the lumbosacral spinal cord prevented both the emission and expulsion 
phases of ejaculation triggered by sensory stimulation in male rats. In contrast, the activation of 
MOR or DOR following infusions of lower doses of the MOR agonist DAMGO and the DOR 
agonist Deltorphin II significantly enhanced ejaculatory reflexes induced by sub-threshold levels 
of DPN stimulation (5 – 10 Hz) in male rats. Interestingly, intrathecal infusions of the MOR 
agonist but not the DOR agonist triggered both emission and expulsion reflexes in a large 
percentage (75 %) of male rats without added sensory stimulation of the DPN. These findings 
indicate that activation of MOR but not DOR is sufficient to trigger ejaculatory reflexes in 
anesthetized and spinalized male rats. However, activation of MOR but not DOR with a higher 
dose of agonist resulted in an inhibition of ejaculatory reflexes induced by DPN stimulation in 
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male rats. This finding is consistent with a previous study which found that a high doses of 
intravenous morphine inhibit rhythmic bursting of the BCM, associated with the expulsion phase 
of ejaculation in male rats (Carro-Juarez and Rodriguez-Manzo, 2009). Taken together, the 
current study provides insight into the role of opioid receptors specifically found in the 
lumbosacral spinal cord, in nuclei comprising the spinal ejaculation generator, in the control of 
ejaculatory reflexes in male rats.  
 
7.1.3 Chapter 4: Activation of Galanin and CCK Receptors is Required for Ejaculatory 
Reflexes in Male Rats 
 
The main finding of Chapter 4 is that galanin and CCK receptor activation in LSt target regions 
is required for ejaculatory reflexes in male rats by acting on galanin and CCK receptors in the 
lumbosacral spinal cord. Moreover, intrathecal infusions of galanin or CCK receptor antagonists 
galantide and proglumide respectively, abolished DPN stimulation-induced emission and 
expulsion reflexes in male rats. Conversely, galanin and CCK agonists enhanced ejaculatory 
reflexes triggered by DPN stimulation. In particular, galanin and CCK agonists were most 
effective at facilitating ejaculatory reflexes triggered by subthreshold levels of DPN stimulation 
(5 – 10 Hz) and all male rats demonstrated significantly greater numbers of SVP increases, BCM 
events and bursts following infusions of either agonist followed by low levels of DPN 
stimulation.  However, infusions of galanin or CCK alone were not sufficient to trigger 
ejaculatory reflexes in male rats without added sensory stimulation of the DPN. This finding 
suggests that the release of multiple neuropeptides, including galanin, CCK, enkephalin and 
GRP, is necessary to trigger ejaculatory reflexes in male rats. However, the release of only one 
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of these neuropeptides is not sufficient to induce ejaculatory reflexes in all male rats without 
added sensory stimulation of the DPN. Since infusions of either the galanin antagonist galantide 
or the CCK antagonist proglumide blocked ejaculatory reflexes but did not prevent the neural 
activation of LSt cells induced by DPN stimulation in anesthetized and spinalized male rats 
suggests that galanin and CCK likely act on receptors expressed on LSt target regions, including 
autonomic preganglionic neurons in the IML, CAN and SPN and on motor neurons in the SNB 
in the lumbosacral spinal cord to exert their effects on ejaculatory reflexes in male rats. 
However, the expression of galanin and CCK receptors in the lumbosacral spinal cord remains to 
be investigated in future experiments. Finally, both galanin and CCK may be used to 
pharmacologically treat premature ejaculation by increasing the latencies for emission and 
expulsion during sexual activity in men.  
 
7.1.4 Chapter 5: Activation of Mu opioid and GRP receptors in the lumbosacral spinal 
cord can improve ejaculatory reflexes in male rats with chronic contusion SCI 
 
These studies utilized a model of chronic contusion SCI in male rats. The main finding of these 
set of studies was that infusion of the GRP receptor agonist GRP 20-29 and the MOR agonist 
DAMGO rescued ejaculatory reflexes in male rats with chronic SCI (4 – 5 weeks). Specifically, 
intrathecal infusions of GRP 20-29 facilitated ejaculatory reflexes in all sham males and 66% of 
SCI males following subthreshold levels of DPN stimulation (5 – 10 Hz) and triggered emission 
and expulsion in 62% of sham males compared to 55% of SCI male rats. Similarly, intrathecal 
administration of DAMGO rescued both emission and expulsion in a large subset of SCI males 
(54 %). However, intrathecal infusions of DAMGO prevented ejaculatory reflexes triggered by 
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DPN stimulation in both sham and SCI males, a finding which is consistent with previous reports 
of inhibitory effects of opioids on ejaculatory reflexes in male rats (Carro-Juarez and Rodriguez-
Manzo, 2009). In contrast to GRP and DAMGO, intrathecal infusions of galanin or the DOR 
agonist deltorphin II did not restore ejaculatory reflexes in SCI male rats. This finding suggests 
that galanin and DOR receptors may be substantially diminished in the lumbosacral spinal cord 
following spinal cord trauma in SCI males. In addition, there may be insufficient amounts of 
neuropeptides released following DPN stimulation in SCI males due to altered transmission of 
sensory signals to the lumbosacral spinal cord following trauma. Overall, this set of experiments 
demonstrated that administration of DAMGO and GRP can restore emission and expulsion 
reflexes in a large subset of male rats with chronic SCI suggesting that the densities of MOR and 
GRP receptors remain predominantly unchanged following chronic SCI although this hypothesis 
remains to be investigated in future studies. Finally, GRP can be used to treat ejaculatory 
dysfunction in men with SCI.  
 
7.1.5  Chapter 6: Systemic Infusions of 7-OH-DPAT rescued ejaculatory reflexes in male 
rats with chronic contusion SCI 
 
The main finding of Chapter 6 was that systemic administration of the dopamine D3 receptor 
agonist 7-OH-DPAT rescued ejaculatory reflexes in male rats with chronic contusion SCI. 
Infusion of 7-OH-DPAT induced emission and expulsion reflexes in SCI males without added 
sensory stimulation of the DPN. Furthermore, 7-OH-DPAT infusions enhanced ejaculatory 
reflexes triggered by threshold levels of DPN stimulation (30 – 60 Hz) in SCI males. 
Remarkably, there were no significant differences observed in emission and expulsion reflexes 
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between sham and SCI males following infusions of 7-OH-DPAT indicating that the distribution 
and densities of D3 receptors in the lumbosacral spinal cord and ejaculation generator are not 
affected by chronic contusion SCI in male rats.  However, diminished DPN stimulation-induced 
ejaculatory reflexes persisted in SCI males compared to sham males even after infusion of 7-OH-
DPAT suggesting that the transmission of sensory signals following sensory stimulation of the 
DPN is severely impaired in SCI males. This disruption of sensory transmission to the LSt cells 
via the DPN may be attributed to several factors including neuroplasticity of the fibers of the 
DPN resulting in diminished relay of sensory signals from the reproductive organs to the 
lumbosacral spinal cord. In addition, the denervation of descending pathways to the lumbosacral 
spinal cord that previously modulated the ejaculatory reflex may have resulted in impaired 
emission and expulsion reflexes following sensory stimulation. Indeed, previous experiments 
have found that the destruction of descending pathways innervating the lumbosacral spinal cord 
leads to the denervation of spinal neurons. The release of neurotrophic factors as a result of the 
trauma results in neuroplasticity and neurogenesis of afferent neurons, including those of the 
DPN as well as changes in the connections of these neurons. All of these factors together may 
contribute to the marked changes in the transmission of sensory information to the ejaculation 
generator during sexual activity or stimulation of the DPN. Taken together, the results of Chapter 
6 demonstrated that systemic infusions of 7-OH-DPAT restored ejaculatory reflexes and 
enhanced ejaculatory reflexes following threshold levels of DPN stimulation in anesthetized and 
spinalized SCI male rats by acting on D3 receptors in the lumbosacral spinal cord. In conclusion, 
7-OH-DPAT may be incorporated in the treatment of ejaculatory dysfunction in men with 
chronic SCI.  
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7.2  Future Directions  
 
The current set of studies have made significant progress in determining the functional role of 
neuropeptides released from LSt cell axons onto autonomic and motor target areas in the 
lumbosacral spinal cord in the control of ejaculatory reflexes in male rats. In addition, these 
experiments have demonstrated that MOR, GRP and the D3 receptor agonist 7-OH-DPAT can 
restore ejaculation in male rats with chronic SCI. However, many more questions remain 
regarding the control of ejaculatory reflexes both in intact males and in males after chronic SCI.  
First, it is imperative to elucidate the expression and densities of GRP, MOR, DOR, galanin, 
CCK and D3 receptors in the lumbosacral spinal cord, particularly in LSt cell target areas 
including autonomic preganglionic nuclei (IML, CAN and SPN) and motor neurons of the SNB 
in order to determine precisely how the neuropeptides released onto LSt target areas exert their 
effects on ejaculatory reflexes in normal, healthy male rats and in male rats with chronic SCI. 
We confirmed that lower doses of DAMGO facilitate ejaculatory reflexes following subthreshold 
levels of DPN stimulation in male rats. Thus, it will be useful to test in future experiments 
whether intrathecal infusions of lower doses of DAMGO followed by DPN stimulation (5 – 60 
Hz) can restore ejaculatory reflexes in male rats with chronic SCI.  Finally, it is important to 
investigate the nature of the altered transmission of sensory inputs to the LSt cells by the DPN 
following chronic SCI. Specifically, synaptic alterations to the fibers of the DPN need to be 
examined and tract tracing studies can elucidate changes to the sensory pathway from the DPN 
to the lumbosacral spinal cord in male rats with chronic spinal injuries.   
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